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SUMMARY
The Inhibition of mitochondrial translocation of ions ADP, Pi,
-| |
Ca and dicarboxylic acidtby sulfobromophthalein (SBP), agaric 
acid (AA), hexachlorophene (HCP), fhodamine 6G (Rh6G) and 
other inhibitors, ionophoross antibiotics and uncouplers of oxidative 
phosphorylation has been examined in rat liver mitochondria. It 
was found that the exchange of ADP is competitively inhibited by 
SBP and AA, and uncompetitively by HCP. 2, 4-dinitrophenol 
stimulated ATPase is inhibited also by SBP, AA and HCP. SBP and 
AA were also found to inhibit the ADP binding to rat liver mitochondria. 
However, it was shown that Rh6G has no effect on ADP translocase 
under the present conditions.
3
SBP, AA and HCP inhibit the H-atractyloside binding to
mitochondria and submitochondrial particles, while Rh6G has no 
3 14effect on H-atractyloside binding. C-HCP has a high affinity
_ O
binding site (K = 2.2  x 10 °M ) and low affinity binding site (Kd =
1.5x10  ^M ) and -HCP binding was not affected by SBP, AA,
atractyloside, Rh6G and other inhibitors used in the present work.
On the other hand, RhnG has one affinity binding site (K^ = 1.3 x 
-5 1410 M ). Both C-HCP and Rh6G binding depends on mitochondrial
phospholipids composition.
The interaction of HCP, Rh6C.t DBCT and triethyltin and
ionophorous antibiotics with calcium translocation, binding and
release from mitochondria shows that the above compounds inhibit
the calcium translocation and binding to mitochondria, and they also
induced a release of accumulated mitochondrial calcium.
Experiments carried out with rat liver mitochondria show that
SBP, HCP, Rh6G, DCCD, DBCT, triethyltin and ionophorous anti-
32biotics were potent inhibitors of the ATP- Pi exchange reaction.
32However, agaric acid caused only a slight effect. The ATP- Pi
id
exchange reaction in submitochondrial particles was inhibited by 
HCP, Rh6G( DCCD, triethyltin, venturicidin and uncouplers of 
oxidative phosphorylation.
The results of the present study demonstrate that, SBP and HCP
are potent inhibitors of Pi uptake by mitochondria. Furthermore,
32SBP was found to inhibit the Pi-Pi exchange in mitochondria. 
Agaric acid and Rh6G can inhibit the Pi uptake , ■
p r e s e n t "  at high concentrations. SBP was also shown to 
inhibit the dicarboxylate uptake and dicarboxylate-dicarboxylate 
exchange, which are mediated by the dicarboxylate carrier.
1CHAPTER 1 
INTRODUCTION 
1.1 General introduction
The transport of ions by mitochondria has now become one of the most 
popular topics in the field of bioenergetics, and is perhaps the most important 
alternative to oxidative phosphorylation as a means of utilizing energy made 
available by the respiratory chain. Due to the impermeability of the 
mitochondrial membrane, mitochondria transport substrate anions, inorganic 
phosphate, and adenine nucleotides in a series of exchange-diffusion processes, 
catalysed by specific carrier systems. In addition, mitochondria can directly 
utilize metabolic energy to concentrate a number of monovalent and divalentj [ |
cations against their chemical gradient, e.g. K and Ca
A ll of these processes are linked to the energy conservation system in the 
mitochondrial inner membrane as emphasized in the chemiosmotic hypothesis 
proposed by Mitchell (19t>1 ) as has been discussed in many reviews (Pressman, 
1976; Stryer, 1975).
The major feature of mitochondrial membrane structure and energy 
conservation mechanisms are discussed in detail below.
1.2 A rchitecture of mitochondria and localization of their functions
The mitochondrion is a subcellular organelle whose dimensions are 1 to 
2 microns (Young, Blondin and Green, 1972 ; Sluse and Sluse-Goffart, 1974). 
As schematically represented in Fig. 1.1. the mitochondria consists of two 
membranes, an inner and an outer membrane, each of which forms a closed 
surface. Active transport in the mitochondrion thus involves an energy-linked 
flux of ions across the inner mitochondrial membrane.
The inner mitochondrial membrane is highly structured. It has been 
hypothesized to consist of lipoprotein tripartite repeating units as shown in 
Fig. 1.2. Each tripartite repeating unit consists of a base piece, which 
contains the components of the mitochondrial electron transfer chain, a head 
piece which is the site of the mitochondrial ATPase, and a stalk which links 
the basepiece and headpiece. It is claimed that the primary function of the 
mitochondrion is to couple electron transfer, which occurs in the "basepiece", 
to ATP synthesis, which occurs in the "headpiece".
- 1* '  "ft * « ■ £  . - I
r v  p » - ••
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FIGURE 1.1 Schematic representation of 
the mitochondrion. OM> outer membrane; 
M, matrix space; CMj cristal membrane; 
IBM, inner boundary membrane; IC, intra- 
cristal space; (from Young et a l., 1972).
FIGURE 1.2 Schematic representation of 
inner mitochondrial membrane as made up of 
tripartite repeating units. Each repeating unit 
consists of a basepiece, a headpiece, and a 
connecting stalk; (from Young et al.. 1972).
FIGURE 1.3 Schematic representation of 
coupling scheme in conformational model of 
oxidative phosphorylation; (from Young et a l. . 
1972).
H E A T
E L E C T R O N
T R A N S F E R
"EN ER G IZED "
CONFORM ATION
A T P
ION TR A N SLO C A TIO N
3Electron transfer is reversibly coupled to the generation of the 
energized or metastable conformation and ATP synthesis is reversibly 
coupled to the relaxation of the energized conformation. Once generated, 
either by electron transfer or by ATP hydrolysis, the energy of the 
intermediate metastable conformation can also be utilized for ion 
translocation or it can be dissipated as heat in the presence of uncouplers 
of oxidative phosphorylation (Fig. 1.3).
In isolated mitochondria, the external membrane does not constitute a 
barrier for the rapid flux of molecules with molecular weight lower than 
5000 (Sluse and Sluse-Goffart, 1974). This is not true of the inner 
membrane which seems to be Impermeable to the free diffusion of a large 
number of substances and in particular to the diffusion of the substrates and 
products of intra- and extramitochondrial metabolism. The inner membrane 
seems to be freely permeable only to a certain number of small neutral 
molecules of molecular weight lower than 150 that equilibrate with the matrix 
space in less than one millisecond.
Almost a ll reactions of the citric acid cycle and substrate-level phosphorylation, 
as well as pyruvate dehydrogenation, take place in the matrix space (Fonyo et a l.. 
1976). The enzymes of the respiratory chain and of the phosphorylation 
coupled to it are exclusively located in the inner membrane, and it should be 
borne in mind that the cristae are extensions of the inner membrane. In 
addition, one single enzyme of the citric acid cycle, succinate dehydrogenase, 
is also an integral part of the inner membrane. The functional significance 
of the outer membrane is poorly understood, although its enzymatic 
composition is known. Nucleoside dlphosphokinase and adenylate kinase are 
found in the space between the two membranes.
Cytochrome c of the respiratory chain is located loosely bound to the 
membrane at the surface facing the cytoplasm (called the *c' face).
Succinate dehydrogenase and the enzymes o f ATP synthesis are at that surface 
which faces the matrix ('m ' face) (Fig. 1.4). It follows logically that Pi,
ADP and ATP have to cross the inner membrane constantly. If any substrate 
from the cytoplasm enters the citric acid cycle, or, on the other hand, If the 
cycle furnishes intramitochondrially the carbon skeleton for cytoplasmic 
synthesis, the corresponding organic ions will again pass through the inner
membrane.
3Electron transfer is reversibly coupled to the generation of the 
energized or metastable conformation, and ATP synthesis is reversibly 
coupled to the relaxation of the energized conformation. Once generated, 
either by electron transfer or by ATP hydrolysis, the energy of the 
intermediate metastable conformation can also be utilized for ion 
translocation or it can be dissipated as heat in the presence of uncouplers 
of oxidative phosphorylation (Fig. 1.3).
In isolated mitochondria, the external membrane does not constitute a 
barrier for the rapid flux of molecules with molecular weight lower than 
5000 (Sluse and Sluse-Goffart, 1974). This is not true of the inner 
membrane which seems to be impermeable to the free diffusion of a large 
number of substances and in particular to the diffusion of the substrates and 
products of intra- and extramitochondrial metabolism. The inner membrane 
seems to be freely permeable only to a certain number of small neutral 
molecules of molecular weight lower than 150 that equilibrate with the matrix 
space in less than one millisecond.
Almost all reactions of the citric acid cycle and substrate-level phosphorylation, 
as well as pyruvate dehydrogenation, take place in the matrix space (Fonyo et a l . , 
1976). The enzymes of the respiratory chain and of the phosphorylation 
coupled to it are exclusively located in the inner membrane, and it should be 
borne in mind that the cristae are extensions of the inner membrane. In 
addition, one single enzyme of the citric acid cycle, succinate dehydrogenase, 
is also an integral part of the inner membrane. The functional significance 
of the outer membrane is poorly understood, although its enzymatic 
composition is known. Nucleoside diphosphokinase and adenylate kinase are 
found in the space between the two membranes.
Cytochrome c of the respiratory chain is located loosely bound to the 
membrane at the surface facing the cytoplasm (called the 'c' face).
Succinate dehydrogenase and the enzymes of ATP synthesis are at that surface 
which faces the matrix ('m ' face) (Fig. 1.4). It follows logically that Pi,
ADP and ATP have to cross the inner membrane constantly. If any substrate 
from the cytoplasm enters the citric acid cycle, or, on the other hand, if the 
cycle furnishes intramitochondrially the carbon skeleton for cytoplasmic 
synthesis, the corresponding organic ions will again pass through the inner 
membrane.
4FIGURE 1.4 Scheme of mitochondrial structure and compartmentation. 
Penetration is indicated by arrows. A part of the inner membrane is 
shown enlarged in the right half of the figure; (from Fonyo et al_., 1976).
51.3 Proposed mechanisms for oxidative phosphorylation
Oxidative phosphorylation is the process by which respiratory chain 
energy is made available to the ATPase so that it can produce ATP. The 
mechanism of oxidative phosphorylation is not yet known. Three kinds of 
mechanisms have been proposed:
1. The chemical-coupling hypothesis (Slater, 1953) was formulated by 
analogy to glyceraldehyde-3-phosphate oxidation. The demonstration that 
energy transfer can take place between the individual coupling sites indicates 
that coupling may proceed by way of non-phosphorylated intermediates. 
These are postulated to be the electron carriers in the respiratory chain. 
The reaction pathways leading to the formation of ATP are suggested to be
AH2 + B + I -i. A ~  I + BH2 (D
A ~ I  + X __ 3. A + X ~  I (2 )
I ~  X + Pi ç = ___S I + X - P (3 )
X ~ P  + ADP -— __ * X + ATP (4 )
The simplest scheme is one in which a high -energy compound denoted as 
A ~  I is formed when the reduced form of A transfers its electrons to the 
oxidized form of B (A and 13 are electron carriers in the respiratory chain, 
whereas I is some other component). Then, the high-energy bond in A ~  I 
is split as ADP is phosphorylated to ATP.
2. The chemiosmoric hypothesis (Mitchell, 1961) was postulated to provide 
an explanation for the requirement of an intact membrane for phosphorylation, 
since this requirement is not implicit in the chemical-coupling hypothesis.
It also sought to explain the failure of all attempts to identify the intermediate 
X and I. In its simptest form, the chemiosmotic hypothesis consists of the 
generation of a proton gradient across the proton impermeable inner membrane 
by the electron transport chain. This proton gradient then drives the 
synthesis of ATP from ADP and Pi by means of an anisotropic ATPase.
The proposal depends on the possibility that the ATPase may lie in the 
membrane, isolated from the aqueous phase on both sides, but accessible to 
OH ions on one side and to H+ on the other. If we consider the hydrolysis 
of ATP,
6ATP + H20  ^ ■ ■> ADP + Pl (5)
This reaction may be written
ATP + H+ + OH\  ADP + Pl (6 )
given that such an anisotropic ATPase, hydrolysis of ATP would be 
accompanied by the effective translocation of protons from one side of the 
membrane to the other. Similarly, the reverse reaction, ATP synthesis, 
would be effected by a flow of protons across the membrane in the opposite 
direction.
3. The conformâtionaChypothesis (Boyer, 1964) and a new expanded version
known as the Electromechandchemical model (Green and Ji, 1972*). The
driving force for the synthesis of ATP is a conformational change in the
coupling apparatus. The basic unit of mitchondrial energy conservation is
suggested to be a 'supermolecule'. The supermolecule consists of two 
components, one of which catalyses a polarising reaction and one which 
catalyses a depolarising reaction. The depolarising
element, the ATPase, is polarised by separation of electrons and protons in 
the electron transfer complexes. A conformational strain is set up in the 
ATPase such that conditions are energetically suitable for a chemical 
reaction between ADP and Pi. Current evidence tends to favour the chemio- 
smotic hypothesis although the other hypothesis have not been firmly 
excluded. Some of the evidence for specific reaction steps in oxidative 
phosphorylation has come from studies of the mode of action of specific 
inhibitors and specific information on mitochondrial transport processes can 
also be gained by use of specific inhibitors of ion transport.
1.4 Inhibitors and uncouplers of oxidative phosphorylation used in the 
present study
Three specific inhbitors are currently used in experiments on adenine 
nucleotide transport, namely atractyloside, carboxyatractyloside (for review 
see ref. Vignais_et aj, 1973b) and bongkrekic acid (Henderson and Lardy, 1970; 
Henderson et al_., 1970). Atractyloside and carboxyatractyloside (Fig. 1.5) 
are glucosides whose aglycone is a diterpene. Both molecules contain two 
sulfate groups and one isovaleric acid residue (Lefrance, 1g68: Defaye et a l. . 
1973). Carboxyatractyloside differs from atractyloside by a supplementary 
carboxyl group at the C-4 of the diterpene nucleus (Defaye et al_., 1971 ).
7CH —  C (o h ) ------CH - ^  H^
COOH COOH COOH 
Agaric acid (AA)
9 ° ^  ÇOOH 
CH=ÇH /V CH=C
CH, FH2 ÇH=CH CH^ ;C=CB CH ,
COOH
I n ÇH=CH HxCH2  j
CH=Ç Bongkrekic acid (BkA)
ÇH
COOH
Figure 1.5 Structures of SBP( Atrf CAT, AA, HCP, Rh6G, RhB and BkA
8Bongkreklc acid (Fig. 1.5) is a long-chain unsaturated fatty acid having 
seven double bonds, three carboxyl groups and one methyl group (Vignais, 
1976).
Atractyloside is a competitive inhibitor of adenine nucleotide transport 
(Vignais_et£l., 1973a). carboxyatractyloside, a non-competitive inhibitor 
(Vignais e ta L , 1973a ); Bongkrekic acid is an uncompetitive inhibitor 
(Lauquin et a l. . 1976). A ll can be radio-actively labelled, thus facilitating 
ligand-binding studies. The first binding studies were carried out with 
biosynthetically labelled inhibitors (Vignais_et ah , 1971a). Radiochemically 
labelled atractyloside (Brandolin et aj_., 1974) and bongkrekic acid (Lauquin 
and Vignais, 1976) can now be readily made with a high specific radioactivity.
Vignais_et al. (1961 and 1962) reported that atractyloside was able to 
block partial reactions of oxidative phosphorylation in mitochondria, such as 
the ATP-Pi exchange and the 2, 4-dinitrophenol stimulated ATPase activity. 
Inhibition of adenine nucleotide transport by bongkrekic acid requires that 
the pH of the incubation medium be lower than 7, and to be compatible with 
the effectiveness of adenine nucleotide transport, incubations are routinely
3
carried out at pH 6.5 - 6. 8. Studies with H-bongkrekic acid show that the 
protonated acid diffuses readily through the inner mitochondrial membrane 
and enters the matrix space (Lauquin and Vignais, 1976); bongkrekic acid 
may, therefore, be considered as a penetrant inhibitor. On the other hand, 
atractyloside and carboxyatractyloside remain bound to the outer surface of 
the inner mitochondrial membrane; they are non-penetrant inhibitors 
(Klingenberg, 1970).
Meisner (1973) reported briefly that sulfobromophthalein (SBP) is an 
effective inhibitor of the adenine.nucleotide exchange, and the Pi/OH as well 
as Pi/malate uptake in mitochondria. SBP is also called bromosulfophthalein, 
hepartest, bromthalein, bromsulphalein and brom -tetragnost, 
(C^QHgBr^NagO^S^). SBP is used in medicine, in liver function tests.
The effect of agaric acid on the transport of ADP and ATP has been 
examined by Chavez and Klapp (1975) in rat liver mitochondria. Respiration 
stimulated by ADP is progressively inhibited by agaric acid; maximal 
inhibition is attained at 40 p,M agaric acid. ATPase activity is Inhibited 30%
9by 20 u,M agaric acid. The exchange of adenine nucleotide is competitively 
inhibited by agaric acid. Agaric acid is also called agaricic acid, laricic
acid, agaricin, n-hexadecylcitiric acid or a-cetylcitric acid, (C H O • I 5H O ).
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It is used in medicine, as an anhfdrotic. One optical form of agaric acid
(o’-hexadecylcitric. acid) occurs in the basidiomycete, Polyporus officinalis.
It has been synthesised by Evans (1959).
Since the introduction of hexachlorophene, HOP or 2, 2-methylenebis -
(3, 4, 6-trichlorophenol) as an antibacterial additive to soaps, detergents
and cosmetics, a large number of toxicological studies have been carried out.
These studies dealt with the systemic and the oral acute and subacute toxicity
in laboratory animals, also with the toxic symptoms and deaths observed in
cows and sheep where HCP is used for the control of fascioliasis. Reports
on toxic effects in man and poisoning from improper use have also been
published (Gump, 1969). The primary lethal action of HCP thus appears to
be respiratory inhibition at a site within the membrane-bound part of the
electron transport chain (Frederick£t a_L, 1974).
The lipophilic dye, rhodamine 6G, has been shown to be a potent inhibitor
of oxidative phosphorylation (Gear, 1974). ATP -supported Ca^ accumulation
was blocked. Concentrations of rhodamine 6G above 10 pM slowly uncouple
| |
respiration and inhibit respiration-dependent Ca uptake. Neither the
dinitrophenol-stimulated ATPase nor uncoupled respiration of intact
mitochondria were inhibited by the dye, even at 50 pM. The related compound,
rhodamine B, a free acid and uncharged at pH 7, was completely without
influence on mitochondrial energy-linked functions. Rh6G blocks adenine
14 14nucleotide binding to intact mitochondria, both for C-ATP and C-ADP 
(Gear, 1974). Gear concluded that rhodamine 6G blocks the adenine 
nucleotide translocase apparently being similar to atractyloside and bongkrekic 
acid. However, in sharp contrast to these inhibitors, rhodamine 6G did not 
inhibit the 2, 4-dinitrophenol-stimulated ATPase of intact mitochondria.
Triethyltin and other trialkyltins affect the mitochondria in two distinct 
ways. Firstly, they are potent inhibitors of coupled respiration and of 
phosphate esterification of respiring mitochondria (Aldridge, 1958; Aldridge 
and Threlfall, 1961; Sone and Hagihara, 1964). In this respect they appear
9by 20 pM agaric acid. The exchange of adenine nucleotide is competitively
inhibited by agaric acid. Agaric acid is also called agaricic acid> laricic
acid, agaricin, n-hexadecylcitiric acid or cr-cetylcitric acid, (C^H ^O ,^ 1 ) .
It is used in medicine, as an anhfdrotic. One optical form of agaric acid
(of-hexadecylcitric. acid) occurs in the basidiomycete, Polyporus officinalis.
It has been synthesised by Evans (1959).
Since the introduction of hexachlorophene, HCP or 2, 2 -methylenebis -
(3, 4, 6 -trichlorophenol) as an antibacterial additive to soaps, detergents
and cosmetics, a large number of toxicological studies have been carried out.
These studies dealt with the systemic and the oral acute and subacute toxicity
in laboratory animals, also with the toxic symptoms and deaths observed in
cows and sheep where HCP is used for the control of fascioliasis. Reports
on toxic effects in man and poisoning from improper use have also been
published (Gump, 1969). The primary lethal action of HCP thus appears to
be respiratory inhibition at a site within the membrane-bound part of the
electron transport chain (Frederick et a 1., 1974).
The lipophilic dye, rhodamine 6G, has been shown to be a potent inhibitor
of oxidative phosphorylation (Gear, 1974). ATP-supported Caf ( accumulation
was blocked. Concentrations ofrhodamine 6G above 10 pM slowly uncouple
| |
respiration and inhibit respiration-dependent Ca uptake. Neither the
dinitrophenol-stimulated ATPase nor uncoupled respiration of intact
mitochondria were inhibited by the dye, even at 50 pM. The related compound,
rhodamine B, a free acid and uncharged at pH 7, was completely without
influence on mitochondrial energy-linked functions. Rh6G blocks adenine
14 14nucleotide binding to intact mitochondria, both for C-ATI’ and C-ADP 
(Gear, 1974). Gear concluded that rhodamine 6G blocks the adenine 
nucleotide translocase apparently being similar to atractyloside and bongkrekic 
acid. However, in sharp contrast to these inhibitors, rhodamine 6G did not 
inhibit the 2, 4-dinitrophenol-stimulated ATPase of intact mitochondria.
Triethyltin and other trialkyltins affect the mitochondria in two distinct 
ways. Firstly, they are potent inhibitors of coupled respiration and of 
phosphate esterification of respiring mitochondria (Aldridge, 1958; Aldridge 
and Threlfall, 1961; Sone and Hagihara, 1964). in this respect they appear
to behave somewhat like oligomycln, being capable of inhibiting not only
32oxidative phosphorylation, but also partial reactions such as the Pi-ATP 
exchange reaction and mitochondrial ATPase activity (Aldridge and Street, 
1964). Secondly, and in addition to its inhibitory action on mitochondrial 
phosphorylation, triethyltin has been found to uncouple mitochondrial 
respiration and induce mitochondrial ATPase activity (Aldridge, 1958). 
Stockdale et al. (1970) have succeeded in separating the two effects of the 
trialkyltin compounds. They found that when mitochondria were incubated 
in sucrose medium in the absence of permeating anions, only the oligomycin- 
like effects of the trialkyltin compounds were observed; that is, inhibition of 
coupled respiration. No inhibition of other uncoupler stimulated respiration 
was observed, and neither was mitochondrial swelling. Incubation of 
mitochondria with trialkyltins in the presence of permeant anions such as 
contained in KC1 buffers resulted, on the other hand, in an uncoupling effect. 
Uncoupling by tria Iky Itin compounds is probably due to the action of the 
anion-hydroxyl exchange reaction which trialkyltin compounds appear to be 
able to mediate (Selwyn e£al_. ,1970a) followed by leakage of the anion from 
the mitochondria ; this results in a discharge of both the pH and membrane 
potentials. Manger has observed that triethyltin chloride inhibits intra- 
mitochondrial accumulation of substrate anions (Manger, 1969) and this 
effect is presumably related to the discharge of the pH gradient and 
accumulation of chloride ion within the mitochondrion caused by the trialkyltin 
mediated anion -hydroxide exchange.
Valinomycin interferes with oxidative phosphorylation in mitochondria by 
making them permeable to K+ . The result is that mitchondria use the energy 
generated by electron transport to accumulate K+ rather than to make ATP. 
Binet and Volfin (1975b) reported that the stability of the membrane is
j | [ [
regulated by the presence of a low amount of Mg . If this Mg is released
| |
by the means of ionophores (e .g . A23187), the membrane Ca becomes 
labile and this process leads to the loss of the impermeability of the 
mitochondrial membrane. Leucinostatin (Lardy et a l.. 1975) and X-537A 
(Akerman et a l., 1974) may have the same effect as A23187.
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Many chemicals have been found to exert an uncoupling effect (e .g . DNP>
FCCP, Cl-CCP, 1799 and pentachlorophenol) on mitochondrial oxidative
phosphorylation. While the mechanisms by which these compounds uncouple
are not entirely clear> there are a number of common effects which serve
to characterize this group. These include (1 ) an increase in mitochondrial
respiration rate when the incubation medium is deficient in phosphate acceptor
or inorganic phosphate> (2 ) a decrease in orthophosphate uptake, (3) increased
32mitochondrial ATPase activity,and (4) inhibition of the ATP- Pi exchange 
reaction (Parker, 1965). Most uncoupling agents are weakly acidic and 
lipophilic and are presumed to exert their uncoupling effects through a 
nonspecific interaction with the mitochondrial membranes.
1.5 Ion carrier systems 
A . Adenine nucleotide carrier
The finding by Bruni_et aL (1964) that Atr inhibits the binding of external 
ADP to mitochondria opened the way to further studies that led to the 
identification of the adenine nucleotide (Adn) translocator in the inner 
mitochondrial membrane (Klingenberg and Pfaff, 1966) and to the 
characterization of Atr as an inhibitor of the transmembrane exchange between 
internal and external Adn (Duee and Vignais, 1965).
The adenine nucleotide translocase is especially important since it 
performs two interrelated functions (Spencer and Bygrave, 1972). First, it 
is able to control the relative concentration of ATP and ADP, perhaps the 
most important chemical species in the cell, in the cytoplasm and 
mitochondrial matrix. These two compounds are involved in many aspects 
of cell metabolism, if not as substrates for a reaction, then certainly as 
chemical effectors or modifiers of numerous enzymic reactions. Secondly, 
the translocase is responsible for the transport of ADP and ATP into and out 
of the mitochondria, and in this way it acts as a channel in the energy 
metabolism of the cell by assisting in the production of ATP (Klingenberg et al.. 
1976).
ADP or ATP is transported across the inner mitochondrial membrane by
an exchange-diffusion mechanism as shown by the fact that when mitochondria 
14 14are incubated with [ C]ADP or [ C]ATP, the radioactivity is taken up by
mitochondria, but there is no change in the internal Adn pool; for each 
molecule of ADP or ATP.entering the mitochondrion there is one molecule 
of ADP or ATP leaving the mitochondrion (Klingenberg and Pfaff, 1965; Pfaff 
et_al_., 1965).
Another interesting feature is the effect of the Adn transport on the 
morphology of mitochondria; changes occurring in the conformation of the 
inner mitochondrial membrane upon addition of ADP or ATP suggest that 
protein components of this membrane in close proximity to the Adn 
translocator are able to change their conformation in response to the 
functioning of the Adn translocator.
A schematic survey of the metabolite fluxes through the mitochondrial 
membrane is depicted in Fig. 1.6. In principle, in the same manner as 
in an intact cell, a selected number o f substances are taken up or 
released from the mitochondria which, with their largely impermeable 
membrane, retain not only enzymes and co-enzymes but also cations 
and certain metabolites (Klingenberg, 1970).
Figure 1.6 The metabolite flux through the mitochondrial membrane 
(TCC = Tricarboxylic acid cycle)
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Mitchell (1961) suggested that the low permeability of the inner 
membrane to the substrates and products of those reactions that are 
catalysed by the intramitochondria 1 enzymes/would be a serious limiting 
factor for such an activity if the membrane did not contain specific 
carriers for these metabolites and products. Thus these carriers may 
regulate intramitochondrial metabolism by permitting transfer of 
metabolites through the mitochondrial membrane. The evidence 
available for the existence of anion translocators in the inner membrane 
is based on three classical criteria of the so-called facilitated 
transport. The first criterion is a saturation kinetics of the Michaelis 
type which suggest that the carriers contain specific sires to which 
the substances undergo reversible binding. The second criterion is 
the specificity for the substances transported; it has thus been 
postulated that mediated-transport systems in membranes contain a 
binding site complementary to the substance transported, resembling 
in its specificity the active site of enzyme molecules. The third 
criterion is that it may be inhibited quite specifically . Some carriers 
are inhibited competitively by substances structurally related to the 
substrates, and non -competitively by reagents capable of blocking or 
modifying specific functional groups of proteins, such as sulphydryl 
group-blocking agents or amino-group-blocking agents.
The different models which have been proposed (Vignais^t al_., 1973b) to 
take account of some of the properties of the ADP carrier and in particular 
of the competitive displacement of ADP by Atr are shown in Fig. 1.7. In 
all these models, loading of the carrier is a prerequisite to its 
mobility and therefore to its functioning.
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FIGURE 1.7 ADP Carrier Models (from Vignais et a l., 1973b).
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The first two models (Weidemann et a l.. 1970) assume no conformational 
change. Model 1 is a mobile single site carrier,with orientation of its ADP 
site alternatively to the inner and outer side of the membrane. Once loaded 
with ADP or ATP of one compartment,when juxtaposed to one side of the 
membrane, the carrier moves by translation to the other side and exchanges 
its bound ADP with free ADP of the other compartment. Model 2 is a dimer 
carrier with 2 sites diametrically opposite. Once loaded on its two faces the 
carrier can rotate and bring nucleotides to the other side of the membrane. In 
these two models, Atr is supposed to bind at the same site as ADP.
The functioning of models 3 and 4 involve allosteric transconformation.
Model 3 represents an allosteric interconversion of ADP and Atr binding sites 
as first suggested by Vignais et a l. (1966). Model 4 (Vignais et al. 1971b) 
includes a regulatory site besides the carrier, to explain the asymmetric 
behaviour of the translocation process (preferential exchange of external ADP 
for internal ATP). The regulatory unit is assumed to contain two distinct 
interacting sites, one for ADP, the other for Atr. In the absence of ADP or 
when Atr is bound to the regu Latory unit, the ADP carrier is in an inactive state 
corresponding to a definite conformation (4c). Once ADP is added, it binds 
firs t to its regulatory site; this results in a conformational change of the 
membrane propagated to the carrier which takes an active form capable of 
binding and transferring ADP by rotational diffusion (4a) or by opening of a 
pore (4b). Model 4b illustrates the principle of a pore opened through the 
membrane and whose opening and specific functioning is under the control of a 
regulatory unit.
The carrier is most probably a highly hydrophobic protein embedded in a
lipid structure. The fluidity of the lipid part of the membrane determines the
rate of the transport process (Fonyo jst al_., 1976).
Apart from the protein-lipid interaction there are indications that the carrier
forms an integrated functional unit with the enzyme which catalyzes the phosphoryl-
14ation of ADP to ATP, the so-called -ATPase system. When [ C] ADP was
incubated with mitochondria under conditions where oxidative phosphorylation 
14occurred, it was not f C] ADP that was detected in the matrix space of mlto- 
14 14chondria, but [ C] ATP. Consequently, [ C] ADP did not mix with the intra- 12
1 2mitochondrial [ C] ADP pool but was phosphorylated as it entered the inner
compartment during its passage through the membrane. To explain this 
finding it has been postulated that the ADP carrier is in close spatial proxlmity to, 
and eventually forms a functional unit with,the -ATPase system (Vignais et a l., 
1975).
The "physiological" exchange reaction catalyzed by the carrier is between 
ADP external and ATP internal. Other exchanges may also occur: between ATP 
external and ADP internal (as in measuring ATPase activity in mitochondria), 
between ADP and ADP, and between ATP and ATP. Since the highest pK& value
of ADP is 6.65 and that of ATP is 6.97, at the pH of the cell ADP is almost in
3 - 4-
the fully ionized form (ADP ), while ATP is mostly fully ionized (ATP ) with
3 - 3-
a fraction present as HATP (FonyoetaT, 1976). ADP may exchange with 
3 .
HATP resulting in an electroneutral exchange; however, the exchange may 
3- 4-also occur between ADP and ATP , and in this case the process is e lectro-
genic, which is charge-compensated by Pi uptake (Fig. 1.8).
Because of the availability of tightly bound specific ligands in radioactive
35form, the Adn carrier seemed particularly well suited for isolation. [ S] 
carboxyatractyloside (CAT) was used by one group of investigators to label 
the carrier in the intact mitochondria, and the labelled protein fraction was 
then purified (Klingenberg jU a_L, 1974). Another group of workers pretreated 
the mitochondria with either Atr or CAT and then put the lysed mitochondria on 
an affinity column in which succinylatractyloside was bound to sepharose.
3
Finally the Atr binding protein was eluted with H-labelled Atr, which replaced
the unlabelled Atr and became bound to a protein (Brandolin _et al., 1974). A
third approach was to use [ * *C]N-ethylmaleimide (NEM) as a marker
(Klingenberg et a l.. 1-174). ft had been shown earlier that ADP stimulates
the alkylation of a mitochondrial component by NEM. An attempt was made to
14isolate that protein fraction into which [ C]NEM incorporation was stimulated 
by ADP.
Metabolic significance of ADP and ATP transport
The transport of ADP and ATP together with Pi is the most powerful transport 
system in eukaryotic cells which relies mainly on respiratory energy. The main 
function is the exchange of ADP, originating from energy consuming reactions in 
the cytosol, against ATP, generated in the mitochondria (Fig. 1.9) (Klingenberg,
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1976). The ADP> ATP carrier is the exclusive link between intra_and extra- 
mitochondrial Pi-transfer reactions.
Mitochondria have a striking ability to transport ADP in 
preference to ATP. This explains the finding that with mitochondria added 
ADP isnearly completely converted to ATP with a relatively sharp break In 
the respiratory rate. In other experiments the efflux of ADP versus ATP 
is shown to be changed by energization in the opposite direction such that the 
efflux of ATP is strongly preferred to that of ADP.
Interpretation of this energy-driven exchange comes from considering that 
ATP has one hegative charge in excess to that of ADP. In the exchange of ADP 
against ATP one negative charge is released from the mitochondria. A 
membrane potential positive outside would electrophoretically pull this charge 
outside under the expense of energy. The energy is taken from the pool of 
energy provided by the respiratory chain which provides positive charges 
outside (Klingenberg, 1976).
The Adn carrier is extremely specific. It catalyzes the transport of ADP 
and ATP but not of AMP. The di- and triphosphates of other nucleotide bases 
are inactive with two possible exceptions: GDP and GTP are transported in 
mitochondria of brown fat and UDP and UTP in mitochondria of yeast cells> 
where these nucleotides have an important specific role in metabolism. Some 
synthetic methylene and hypophosphate analogues are also transported by the 
carrier (Fonyo££al_.t 1976) . The specificity for nucleotides of adenine is 
particularly significant in view of the fact that all the different nucleotide 
triphosphates are present in mitochondria and are necessary for mitochondrial 
biosynthesis of DNA, RNA and protein. The mitochondrial pool of nucleotides 
thus is segregated from the cytoplasmic pool (Lehningerj 1971). The AMP is 
not transported, so that the intra- and extramitochondrial AMP remain 
separated (Klingenberg, 1970). This has important metabolic 
consequences in that the intra - and extramotochondrial AMP depots are
rephosphorylated to ADP by separate systems, within the mitochondrial matrix 
by the GTP-AMP-transphosphorylase coupled to the substrate level phosphoryl­
ation and outside by the adenylate kinase which is exclusively located in the 
intramembrane space.
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FIGURE 1.9 The role of the ADP( ATP carrier in mitochondrial 
phosphate transfer reactions.
The function of the intramitochonuriai Adn pool as an intermediate 
in the synthesis of the extramitochondrial ATP. localization of 
transport systems on the impermeable inner mitochondrial membrane 
and diffusion through the permeant outer mitochondrial membrane. 
Exclusion of Adn fcy the inn-er mitochondrial membrane and 
localization of AMP re-utilizing phosphate transferases in the peri- 
mitochondrial and iniramitochon.drial space (from Klingenberg> 1376).
B. Calcium carrier
Of the various ions which can be transported across the cell and intra-
[ |
cellular membrane systems( of key importance is Ca . An impressive
list of reactions taking place in various cells are known to be influenced by
this cation, as seen in Table 1. 1  (Carafoli £t aJL , 1976), and it is thus rather
| [
obvious that the regulation of the intracellular concentration of Ca is a
phenomenon of physiological significance.
The most interesting properties of the process o f active calcium transport
by mitochondria can be summarized as follows (Carafoli and Lehninger, 1971):
the energy source can be either the respiratory chain or the hydrolysis of ATP,
inhibition being induced by respiratory inhibitors in the first case, and by
oligomycin in the second. Both ATP and the activity of the respiratory chain
energize the uptake by generating a membrane potential across the inner
membrane (Rottenberg and Scarpa, 1974), which is probably the immediate
pulling force for the uptake of calcium.
Experiments mentioned by Carafoli jst al_. (1976) indicate that a large
fraction of the endogenous pool is in a dynamic steady state, suggesting that
calcium, or a large fraction of it, is not maintained in mitochondria as
insoluble salt. This is a rather important conclusion. If it is assumed, for
instance, that all the endogenous mitochondrial calcium is ionized, its concent-
-2
ration within the organelle would be about 10 M, that is, five to six orders of”7 -8
magnitude higher than that in the cytosol (10 - 10 M ). This in turn opens
the question of how the balance of calcium between mitochondria and the cytosol 
is regulated in vivo , given the fact that the amount of calcium present in mito­
chondria under normal conditions seems to be relatively constant, and rarely 
becomes much larger than 10 - 15 it moles per mg of protein. This is, perhaps 
the most important problem in the physiology of mitochondrial calcium. It 
clearly requires, however, that the process by which mitochondria assume 
cytosolic calcium be reversible, otherwise this efficient uptake mechanism 
would lead to mitochondrial calcification.
When both calcium and phosphate are present in the incubation medium,the 
maximum level of calcium accumulated by the organelle increases several fold.
In this case, however, most of the calcium is accumulated in the form of an 
insoluble phosphate salt, and can logically be considered of little importance for
TABLE 1.1
Calcium-dependent reactions in cells
1) Activation of enzyme systems:
Glycogenolysis (phosphorylase kinase) ; lipases and phospholipases; 
»-glycerophosphate dehydrogenase; pyruvate dehydrogenase; succinate 
oxidation; synthesis of some phospholipids; NADH dehydrogenase (plant 
mitochondria); cytochrome c to mitochondrial membrane.
2) Inhibition of enzyme systems:
Pyruvate kinase; synthesis of some phospholipids; substrate oxidation 
(NADH leakage) in lung mitochondria.
3) Activation of contractile and motile systems:
Muscle myofibrils; cilia and flagella; microtubules and microfilaments; 
cytoplasmic streaming; pseudopod formation.
4) Hormonal regulation:
Formation and/or function of cyclic. AMP; release of insulin) steroids) 
vasopressin; oxytocin( catecholamines, thyroxine and progesterone.
5) Membrane-linked functions:
Excitation-secretion coupling at nerve endings; excitation-contraction
coupling in muscles; exocrine secretion (pancreas> salivary glands and
HC1 in the stomach); aggregation of platelets; action potential (nerve 
+ +and muscle cells); Na +k -activated ATPase of several membranes; 
tight junctions; cell contact; binding of prostaglandins to membranes.
From Carafoli^t aj_. t (1976).
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the rapid regulation of cytosolic calcium (Carafoli e ta ]. . 1976). An 
interesting problem, however, is whether,in the conditions prevailing, the 
intracellular uptake of calcium uncomplicated by the simultaneous uptake of 
phosphate ,is possible. The high concentrations of inorganic phosphate present 
in the cytosol have recently prompted Lehninger (1974) to suggest that phosphate 
could play an essential role in the uptake of calcium, as visualized in the scheme 
of Fig. 1.10.
_|_
(B) Uptake of Ca alone 
(from Carafoli jet al_., 1976).
Three types of calcium transport have been identified in rat liver mitochondria 
(Carafoli and Rossi, 1971):
1) The energy-linked transport is usually stoichiometric with electron flow, and 
is accompanied by alka linization of the membrane.andby ejection of hydrogen ions, 
and depends on the conservation of energy up to a level prior to the point of action 
of oligomycin.
2) The metabolism-independent binding most likely reflects the complexing of 
calcium with the phospholipids of the mitochondrial membranes,
3) The high-affinity binding is carried out by a very small number o f sites 
(sometimes less than one per mg of mitochondrial protein ) having a very high_ y  _ g
affinity for calcium (KnirlO to 10 M ).  They are inhibited by uncouplers, by
local anaesthetics and by lanthanum at very low concentration. They function in 
the total absence of metabolism. Some agents that inhibit the high affinity binding 
also inhibit the energy-linked calcium accumulation. It would seem logical to 
postulate that high-affinity binding is a necessary preliminary step in the energy- 
linked translocation of calcium.
The divalent cation composition of the outer membrane is variable, but isj [
particularly high in Mg content (Bogucka and Wojtczak, 1971). This indicates
I 4, j j
that Mg and Ca do not play the same role in the inner membrane and in the 
outer membrane. As the principal functions of the mitochondria are located in 
the inner membrane which represents 85% of the total membranes. Binet and 
Volfin (1975a)have considered that the movements of the membrane divalent 
cations studied occur essentially in the inner membrane.
Calcium, through its positive charges, is implicated in a ternary complex 
between anionic groups of membrane proteins (and possible glycoproteins) and/or 
phospholipids. Calcium would act as a cement between the components of the
J |
membrane and contribute to its stability. In contrast, Mg , present in much 
smaller amount in the mitochondrial membrane, exerts essentially a regulatory| j
role in the maintenance of the membrane integrity. The presence of this Mg 
on a number o f membrane sites is essential for some functions of the mito­
chondrial membranes and especially for the maintenance of the impermeability
| |
of the mitochondrial inner membrane. The displacement of this regulatory Mg 
by calcium, by uncouplers of oxidative phosphorylation or by specific ionophores 
(Binet and Volfin, 1975b), induces severe modifications of the mitochondrial 
functions including uncoupling of oxidation phosphorylation, and to a lesser extent 
the impermeability of the membrane for k+ and other ions or molecules.
C. Phosphate and dicarhoxylate carrier
Mitchell (1953) discovered a phosphate exchange-diffusion carrier in
Micrococcus pyogenes that was strongly inhibited by organic mercurials. His
theory and observations suggested that a study of the effect o f organic mercurials
on phosphate metabolism in isolated mitochondria might reveal the existence of
a similar carrier in the mitochondrial membrane, Tyler (1968) found that the
organic mercurial sodium mersalyl inhibited respiration and swelling dependent
on the entry of inorganic phosphate into rat liver mitochondria.
Pi transported by two carriers: either by the Pi carrier in exchange for OH
ions (this being inhibited by NEM), or via the dicarboxylate carrier in exchange
for dicarboxylate ions (which is inhibited by the substituted malonates). Therefore
32 31the Pi-Pi exchange (that is, Pi- Pi exchange) is catalyzed by both carriers, and 
neither NEM alone nor substituted malonates alone inhibit the process, but their
combination results in complete inhibition (Meljer et a l.. 1970). The
32 31affinity of both carriers for Pi appear to be sim ilar. Most of the Pi- Pi 
exchange, however, occurs via the Pi carrier (Coty and Pedersen, 1974).
A question which naturally emerges is whether the Pi transporting site 
of the Pi carrier and that of the dicarboxylate carrier are identical. The 
specificity of inhibitors argues against the identity of the sites.
Kinetic analysis of the dicarboxylate carrier revealed that all the 
dlcarboxylates and dicarboxylate analogues compete for the same site and 
that Pi has a binding site distinct from the dicarboxylate site (Palmieri 
e ta L , 1971).
D. Tricarboxylate carrier
This carrier transports tricarboxylates (citrate, isocitrate, cis-aconitate) 
and dicarboxylates (malate, succinate, but not malonate) as well as 
phosphoenolpyruvate.
E. Oxoglutarate carrier
Exchange characteristics as well as inhbitor studies revealed that 
2 -oxoglutarate is transported via a specific carrier of its own, which 
catalyzes an electroneutral exchange between oxoglutarate, malate, 
succinate, malonate and some other dicarboxylates. As expected, the 
exchanges malate-malate, malate-malonate, malonate-malonate, etc. may 
also occur.
1 .6  The coupling of metabolite transport to electron transport
The various metabolite-transport systems shown in Fig. 1.11 are 
passive systems (Lehninger, 1975); in the absence of respiration they 
transport metabolites down concentration gradients in the direction that 
w ill result in thermodynamic equilibrium across the membrane. However, 
these systems can also transport their substrates against gradients of 
concentration when they are coupled to electron transport as a source of 
energy . We have already seen that the energy derived from electron 
transport can drive the formation of an H+ -ion gradient across the 
mitochondrial membrane. This gradient in turn may be utilized to transport 
certain metabolites against gradients, into or out of mitochondria. For 
example, phosphate can be accumulated from the surrounding medium by 
respiring mitochondria, against a concentration gradient, through the action
25
Figure 1.11 Important transport systems of the inner membrane in 
rat-liver mitochondria (c irc les). They can function in 
either direction in response to the concentration gradients 
of the transported metabolites. (From Lehninger, 1975).
26
of the phosphate carrier. The phosphate gradient so generated can 
cause the accumulation of malate against its gradient via the 
dicarboxylate carrier. The malate gradient can in turn be used to 
generate a gradient of citrate via the tricarboxylate carrier. In 
this way, through shared substrate specificities, the various transport 
systems of the mitochondria can be linked to the electron-transport 
chain as a source of energy.
1.7 Bindings of inhibitors to mitochondria and submitochondrial particles
3 14Due to the importance of the inhibitors ( H-Atr, C-HCP and Rh6G) 
which were used in the present study, their binding to mitochondria and 
submitochondrial particles were investigated.
The question which naturally arises is why study binding ? Azzone and 
Massari (1973) consider the binding process of utmost importance for 
several reasons: (a) it may represent a step in the translocation process,-
(b) it is conceivable that the metabolic force is acting at this level.and
(c ) the analysis of the ligand microenvironment provides useful 
information on the membrane structure.
Binding studies are an increasingly important tool for studying
molecular interactions in pharmacology and in chemical and biochemical
research. Drug binding is becoming clinically important because
pharmacologists now believe that the therapeutic and toxic effects of a drug
are directly related to the level of free (unbound) drug in the blood.
Several recent studies have recommended that plasma binding of certain
drugs be evaluated routinely to determine the proper dosage for each patient
(Cosmides, 1974). Because the extent of binding varies from patient to
patient, individuals receiving the same drug dosage may be getting proper
therapy, or too little benefit, or an overdose. This problem can be very
serious. Anticonvulsants and heart-treatment drugs are among the
earliest candidates for routine assay.
321.8  ATP- Pi exchange reaction
The present work describes another activity of the mitochondria, 
submitochondrial particles and enzyme complex, namely the exchange 
reaction between orthophosphate and the terminal phosphate of ATP which
occurs in the absence of oxidation. This reaction is designated as the
32ATP- Pi exchange.
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The reversible exchange of orthophosphate with the phosphate of ATP
is considered to be part of the energy-transferring chain in oxidative
phosphorylation. This reaction has been demonstrated in mitochondria
(Boyer jet ad., 1954; Boyer£tal_., 1956; Swanson, 1956; C o w ^ a L , 1957),
in particles derived from mitochondria by various means but which still
carry out oxidative phosphorylation (Cooper et a l.. 1955; Cooper and
Lehninger, 1957; Wadkins and Lehninger, 1957 and 1959; Bronk and Kielly,
1957), and in enzyme complexes (Hatefi_et ad., 1975). In view of the
32association between the ATP- Pi exchange reaction and oxidative
phosphorylation, and the inhibition (by agaric acid, sulfobromophthalein,
hexachlorophene and other inhibitors used in the present work) of ADP,~Pi
translocations, as well as the inhibition o f the 2, 4-dinitrophenol stimulated
32
mitochondrial ATPase, the influence of these inhibitors upon the ATP- Pi 
exchange reaction has been examined.
1.9 The aims of this thesis
The aims of the work presented in this thesis were as follows:-
1. To study the nature of the effect of SBP, HCP and agaric acid on ion
transport reactions and their binding to rat liver mitochondria.
142. To clarify the binding of C-HCP and Rh6G to mitochondria and to
3
study the effect of SBP, IICP and agaric acid on H-atractyloside binding to 
mitochondria and subtnirochondrial particles.
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3. To elucidate the effect of SBP, HCP and agaric acid on ATP- Pi 
exchange reaction.
4. To compare the effects of the above inhibitors with the effecbof others,
such as atractyloside, carboxyatractyloside, bongkrekic acid, triethyltin, 
DBCT, DCCD, ionophorous antibiotics and uncouplers of oxidative
phosphorylation.
CHAPTER 2
ADP TRANSLOCATION IN MITOCHONDRIA
2.1 INTRODUCTION
Studies of the mitochondrial adenine nucleotide (Adn) translocase 
system have been greatly facilitated by the use of specific high affinity 
inhibitors such as:
Atractyloside Winkler et al. (1968).
The use of these inhibitors has been the major experimental tool for 
analysis of the function and structure of the translocase system and 
the development o f current theories of the mechanism of the carrier 
system. The study of other inhibitors of the translocase system may 
thus be of value, and this chapter describes studies with three other 
inhibitors which are effective inhibitors of adenine nucleotide translocase 
in rat liver mitochondria. These inhibitors are
Suflobromophthalein (SBP)
Agaric acid (AA )
Hexachlorophene (HCP)
SBP has been briefly reported by Meisner (1973) to inhibit Adn 
translocase, and is of interest as it has some general structural 
features similar to those of atractyloside (A tr), but no detailed 
investigation of its mode of action has been reported. Agaric acid
Car boxy atractyloside 
Bongkrekic acid
Fatty acyl Co. A
Lauquin and Vignais (1973). 
Vignais e taL  (1973b). 
Klingenberg (1976).
Vignais (1976).
Vignais et^aL (1973a). 
Henderson j5taj_. (1970). 
Henderson and Lardy (1970). 
Kemp£taj_. (1971).
Erdelt et aL (1972). 
Klingenberg (1976).
Duszynski and Wojtczak (1974).
has been reported to Inhibit translocase activity in a recent study by 
Chavez and Klapp (1975) who have shown that it is a competitive 
inhibitor o f ADP translocation in contrast to bongkrekic acid which is 
also a lipophilic tricarboxylic acid, but is an uncompetitive inhibitor.
There is no previous work concerning the effect of hexachlorophene 
on translocase activity. However, HCP is reportedly an uncoupler of 
oxidative phosphorylation in mammalian systems (Caldwell et al, „ 1972; 
Cammer and Moore, 1972).
This chapter describes studies on the mode of inhibition of rat liver 
mitochondrial ADP translocase by SBP, AA, HCP, bongkrekic acid (BkA ) 
atractyloside (Atr), uncouplers and ionophorous antibiotics, as well as 
studies of the effect of Atr, SBP and AA on the binding of radioactive 
ADP to the mitochondrial membrane and the effect of these inhibitors on 
the ATPase activity.
The effect of rhodamine 6G (Rh6G), claimed to be an ADP translocase 
inhibitor by Gear (1974), w ill also be discussed.
2.2 MATERIA 1 S AND METHODS
MATERIALS
14C-ADP was obtained from the radiochemical centre (Amersham, U.K. ). 
ATP, ADP, adenosine-3-monophosphate, valinomycin, oligomycin, 
butacaine hemi-sulfate, agaric acid and Tris(hydroxymethyl)aminomethane 
were obtained from [Sigma (London) Chemical Co., Kingston-upon-Thames, 
U .K .l. HCP, SBP were obtained from Koch-light Laboratories, Ltd., 
Colnbrook, Buckinghamshire, England. C1--CCP was obtained from 
Calbiochem (Los Angeles, California, U .S .A .). PCP, Rh6G and RhB 
were obtained from B.D.H., (B.D.H. Chemicals Ltd., Poole, Dorset, U .K .). 
DNP and EDTA were obtained from Hopkin and Williams, Ltd., England.
Rh3G and RhS were obtained from Phase Sepharations Ltd. FCCP was 
obtained from Pierce Chemicals, X-537A from Hoffman-La Roche Inc..,
CPDS from New Cell Biochemicals, 631 Hear Avenue, Berkeley, California 
94710, U .S.A . 1799 was a gift from Dr. P.G. Heytler (E .I. Du Pont 
de Nemours and Co. Inc., Wilmington, Delaware, U .S .A . ). TET was 
prepared from triethyltin hydroxide, a gift from Dr. J. Price, Tin 
Research Institute. Leucinostatin (A20668) was obtained from Eli Lilly 
and Co. and also as a gift from Dr. R. Hamtl. Venturicidin was a gift from
Dr. I.D. Fleming (Glaxo Laboratories> Stoke Poges, U .K . ) .  Bongkrekic 
acid was a gift from Dr. W. Berends( Technical University, Delft, The 
Netherlands. PPO was obtained from Nuclear Enterprises, Ltd.,
Sighthill, Edinburgh 11, Scotland. Atractyloside and carboxyatractyloside 
(CAT) were purchased from Boehringcr, Mannheim, Germany. Cellulose 
filters, 0.45 p.M HAW 02500 were obtained from Millipore. A ll other 
chemicals were of analytical reagent grade.
METHODS
Preparation of mitochondria and submitochondrial particles
Liver mitochondria were prepared from Wistar female rats (200-300g) 
by the method of Johnson & Lardy (1967) utilizing buffered sucrose (0.25 M 
sucrose, 1 mM EDTA and 10 mM Tris-HCL, pH 7.4) as described by 
Duszynski and Wojtczak (1974). Protein was determined by a biuret 
method (Gornall, Bardawill and David, 1949). Submitochondrial particles 
(referred to as particles) were obtained by sonication of rat liver 
mitochondria (20 mg protein per ml, in sucrose-Tris-EDTA buffer) 
utilizing a M.SE. 150 W Sonicator at maximal power for four successive- 
periods of 30 seconds at 0°. Submitochondrial particles were isolated 
by centrifuging at 10000 xg for 10 min to remove large particles and 
unbroken mitochondria and the turbid supernatant was centrifuged at 
80000 xg for 30 min. The pellet was resuspended in buffered sucrose- 
Tris-EDTA.
Estimation of ADP translocase activity
ADP translocase activity in well coupled mitochondria was estimated 
either by "Forward Exchange" or "Back Exchange" methods essentially 
as described by Pfaff and Klingenberg (1968). Mitochondria (1 mg protein) 
in 1 0 ml of the incubation buffer (either 0.25 M sucrose, 1mM EDTA and 
10 mM Tris-HCl, pH 7.4, as described by Duszynski and Wojtczak, 1974- 
or 110 mM KC1, 20 mM Tris-HCl, pH 7.4 and 0.2 mM EDTA, as 
described by Vignais et a_L, 1975; or 15 mM KC1, 1 mM EDTA, 90 mM 
sucrose, 50 mM Triethanolamine-HC1, pH 6.5 and 5 mM MgCl^, as 
described by Kemp e ta j., 1971) with or without inhibitors for 10 min at
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4-5° and the reaction initiated by rapid mixing with 0. 5 ml of the
14same Incubation buffer containing either C-ADP (in Forward 
Exchange) or ADP (in Back Exchange) so that the final adenine 
nucleotide concentrations ranged from 2 to 200 pM. The reaction 
was terminated at 30 sec by rapid filtration (2 sec) through 0.45 pm 
Millipore filters and washed quickly with 5 ml of ice-cold incubation 
buffer. The filtration was carried out in special holders which were 
individually linked to a negative pressure reservoir maintained by a 
vacuum pump( consequently a large negative pressure could be applied 
to any filter holder enabling very rapid filtration (2 sec) and reaction
termination times to be achieved.
14 14In "Back Exchange" ( C-ADP efflux) data expressed as A[ C]ADP
14
was determined by subtracting the amount of C-ADP found in the
presence of unlabelled adenine nucleotide from that in its absence.
14Preloading of mitochondria with C-ADP was carried out essentially
as described by Vignaisjet ah (1973a). Rat liver mitochondria (50 mg
protein in 10 ml o f 0. 25 M sucrose, 1 mM EDTA and 10 mM Tris-HCl,
14 opH 7.4) were incubated with 90 pM C-AD? for 15 min at 4 ; after 
two successive washings by resuspension and centrifugation in the 
incubation buffer, they were resuspended in sucrose-EDTA-Tris 
buffer.
A ll measurements of ADP translocation were carried out by Millipore
filtration (Winkler et al_., 1968).
Estimation of ADP binding to mitochondria 
14Binding of C-ADP was carried out by the method of Wiedemann,
Erdelt and Klingenberg (1970) using liver mitochondria depleted of
endogenous adenine nucleotides by the arsenate method. Depleted
mitochondria (1 mg) were incubated in 1 ml suspension buffer (0.25 M
sucrose, 20 mM triethanolamine-HC1, pH 7.0, 1 mM EDTA; 0.5 mM
adenosine-3-mono-phosphate). Binding was initiated by 0.5 ml
14
suspension buffer containing C-ADP. Final volume 1.5 ml, the
* m
\
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temperature of the binding medium was 0°. The reaction was carried 
out in centrifuge tubes, 1 x 7.5 cmf as follows:
14(a) Control reaction without inhibitors; mitochondria and C-ADP
added to the buffer at zero time and the tubes centrifuged after 2 min.
14(b) Inhibitors added before C-ADP addition; mitochondria and
14inhibitors were added at zero time and at 1 min C-ADP was added
and after a further 2 min incubation time the tubes were centrifuged.
14 14
(c) Inhibitors added after C-ADP addition; mitochondria and C-ADP
were added at zero time and inhibitors at 2 min and the tubes
centrifuged after a further minute.
Assay tubes were centrifuged for 15 min at 10000 xg in plastic
adapter designed to fit SS-34 rotor of the Sorvall RC^-B.
The supernatants were removed by aspiration and the mitochondrial
pellets washed once with ice-cold sucrose medium (1 m l). The washing
medium was removed by careful aspiration with a fine plastic tip
attached to a water pump. The pellets were resuspended in 2% (w/v)
14
Triton X-100 (1 m l) for scintillation counting of bound C-ADP.
From the labelled adenine nucleotide measured in samples (a )f (b) 
and (c) the three single portions can be evaluated as follows: 
labelled adenine nucleotide bound to the carrier sites = atractyloside- 
removable binding (a-c), labelled adenine nucleotide exchanged with 
the endogenous adenine nucleotide in the mitochondria (c -b ) and the 
unspecifically bound labelled adenine nucleotide (b).
Measurement of radioactivity
In translocase experiments, the Millipore filter was dried and the
amount of radioactivity in the filter that contained the mitochondria was
measured in a Packard Tricarb liquid scintillation counter in a
POPOP/PPO system, using 10 ml of a scintillation mixture containing
4.0 g PPO (2. 5 diphenyloxyazole ),0. 2gdimethyl POPOP [ 1( 4, di -2(5-
phenyloxyazolyl benzene)] in 1 L of toluene (Patterson and Green> 1965).
In the binding experiments, the pellets were dissolved in 1.0 ml of
142% (w/v) Triton X-100 for scintillation counting of bound C-ADP, and
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added to 10 ml of a scintillation mixture containing 500 m l Triton 
X-100, 1 L of toluene and 7.0 g of butyl BPD.
ATPase assay
The ATPase assay was carried out by the method of Myer and Slater 
(1957) in a reaction mixture containing 50 mM Tris-HCl, pH 7.4, 75 mM 
KC1, 1 mM EDTA, 0.1 M sucrose, 0.003 M MgCl2, 10 mM ATP, in 
final volume of 1.0 ml. In all cases 1.0 mg of mitochondrial or 
submitochondrial particles protein was used for each assay and this 
was preincubated in the reaction mixture for 10 min with inhibitor and 
with 2, 4-dinitrophenol (DNP) when necessary. Atractyloside, agaric 
acid and HCP were dissolved in ethanol. SBP and DNP were dissolved 
in aqueous solution. The assays were started by the addition of ATP 
and were run for 5 min at 30°; 0.5 ml o f 10% (w/v) trichloroacetic 
acid was added to stop the reaction. After centrifugation , to sediment 
the protein, 0. 5 ml samples of the supernatant were used for the 
determination of phosphate according to the method of Fiske and 
Subbarow (1925). In a control assay, addition of ethanol alone has no 
effect on ATPase activity.
1.3 RESULTS
Time course of ADP uptake 
14The time course of C-ADP uptake and efflux (in exchange with
14 oexternal ADP) of C-ADP by intact rat liver mitochondria at 5 C are
shown in Figs. 2.1 and 2.2 respectively. There is a rapid phase which
is linear for 30 sec, followed by a much slower phase extending over 5
min. Consequently, a time period of 30 sec was chosen for all
subsequent experiments. These results are in agreement with the very
rapid uptake followed by a slow increase observed in rat liver mitochondria
by Duszynski and Wojtczak (1974) and Winkler , (1968).
14The amount of C-ADP taken up or effluxed by rat liver mitochondria 
in the rapid phase, measured after 30 sec is 4-5 n moles of ADP per mg 
or protein; longer incubations gave increasingly higher values, approaching
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Figure 2.1 Time course of the uptake of ADP
Rat liver mitochondria (1 mg protein) were incubated
at 5° in 1.5 ml buffer (0.25 M sucrose, 1 mM EDTA
and 10 mMTris-HCl, pH 7.4) containing 40 p.M 
14C-ADP for the indicated time before sampling. 
Other details were described in "Method". Results 
are mean ± S.D. of five experiments.
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14
Figure 2.2 Time course of the C-ADP efflux in exchange with
external A DP 
1 4C-AOP-labelled mitochondria (0.5 mg protein) were 
Incubated in 1.0 ml of 0.25 M sucrose, 1 mM EDTA and 
10 mM Tris-HCl, pH 7.4 at 5°. ADP In 0.5 ml was 
added to a final concentration of 50 pM. The incubation 
lasted for indicated time before termination by 
Millipore filtration. Other details are described in 
"Method". Results are mean ± S.D. of five experiments.
is approximately equal to the total adenine nucleotide content of
freshly isolated rat liver mitochondria (Brierley and O'Brien, 1965;
Winkler £t al_. , 1968; Vignais ^ tal_., 1973a).
14
Effect of nucleotide concentration on C-ADP uptake and efflux
14
Figure 2.3 shows the effect of increasing C-ADP concentration 
14on the amount of C-ADP taken up by mitochondria following a 30 sec
incubation at 5°. It is seen that the amount of labelled nucleotide in
the mitochondria increases with the concentration in the medium.
From the data, a (ADP) value of approximately 7.4 pM was
calculated. This value is lower than the values of 12 to 17 pM found
by (Klingenberg, 1970; Spencer and Bygrave, 1972 ; Shrago et a l.. 1974)
and higher than the values of 1 to 3 pM reported by (Souverijn et a l.,
1973; Weidemann et a l . . 1970; Winkler and Lehninger, 1968).
14In the case of the C-ADP efflux from mitochondria in exchange 
with externally added ADP (Fig. 2.4) a (ADP) value of approximately
6.7 uM was obtained which is similar to the K value obtained in the
14 m
forward exchange assay of C-ADP.
Effect of atractyloside and carboxyatractyloside on the mitochondrial 
adenine nucleotide translocation
Three specific inhibitors of adenine nucleotide translocation are
known: Atr, CAT (Gummiferin ) and BkA (Vignais £t a l., 1973b).
Bruni, Luciani and Contessa first described the ability of Atr to prevent
uptake of isotopically labelled nucleotides into mitochondria (Bruni et a l.,
1964; Bruni et a l. , 1966). Since that time, a number of techniques
have been developed for studying the kinetics and specificity of the
nucleotide translocase and its susceptibility to atractyloside (Winkler
et ah, 1968; Duee and Vignais, 1969; Klingenberg and Pfaff, 1968).
Results obtained with Atr and CAT by utilizing the technique
described under "Methodsand Materials" are shown in Fig. 2.4 and
Table 2.1. Atr (0.94 pM) increased the K value of ADP fromm
an upper limit of about 10-15 n moles per mg of protein. This value
Figure 2.3 Double reciprocal plot of the exchange of ADP
ADP exchange was measured as described in methods; 1 mg
of mitochondrial protein was incubated in media that contained
0. 25 M sucrosef 1 mM EDTA, 10 mM Tris-HCl, pH 7.4 at 
o ’ 14
5 and the indicated concentrations of C-ADP. After 30 sec
of incubation, the reaction was stopped by Millipore filtration.
Each result is the mean of four experiments. K (ADP) =m
7.4 nM.
14Figure 2. 4 Effect of Atr on the kinetics of C-ADP efflux in exchange
with external ADP 
14C-ADP-loaded mitochondria (1.0 mg protein) were incubated
in 1.0 ml of 0. 25 M sucrose> 1 mM EDTA and 10 mM Tirs-HCl, 
o 14pH 7.4> for 10 min at 5 with Atr. The efflux of C-ADP was
initiated by the addition of ADP(5-200 pM). At 30 sec, the
reaction ended by Millipore filtration. The results are mean
of four experiments.
X ----X NO Atr K (ADP) = 6.7 pM’ ’ ’ m
•  ---- •  , + 0.94 iiM | Atr, Km (ADP) = 200 pM
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6.7 |i.M to 200 |iM. Thusf Atr competes with ADP when exchanged 
14with internally labelled C-ADP. The competitive inhibition of 
adenine nucleotide exchange by Atr observed in the present study are 
in agreement with the results of (Lauquin and Vignais, 1973; Vignais 
jstaL , 1973b; Klingenberg, 1974; Klingenberg_et a_l., 1976; Vignais, 
1976).
Carboxyatractyloside (0.2 ng/mg protein) caused 94% inhibition 
14of C-ADP uptake from rat liver mitochondria, thus confirming the 
previous findings that CAT is a potent inhibitor of adenine nucleotide 
translocation from mitochondria (Vignais ^ t aj_., 1973a; Vignais et a l , . 
1973b).
Inhibition by uncouplers and ionophores of ADP translocation
Table 2.1 shows that HCP, Cl-CCP, FCCP, 1799, PCP and DNP 
inhibit ADP uptake in agreement with Meisner (1971) who found that 
the ADP exchange in the presence of m-chlorocarbonyl cyanide phenyl- 
hydrazone is reduced from 2.7 to 1.5 nmoles/min/mg protein.
However, in disagreement with Kemp, Jr. (1970) and Babior et a l. . 
(1973) who found that Cl-CCP, FCCP, DNP stimulate the ADP 
exchange. Moreover, it was shown by Pfaff and Klingenberg (1968) 
and Spencer et al. (1976) that uncouplers strongly stimulateionly the 
ATP exchange and do not greatly influence the ADP exchange. Vignais 
et al. (1973b) reported that FCCP has only a slight effect on ADP 
translocation.
| |
On the other hand, the results of the present study show that Ca
has no effect on ADP uptake, confirming previous studies (Spencer and
| |
Bygrave 1971 ) who mentioned that Ca stimulates the translocation 
of ATP but not of ADP. It was proposed (Thorne and Bygrave, 1974) 
that ADP translocation by tumor mitochondria is particularly sensitive
j j j j
to the added Ca . In the presence of 100 nmoles Ca per mg protein
the rate o f translocation of 50 nM ADP is inhibited some 75%. In other
| |
experiments, Thorne and Bygrave have found that Ca also inhbits the 
translocation of both ADP and ATP in mitochondria isolated from Yoshida
TABLE 2.1
Effect of inhibitors, uncouplers and ionophores on ADP uptake
Mitochondria (1.0 mg protein) were incubated in 1.0 ml of 110 mM
KC1, 20 mM Tris-HClt pH 7.4 and 0.2 mM EDTA for 10 min at 5°
14
with inhibitors, uncouplers and ionophores. C-ADP in 0. 5 ml was
added to a final concentration of 100 pM. The incubation lasted for 
30 sec and was stopped by Mlllipore filtration. The results are of 
the mean ± S.D. of four experiments.
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hepatoma ascites cells but not in mitochondria isolated from the
minimally-deviated M orris 5123C hepatoma cells.
Additions Inhibitor concentration 
log/mg protein
Inhibition
(55)
Carboxyatractyloside 0.2 94 ± 5.6
Atractyloside 0.2 90 ± 5.5
HOP 1 .0 65 ± 2.0
Cl-CCP 3.0 65 ± 5.0
FCCP 3.0 70 ± 3.0
1799 3.0 55 ± 1.0
PCP 5.0 51 dt 3.0
DNP 3.0 35 ± 3.1
TET 1 - 1 0 0
CaCl2 2-5 0
Leucinostatin 5.0 18 ± 1.7
Valinomycin 2.0 76 ± 5.2
Venturicidin 5.0 25 ± 2.0
X-537A 2-5 0
Oligomycin 2J5 0
Butacaine 0.42 14 ±0 .7
CPDS 2-5 0
DCCD 10-20 0
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In the case of the effect o f ionophorous antibiotics on ADP 
translocation, it was found that X-537A has no effect, leucinostatin 
has a slight effect (Table 2 .1 ), Valinomycin (2 M-g/mg protein) 
caused 76% inhibition of the ADP uptake, confirming Shertzer and 
Racker (1976) who showed that in the presence of K^SO^ valinomycin 
inhibited both initial rate and extent of ADP uptake.
Oligomycin has no effect on ADP uptake ; the same findings were 
also reported for ATP translocation by (Bruni et a l. . 1966; Spencer 
and Bygrave, 1972). Butacaineat 0.42 ug/mg protein has a very 
slight inhibitory effect. While Spencer and Bygrave (1974) showed 
that butacaine was the most effective inhibitor with 50% inhibition 
occurring at 10 (iM for 200 p.M ADP. The results of Table 2.1 
clearly show that TET has no effect on ADP uptake, which is in 
agreement with Cain (1976) who showed that there is no inhibition of 
ADP uptake by TET in yeast mitochondria.
Effect of rhodamine compounds on ADP translocation
The results of the present work, Table 2.2, show that Rh6G, Rh3G,
RhB and RhS have no effect on ADP translocation. The results with
RhB, confirming the finding of Gear (1974) that this compound, a free
acid and uncharged at pH 7, was completely ineffective on mitochondrial
energy-linked functions. However, the results with Rh6G on translocase
are in contrast with the finding of Gear, who found that Rh6G blocked
14
adenine nucleotide binding to intact mitochondria, both for C-ATPand 
14C-ADP. Inhibition by 10 p.M Rh6G at low levels of added nucleotide 
was identical with that caused by 10 pM atractyloside, but inhibition was 
only very slight at higher nucleotide concentrations (0.2 mM). From the 
above findings, he concluded that Rh6G blocks adenine nucleotide 
translocator. However, the present study (Table 2.2) shows that Rh6G 
(7-13 u-g/mg protein) has no effect on ADP translocase, with 40 pM ADP. 
When 2 uM ADP was used, it was found that Rh6G (7 ug/mg protein) also 
had no effect on the ADP uptake (1.34 nmol/min/mg protein, no Rh6G; and 
1.3 nmol/min/mg protein with Rh6G ). *
*
»•
Experimental conditions as in Fig. 2.3. Inhibitor incubated with
o 14mitochondria for 10 min at 5 . C-ADP in 0. 5 ml was added to 
a final concentration of 40 pM.
14C-ADP uptake (nmol/min/mg protein) 
Rhodamine concentration
Rhodamine 7 pg/mg protein 13 pg/mg protein
None 8.8  ± 0 .11
Rh6G 8.9 ± 0.07 9.2 ± 0.15
Rh3G 9.1 ± 0.08 8.2 ± 0.45
RhB 9.2 ± 0.06 9.3 ± 0.07
RhS 9.3 ± 0.50 9.2 ±0.30
*
None 1.34 ± 0.05
*Rh6G 1.30 ±0.04
using 2 pM  ^ C-ADP
In flu ence of incubation period on inhibition of ADP uptake by agaric
acid SBP and HCP ----- 1-----------------
Table 2.3 shows the action of the three inhibitors on ADP 
translocase is not time dependent and maximal inhibitory activity is 
observed within 30 sec. Thus these inhibitors are unlike bongkrekic 
acid, which was shown by Henderson e ta l. (1970) to inhibitsa number 
of ADP-ADP, ATP-ATP and ADP-ATP exchange r.«1“.b«u at 23°, 0.7 - 1.1 
nmoles of bongkrekic acid/mg of protein was sufficient for complete 
inhibition with a 10 min incubation before nucleotide addition, whereas 
50 - 70 nmoles/mg was required without the prior incubation period. 
These inhibitors (agaric acid, SBP, HCP) are similar to atractyloside 
as the extent of inhibition by a fixed concentration of atractyloside was 
not augmented by prior incubation with the mitochondria, and atractyl­
oside inhibition of adenine nucleotide exchange appeared to be 
instantaneous (Heldt, 1969 and Henderson et al_. 1970).
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TABLE 2.3
acid, sulfobromophthalein and hexachlorophene
14Experimental conditions as in Fig. 2.3 with 40 pM C-ADP. 
Results are mean ± S.D. of three experiments.
Addition of inhibitors ^C-ADP uptake
nmol/mg of protein nmol/min/mg of protein
1. Agaric acid (12-8)
No agaric acid 7.93 ± 0.43
Added after ADP 7.08 ± 0.25
Added with ADP 3.34 ± 0.31
Added 0. 5 min before ADP 1.80 ±0.16
Added 1.0 min before ADP 2.03 ± 0.07
Added 4.0 min before ADP 1.36 ±0.10
Added 10.0 min before ADP 1.55 ±0.21
2. Hexachlorophene (2-8)
No HCP 10.00 ± 0.50
Added 5 sec after ADP 8.61 ± 0.35
Added 0. 5 min before ADP 5.42 ± 0.43
Added 1.0 min before ADP 5.40 ± 0.20
Added 5.0 min before ADP 5.61 ± 0.24
Added 10.0 min before ADP 5.62 ± 0.10
3. Sulfobroniophthaiein (8.7)
No SBP 8.81 ± 0.30
Added 5 sec after ADP 3.20 ± 0. 20
Added with ADP 0.80 ± 0 .10
Added 1.0 min before ADP 0.80 ± 0.07
Added 4.0 min before ADP 0.82 ± 0.06
Added 10.0 min before ADP 0.72 ±0.11
Note The inhibitor concentrations
(1.5 nniol/mg protein); AA (3 
protein) (Fig. 2.5).
for half maximal inhibition are SBP 
nmol/mg proteii^; HCP (3 nmol/mg
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Effect of different concentrations of inhibitors on ADP transigesse
The action of agaric acid, SBP and HCP on ADP uptake is shown in 
Fig. 2.5, which clearly shows that the half-maximal inhibition of 
ADP uptake when ADP concentration was 40 p.M is as follows:
1.5 nmol SBP/mg protein; 3 nmol AA/mg protein; 3 nmol HCP/mg protein. 
Thus, according to these results, these inhibitors can be arranged 
according to their potency of inhibition of ADP translocase as follows:
SBP > agaric acid s HCP. These inhibitors are not as potent as 
atractyloside as Winkler et aL (1968) has reported a value of 0.8 
y,M for ha If-maximal inhibition with 200 uM ADP.
Effect of SBP. agaric acid and HCP on translocation of various 
concentrations of ADP
Study of the effect of SBP and agaric acid on the ADP translocase 
assay shows that they are potent inhibitors of ADP translocase. A 
double reciprocal plot of this data (Fig. 2.6) indicates that both 
inhibitors are competitive inhibitors of ADP uptake. Dixon plots 
(Dixon, 1953) gave values for K. for SBP of 1.5 pM and for agaric 
acid 1.9 y.M (Fig. 2.8) as compared with the K. of atrac.lyloside 
of 0. 1 p.M (I< Ungen berg, 1970). WhilcFig. 2.7 shows that HCP is 
an uncompetitive inhibitor, since both the apparent and the 
apparent V jire  altered (Gut freund, 1975),
Double reciprocal plots of the effect of SBP and agaric acid 
(Fig. 2.6) and HCP (Fig. 2.7) on the exchange of ADP in mitochondria 
shows the following K (ADP) values:
Inhibitor concentrations (p.M ) apparer f
No inhibitor 7.4
SBP 2.9 40.0
5.7 66.0
11.3 308.0
Agaric acid 1.7 20.0
3.4 29.0
8.5 133.0
HCP 1.85 17.0
9. 25 29.0
18.50 77.0
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Figure 2.6 Double reciprocal plot of the exchange of ADP In the presence 
o f SBP and agaric acid
Experimental conditions as in Fig- 2.3
• ------- •  no inhibitor K (ADP) = 7.4 uM’ ’ m
A -------- A  + 1 .7  iaM AA K (ADP) = 20hM’ ’ m
A ---------A  + 3 . 8  uM A A K (ADP) = 29 uM’ ’ m
■ -------- ■  + 8 .5  |j,M AA K (ADP) = 133 uM’ ’ m
□ -------- □  + 2 .9  nM SBP K (ADP) = 40nM’ ’ m
X ------ X +5.7 iiM SBP, K (ADP) = 66
O ------ O, +  11.3 nM SBP, Km(ADP) = 308 nM
Results are mean of five experiments.
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Figure 2.7 Double reciprocal plot of the exchange of ADP in the 
presence of HCP
Experimental conditions as in £¡3 . 2.3
• ------- •  no inhibitor K (ADP) = 7.4 y,M’ ’ m
O ------- O +1 .8  |iM HCP, K (ADP) = 17 nM’ ’ m
■ -------■  +9.28u,MHCP K (ADP) = 29 nM’ m
A -------A  + 18. 50 nM HCP K (ADP) = 77 y,M* m
The results are mean of six experiments.
A[ SBP] (nM)
Figure 2. 8 Inhibition of the ADP uptake by agaric acid (A ) and
SBP (B) presented in the form of a Dixon plot.
14
The same conditions as those in Fig. 2.3. C-ADP 
in 0.5 ml was added to a final concentration of ( 10 -12 0  ^M). 
The results are mean of five experiments.
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Effect of pH on inhibition of ADP uptake
The influence of pH on the HCP( SBP( AA and BkA inhibition is shown 
In Figs. 2.9 and 2.10. The buffering system used in these experiments, 
covering the pH range 6.0-8.5, were either 50 mM Triethanolamine-HC1 
or 10 mM Tris-HCl. Fig. 2.9 shows that the maximum ADP uptake 
occurs between pH 7.0 and 8.0. BkA (0.7 nmol/mg protein)greatly 
inhibits ADP uptake at pH 6.0 and 6. 5, and its potency of inhibition 
tends to decrease after pH 6.5 and loos* its effect after pH 7. 5. In the 
case of HCP, there is only a slight change in the inhibition of the exchange 
of ADP in the range between pH 6.0 -7 .5 ,; above pH 7. 5 there is little 
inhibition. Thus BkA and HCP have nearly similar effects on ADP 
translocase in basic medium.
As shown in Fig. 2.9A, the SBP curve is similar to the control 
curve. So, the inhibitory action of SBP is not pH dependent within 
the pH range 7.0 - 8.5 , and the SBP effect is markedly different from 
BkA which exhibits a marked dependency on pH (Kemp et a l. . 1971; 
Kllngenberg et_ah, 1973).
It is supposed that agaric acid is partly undissociated at pH 6 -6. 5 
and thus affects translocase activity in a similar way to BkA,as both 
compounds are tricarboxylic acids. However, the results of Fig. 2.9 
show that agaric acid has little effect on translocase in the pH range 
6.0-6. 5, and the maximal inhibition by agaric acid on ADP uptake is in 
the pH range 7-7. 5 which is in agreement with the results of Chavez 
and Clapp (1975).
It was of particular interest to examine the effect of various 
concentrations of BkA on ADP translocase at two different pH as shown 
in Fig. 2.10. BkA (1.2 nmol/mg protein ) at pH'6 . 5 caused 90% 
inhibition of ADP translocation, while the same concentration of BkA 
at pH 7.4 caused only 10% inhibition. This is further support for the 
previous finding that BkA is a pH dependent inhibitor.
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Figure 2.9 The effect of pH on the Inhibition by BkA. HCP. SBP and 
agaric acid of ADP uptake
Mitochondria (2.0 mg protein) were incubated in 1.45 ml of 0.25 M sucrose(
1 mM EDTA and 10 mM Tris-HCI, covering the pH range 6.0 to 8.0, for 10
o 14min (except for BkA i 20 min) at 5 with these inhibitors. [ C] ADP in 
50 y,l was added to a final concentration of 100 |j,M. The incubation lasted 
for 30 sec and was stopped by Millipore filtration. Results expressed 
as mean of three experiments ± S.D.
• ------- • ,  no inhibitors.
I n
A -------A , +2 .6  nmoles AA/mg protein
O ------ O +1 .4  nmoles SBP/mg protein
T-
t
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HcA (nmole/mg protein)
Figure 2.10 Influence of pH on Inhibition of ADP uptake by 
bongkrekic acid
• ------- •  , mitochondria ( 1 .0  mg protein) were incubated in 1 .0
ml of 15 mM KC1, 1 mM EDTA, 90 mM sucrose, 50
mM Triethanolamine-HC1, pH 6.5 and 5 mM MgClj
for 20 min at 5° with 0.14-2.7 nmoles BkA/mg.
14[ C] ADP in 0.5 ml was added to a final concentration 
of 100 iaM. The incubation lasted for 30 sec and was 
stopped by Millipore filtration.
O ------O , conditions similar to • --------•  except that mitochondria
were incubated in 1.0 ml of ,'.25 M sucrose, 1 mM EDTA
and 10 mM Tris-HCl, pH 7.4 for 20 min at 5° with 2.7 -
1426.6 nmoles BkA/mg protein. [ C] ADP in 0.5 ml was 
added to a final concentration of 40 p,M. Results are mean 
± S.D. of three experiments.
Inhibition of ADP binding by SBP. agaric acid and Atr
In intact mitochondria, the exchangeable portion o f adenine 
nucleotides is 10 to 100 times larger than the carrier bound portion t 
therefore a preliminary treatment of the mitochondria is necessary 
to reduce the exchangeable portion by as much as possible, i.e . by 
depletion of endogenous adenine nucleotide and by interconversion to 
non -exchangeable AMP (Weidemann et a l.. 1970). The various 
depletion methods used are freezing, treatment with phosphate and 
treatment with arsenate.
Erdelt^t aj_. (1972) defined the ADP bound to the carrier sites as 
that portion of total ADP bound to mitchondrial membranes, which is 
removed by subsequent addition of atractyloside. The addition of 
atractyloside at different times before and after ADP has served to 
differentiate the carrier-bound or 'specific' portion from the exchanged 
portion of adenine nucleotide.
Results of the present study showed that SBP and agaric acid were 
competitive inhibitors of ADP translocation; thus it is of interest to 
study the effect of these inhibitors on the binding of ADP from rat liver 
mitochondria (Fig. 2.11). A Uneweaver-Burk plot o f the effect of 
SBP and agaric acid on the specific ADP binding by mitochondria (Fig. 2.12) 
shows that SBP (13.5 m>M) and agaric acid (17 pM) increases the Km for 
ADP binding from 4.2 to 10 p,M and 5.7 |j,M respectively, with no change 
in the Vmax, which suggests that there is a competition between SBP, 
agaric acid and the ADP binding.
DNP-stimulated mitochondrial ATPase and submitochondrial ATPase 
activities
Slekevitz j^ a l .  (1958) described the existence of two distinct types
of ATPase in liver mitochondria, one activated by DNP and only present
in intact mitochondria capable of oxidative phosphorylation, and another,
| |
activated by Mg and characteristic of structurally disorganized 
mitochondria devoid of phosphorylative ability.
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14Figure 2.11 Effect of Atr. SBP and AA on C-ADP binding
ASj-depleted mitochondria ( 1 .0  mg protein) were Incubated in 1 .0  ml
(0.25M  sucrose; 20 mM Triethanolamine-HC1, pH 7.0; 1.0 mM EDTA;
o 140.5  mM adenasine-3-monophosphate) at 0 with inhibitor. C-ADP in
0. 5 ml was added to a final concentrations of (2. 5-20 |o,M). At each 
14concentration of C-ADP; Atr (9.0 y.M) or SBP (13.5 uM) or AA (17 y,M) 
were either omitted from the medium (® ) or added after (O) or 2 min 
before ADP (X ). The mitochondria were centrifuged after 2 min incubation. 
Results are mean of four experiments ± S.D. For experimental detail, 
see Method.
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1/f ADP] (hM )
Figure 2.12 Inhibition of specific ADP binding by SBP and agaric acid
(A ) double reciprocal plot. (B) concentration dependence of the
atractyloside-removable binding.
Specific binding = labelled ADP bound to carrier sites = atractyloside - 
removable binding (binding without inhibitor - binding where inhibitors 
added after ADP); data calculated from Fig. 2.11.
• -------•  , no inhibitors, Km (ADP) = 4.2
O -------0,+agarlc acid (17 y,M),Km (ADP) = 5. 2 p.M
X ------- X,*SBP (13.5 (J.M), Km (ADP) = 10.0 nM
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The mitochondrial ATPase activity is believed to represent a reversal 
of the reaction: which leads to ATP synthesis from ADP + Pi (Lardy and 
Wellmant 1953; Ernster and Lee( 1964).
Henderson'and Lardy (1970) indicated three possible loci susceptible 
to Inhibition o f uncoupler-accelerated ATPase in rat liver mitochondria 
by bongkrekic acid. It could inactivate the factors responsible for 
coupling electron transport to oxidative phosphorylation; it could prevent 
access of adenine nucleotides to mitchondrial enzymes contained within 
the cristae; or it could prevent the uptake of Pi required for oxidative 
phosphorylation, thus inhibiting the ATPase via a mass action effect.
The results of the present study, Fig. 2.13, confirms the previous 
findings by (Vignais ^t aL , 1961; Vignais et a L , 1962 and Henderson 
and Lardy, 1970) that Atr inhibits the DNP-stimulated ATPase activity 
in intact mitochondria, and that Atr is, in fact, inactive on ATPase 
activity of submitochondrial particles, confirming the finding of other 
workers (Luciani and Varotto, 1975; Vignais_et a L , 1973a; Henderson 
and Lardy, 1970).
The effect of agaric acid on DNP-stimulated mitochondrial ATPase 
activity is shown in Fig. 2.13; the present results therefore confirm 
the work of Chavez and Klapp (1975) who found that in rat liver 
mitochondria,the ATPase activity is inhibited 30% by 20 m>M agaric acid. 
This result substantiates the findings showing the inhibition of ADP 
uptake by agaric acid. Furthermore, agaric acid has only a slight effect 
on the ATPase in submitochondrial particles. Moreover, SBP, as shown 
in Fig. 2.13, also inhibits the DNP-stimulated mitochondrial ATPase.
The ATPase activity is inhibited 45% by 20 nM SBP, as compared with 
65% Inhibition caused by 20 |iM Atr under the same conditions,, and that 
SBP has very slight effect on submitochondrial particles ATPase. 
However, SBP, as w ill be shown in Chapter 6, also inhibits the Pi uptake 
by mitochondria; thus, the inhibition of mitochondrial ATPase activity 
by SBP is not merely due to the inhibition of adenine nucleotide uptake, 
a result which indicates that SBP is an unspecific inhibitor of ADP uptake.
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Inhibitor (y,M )
Figure 2.13 Effect of agaric acid. SBP. HCP and A tr on the DNP 
stimulated ATPase activity
The mixture (final volume 1.0 m l) contained 50 mM Tris-HCl, pH 7.4, 
75 mM KCl, 1 mM EDTA, 0.1 M sucrose, 0.003 M MgCl2, 10 mM ATP, 
1.0 mg of mitochondrial protein, 0.1 mM DNP. A fter an incubation 
period of 5.0 min, the reaction was stopped. Temperature 30°. 
Results expressed as mean of four experiments ± S.D.
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Figure 2.14 Effect of agaric acid. Atr. SBP and HCP on 
submitochondria 1 particles ATPase 
The mixture (final volume 1.0 ml) contained 50 mM Tris-HCl, pH 
7.4, 75 mM KC1, 1 mM EDTA, 0.1 M sucrose, 0.003 M MgClj,
10 mM ATP, 1.0 mg of submitochondrial particles protein. After 
an incubation period of 10 min, the reaction was stopped. 
Temperature 30°. Results expressed as mean of four experiments
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The effect of HCP on DNP-stimulated mitochondrial ATPase
activity was also — ~  as shown in Fig. 2.13. HCP has
virtually the same effect as SBP on ATPase activity. However, HCP 
■
(20 pM) caused 17% inhibition of submitochondrial particles ATPase 
activity, as compared with 9% inhibition caused by 20 pM Atr. These 
results on the effect of HCP on ATPase activity are in agreement with 
the inhibition of adenine nucleotide translocation.
2.4 DISCUSSION
Atractyloside, a potent inhibitor o f mitochondrial adenine nucleotide 
translocator (Pfaff et a l.. 1965) and ADP binding (Bruni et a l.. 1964) was 
also shown to inhibit Dinitro-phene -stimulated mitochondrial ATPase 
and has no effect on the ATPase of submitochondrial particles (Henderson 
and Lardy, 1970). Due to the Importance of atractyloside and bongkrekic 
acid, they were used in the present work compariMhe results of the 
inhibitors SBP, HCP and agaric acid with their effects.
The results of the present work suggest that SBP, AA and HCP at the 
concentrations mentioned under the "Results" section, are powerful 
inhibitors of oxidative phosphorylation. The effects of SBP, AA and HCP 
on ADP translocase were substantiated when it was found that these 
compounds inhibit the mitochondrial ATPase activity and is inactive on 
ATPase activity of submitochondrial particles. Thus, they are similar 
to the potent inhibitors of adenine nucleotide translocation, namely Atr, 
CAT and BkA (Leucianl et a L , 1971; Vignais et a l.. 1973$.
SBP and AA,which compete with the ADP translocase, were also 
found to compete with the ADP binding in rat liver mitochondria; thus 
SBP and AA are similar to Atr which competes with ADP translocation 
and binding (Weidemann^taL, 1970; Vignais et ad., 1973a;
Kllngenberg, 1976).
The influence of SBP on the rate o f adenine nucleotide translocation 
could Involve an effect on (a) the binding of Adn to the Atr-sensitive 
binding sites on the translocase protein, (b) the translocation of Adn
across the mitochondrial inner membrane or (c ) an effect on a 
combination of those processes. The present results show that, in 
depleted mitochondria (from endogenous Adn ), SBP inhibits the binding 
of ADP to the Atr-sensitive binding sites, and also it inhibits the rate 
of ADP translocation in native rat liver mitochondria.
It was suggested by Chavez and Klapp (1975) that the mechanism by 
which agaric acid inhibits adenine nucleotide exchange was that the 
citrate moiety of agaric acid interacts with the carrier. This inter­
action would be stabilized by hydrophobic interactions between the 
alkyl chain of AA and the hydrophobic phase of the membrane.
The mechanism by which HCP inhibits Adn translocation in the rat 
liver mitochondria is not clear at this time. Several possibilities are 
currently under examination, one of which involves interaction of the 
HCP with the lipoprotein translocator. Results presented in Chapter 
3 indicate:the dependence of HCP binding on mitochondrial membrane 
phospholipid. Other work (by Thorne and Bygrave, 1974; Klingenberg 
_et j i l . , 1975; Spencer and Bygrave, 1972 and 1974y provides strong 
evidence for the direct involvement of phospholipid in Adn translocation. 
The second possibility of inhibition of ADP uptake by HCP may be due 
to its uncoupling effect.
The inhibition of ADP uptake by uncouplers in RIM observed in the 
present work, may be explained according to the suggestion of Klingenberg 
(1975) that in the uncoupled state the exchange with ADP is strongly 
decreased, first of all since less ATP is available for the exchange. The 
comparison with the unenergized state with a high ADP content suggests 
that energy even increases the rate of influx o f ADP. The apparent 
specificity for the entry depends strongly on the energization of the 
membrane which appears to increase the rate of entry of ADP but 
strongly inhibits the entry of ATP. This is in line with the assumption 
that the membrane potential is the main factor controlling the active 
transport by preventing the entrance of an excess of negative charges 
during the ATP-ADP exchange. The abolishment of membrane potential 
and abolishment of the asymmetric exchange by uncouplers or valinomycin 
plus K+ was also confirmed by Vlgnais (1976).
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It can be concluded from this chapter tha^SBP and AA are potent
Inhibitors o f oxidative phosphorylation. They compete with ADP
translocase, while HCP is uncompetitive with ADP translocase.
(
2( 4-dinitrophenol stimulated mitochondrial ATPase was also 
inhibited by SBP( AA and HCP. It is more likely that SBP and AA 
are similar to Atr f while HCP has some properties similar to BkA.
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CHAPTER 3
3h - a t r a c t y l o s id e . 14c -h e x a c h lo r o ph e n e  a n d  
RHODAMINE 6G BINDING TO MITOCHONDRIA
3.1 INTRODUCTION
Atractyloside (A t r ) , one of the toxic compounds of the Mediterranean
thlstlef Atractylis Gummifera. exerts a powerful inhibitory effect on
oxidative phosphorylation in mitochondria (for reviews, see Bruni et al..
1966; Chappell, 1968; Heldt, 1969). The history of Atr research spans
a period of more than one century. It began in 1868 when Lefrance
(1868) succeeded in crystallizing Atr, an important achievement which
opened the way to chemical, toxicological and biochemical studies.
The molecule of Atr is formed of one glucose moiety, a diterpene
nucleus, two sulfate groups and one residue of isovaleric acid (Fig. 1.4).
Its injection into mammals leads to an acute hypoglycemia, causing
convulsions as shown especially by the Italian School of Santi and by
Stalnslas in Algiers in the period 1955 to 1960. Atractyloside toxic
effects were identified to an inhibition of mitochondrial respiration and
ATP synthesis (Bruni et a l . . 1962). Studies undertaken in the same
period by Vlgnais et al. (1961 and 1962) showed that Atr was able to
block partial reactions of oxidative phosphorylation in mitochondria,
such as the ATP-Pi exchange and the 2, 4-dinitrophenol-stimulated
ATPase activity.
35( S)-labelled Atr was recently obtained from Atractylis Gummifera 
35grown in the presence of ( S)-sulfate. By using these radioactive
35
compounds, it was possible to show that ( S)-Atr binds selectively 
and with very high affinity to the inner mitochondrial membrane 
(Klingenberg et al_., 1975,; Vignais and Vignais, 1970; Vlgnais et al.. 
1970). These features qualify Atr not only as a probe to analyse at the 
molecular level the mechafiism of the ADP transport in mitochondria, 
but also as a tracer to follow the course of the purification of the ADP 
carrier, an important objective for the ultimate elucidation of transport 
mechanism.
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Thus It is of use to study the effect of the new inhibitors of
adenine nucleotide translocase> especially sulfobromophthalein,
3
agaric acid and hexachlorophene on H-Atr binding to mitochondria .
It has been shown that HCP is a potent uncoupler of oxidative 
phosphorylation in liver mitochondria in vitro (Caldwell et ah, 1972; 
Cammer and Moore, 1972) as well as in liver mitochondria isolated 
from rats dosed with HCP (Caldwell^t ah, 1972).
HCP is known to hydrogen -bond strongly to proteins (Hague and 
Buhler, 1972). Therefore a variety of factors may be active in 
the production of the toxic effects of HCP, including both direct actions/ 
such as binding by HCP to protein, and/or indirect actions, such as 
uncoupling.
Due to the importance of HCP in inhibition of mitochondrial ions 
transport systems and other related mitochondrial functions, the 
present work was carried out on HCP binding in an attempt to correlate 
its inhibition effects and its binding properties.
The binding of rhodamine 6G (Rh6G), a lipophilic fluorescence dye, 
was shown by Huang£t ah (1969), who studied the binding of Rh6G to 
phosphatidyl choline vesicles. Gear (1974) showed that this dye is 
positively charged at pH 7, compared to its close relative, rhodamine 
B, which Is not. Some studies on Rh6G by Huang et ah (1969) pointed 
to specific binding with well characterized liposome preparations.
It was found that Rh6G strongly inhibited both oxidative phosphoryl­
ation and ATP-supported ion transport, while having little action on 
respiration driven cation uptake by mitochondria (Gear, 1974). 
Interestingly, 2, 4-dinitrophenol-stimulated ATPase was not inhibited 
at all. Concentrations above 10 |iM began to uncouple respiration and 
Inhibit respiration-driven cation transport.
Results of the present study show that Rh6G Inhibits some
32mitochondrial functions, e.g. ATP- Pi exchange reaction and ATP- 
supported calcium transport. Thus it is of use to study Rh6G binding 
to mitochondria in order to correlate between its Inhibition effects 
and its binding properties.
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3.2 MATERIALS AND METHODS 
Materials
3 3H-Atractyloside ( H -Atr) was synthesised by decarboxylation
of carboxyatractyloside in tritiated water (K. Cain and D.E. Griffiths,
14 14unpublished results). Methylene- C-hexachlorophene ( C-HCF) 
was obtained from New England Nuclear Industries, Ltd. Amytal 
(5-etlyl -5-isoamyl barbituric acid) and procaine hydrochloride were 
obtained from Sigma Chemical Co., Kingston-upon-Thames, U.K.
All other inhibitors, uncouplers, ionophorous antibiotics and local 
anaesthetics were obtained from the same sources that were 
mentioned in Chapter 2. A ll other chemicals were of A .R . grade.
The Eppendorf fluorimeter apparatus was obtained from Netheler 
and Hinz GmbH, Hamburg.
Methods
Preparation of mitochondria *3
Rat liver mitochondria and submitochondrial particles were prepared
as described in Chapter 2.
3 14Estimation of H-Atr and C-HCP binding
Liver mitochondria or submitochondrial particles (1 mg protein)
were Incubated for 10 min in 2 ml buffered sucrose (0.25 M sucrose,
1 mM EDTA, 10 mM Tris-HCl, pH 7.4) in cellulose nitrate tubes at
0° with varying amounts of ^H-Atr or ^C-HCP in the presence or
absence of Inhibitors. After an incubation period of 5 min, the tubes
were centrifuged at 5° at 10000 x g for 15 min (for mitochondria) and
80000 x g for 30 min (for particles). The supernatant and pellet were
separated and the tubes drained and wiped free from supernatant. The
pellet was dissolved in 1 ml of 2% w/v Triton X-100 for scintillation
counting of bound atractyloside or HCP and a 1 ml sample of the
supernatant was added to 9 ml of scintillation mixture (Triton X-100,
3
500 ml; toluene, 1 litre and butyl BPD, 7 g )  to determine free H-Atr. 
The results were plotted by the procedure of Scatchard (1949). B = 
bound; F = free; B/F = bound/free; n = number of binding sites.
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Estimation of rhodamine binding to mitochondria
Liver mitochondria (1 mg protein) were incubated for 5 min in 2 ml 
of 0.25 M sucrose, 10 mM Tris-HCl( pH 7.2, 10 mM KC1, 5 mM 
potassium phosphate, 5 mM MgCl2, 0.2 mM EDTA at 0° at varying 
concentrations of rhodamine in the presence or absence of inhibitors. 
After incubating for 5 min the tubes were centrifuged at 10000 x g for 
15 min. The amount of bound dye was determined from the flM. ®v"- 
e se v\ ce of the dye in the supernatant, using an Eppendorf 
fhiorimeter, with excitation filter 366 nm and an emission band pass 
of 530-3000 nm.
Extraction and rebinding of phospholipid to mitochondria
Phospholipid-depleted mitochondria were prepared according to the
method of Fleischer£t aL (1967 ), using 1 volume mitochondrial
suspension and 24 volumes of a mixture o f 90% acetone + 10% water +
12 pi NH„ at 0°. Mitochondria collected by centrifugation at 10000 x g o
followed by washing twice with buffer (0.25 M sucrose, 10 mM Ttis-HCl, 
pH 7.4). The restoration of the phospholipid content was obtained, 
using the individual phospholipids, according to the method of Scarpa 
and Azzone (1969). Phospholipid-depleted mitochondria corresponding 
to 20 mg mitochondrial protein were incubated at 0°  in a medium 
containing 0.25 M sucrose, 10 mM Tris-HCl (pH 7.4) and either 50 mg 
(lecithin) or 25 mg (cardiolipin^or 50 mg (asolectin^or 25 mg 
(phosphatidylethanolamine)( or 25 mg (phosphatidylinositol) in a total 
volume of 2 ml. After an incubation time of 10 min, the mitochondria 
were sedimented at 10000 x g and washed twice with the sucrose-Tris 
medium at 0°  in order to remove the unbound phospholipid present in 
the supernatant.
Measurement of radioactivity
14C and 3H were counted in a Packard Tricarb Liquid Scintillation 
counter in a X-100/toluene/butyl/PBD scintillation mixture (Patterson 
and Green, 1965).
K M u a p p R  .1 "
3.3 RESULTS
Actractyloside binds to the inner mitochondrial membrane which
specifically contains high affinity atractyloside binding sites; only
low affinity binding sites are found in the outer membrane. The Atr
binding characteristics are in good agreement with the fact that the
mitochondrial transport system of ADP and ATP is located in the
inner membrane (Vignais_et al. t 19711»).
3
The characteristics of H-Atr binding to mitochondria are shown
in Fig. 3.1 ; the binding data can be resolved by Scatchard analysis
into two binding sites. The binding site with the highest affinity 
-8
(K = 5.4 x 10 M ) is present at a concentration of approximately 
0.175 nmol/mg protein, the lower affinity site (K^ = 7.7 x 10 M ) 
is present at approximately 0 . 28 nmol/mg protein concentration.
The concentration of high affinity sites has been shown by other 
workers to be 0.15-0.16 nmol/mg protein (Bruni et a l.. 1965; 
Klingenberg et a l.. 1972) in agreement with the results obtained in 
the present work. Figure 3.1 shows that ADP (200 ) completely
abolished the high affinity site, a result which confirms the previous 
findings by Vignais_et a_l. (1971b, 1973a, 1973b). Moreover, the
3
high affinity site o f H-Atr was also completely abolished by SBP 
(F ig. 3.2) and by agaric acid (Fig. 3.3). However, these competitive
3
inhibitors have no effect on H-Atr low affinity site.
On the other hand, HCP in concentration of 24.5 nmol/mg protein
' 3
or 49 nmol/mg protein did not affect the binding affinity of H-Atr to
mitochondria (F ig. 3 .4 ). However, the concentration of high affinity
sites is diminished; the influence of HCP therefore appears to be
non-competititve, a finding which is similar to the effect of bongkrekic
acid on Atr binding shown by Vignais^t al_(1971a),which suggests that 
14 3the binding site of C-HCP and H-Atr are distinct but nevertheless 
can Interact with one another.
Atractyloside also binds to submitochondrial particles, which only 
contain the right-sided configuration, and the concentration of binding
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Figure 3.1 Effect of ADP on H-atractyloslde binding to mitochondria 
Experimental conditions as indicated under methods. The results are 
the mean of four experiments. High affinity site Low affinity site
K ,(M ) n(nmol/mg ) 
d
K.(M ) n(nmol/mg ) a
-#  t no ADP 
■ X + 200 pM ADP
5.4x10 0.175 7.7x10
-6 0.28
t
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Figure 3.2 Effect of SBP on H-atractyloside binding to mitochondria 
Experimental conditions employed were as indicated under Methods.
The results are the mean of four experiments.
High affinity site Low affinity site
K .(M ) n(nmol/mg) 
d
K^(M ) n(nmol/mg )
no SBP 5 .4x 10
-8 0.175 7.7x10 0.28
O - O +24 nmol SBP/mg protein
•
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Figure 3.3 Effect of agaric acid on H-atractyloside binding to mitochondria 
Experimental conditions employed were as indicated under Methods. The 
results are mean of four experiments.
High affinity site Low affinity site
K .(M) n(nmol/mg) K .(M ) n(nmol/mg)d a
5.4x10
-8 0.175 7.7x 10-6 0.28
O
•  ' no agaric acid
O, + 49 nmol agaric 
acid/mg protein
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Figure 3.4 Effect of HCP on H-atractyloside binding to mitochondria. 
Experimental conditions as Indicated under Methods. The results are
mean o f five experiments.
• — — • , no HCP
x — + 24.5 nmol HCP/mg protein
o — O, + 49 nmol HCP/mg protein
High affinity site Low affinity site
K jiM ) n(nmol/mg) K ,(M ) n(nmol/mg) 
d _________ o ________
5.4x10 ' 8 0.175 7.7x10"6 0.28
5.7x10 ’ 8 0.110
5.6 x 10"8 0.045
it was found that the addition of 2, 4-DNP (56 nmol/mg) or Rh6G (2-100
3
nmol/mg) or FCCP (40 nmol/mg) had no effect on the binding of H-Atr 
(0 .3  nmol/mg protein) to mitochondria.
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sites are less than those In intact mitochondriai and these have 
been Interpreted to reflect inaccessibility of the binding sites to 
atractylate because of inversion of membranes (Klingenberg et a l.. 
1975). The-effect of SBP, agaric acid and HCP on ^H-Atr binding 
was also extended to submitochondrial particles (Fig. 3.5). It is 
shown that SBP( agaric acid, HCP and bongkrekic acid caused not
3
more than 80% inhibition of H-Atr binding. These results are in
agreement with Klingenberg et al. (1974) who found that BkA decreases 
35
S-Atr binding in submitochondrial particles^
From the above results, it can be concluded that ADP, SBP and 
3
agaric acid antagonize H-Atr binding to its inhibitory site.
14The characteristics of C-HCP binding to mitochondria are
shown in Fig. 3.6. The binding data can be resolved by Scatchard
analysis into two binding sites. The binding site with the highest 
-8
affinity (K^ = 2 .2  x 10 M ) is present at a concentration of 
approximately 0.25 nmol/mg protein, the lower affinity site (K =
_5 a
1 .5x10  M ) is present at approximately 40 nmol/mg protein. The 
14characteristics of C-HCP binding to submitochondrial particles
are shown in Fig. 3.7. The binding site with the highest affinity 
-8(K j = 2.5 x 10 M ) which is similar to that in mitochondria and is
present at a concentration of 0.4 nmol/mg protein, which is nearly
two times more than that of intact mitochondria. The lower affinity
-5
site in submitochondrial particles (K^ = 0.9 x 10 M ) is more or 
less the same as that in the intact mitochondria and is present at a 
concentration of approximately 34 nmol/mg protein, which is slightly 
less than the value found in intact mitochondria.
Tables 3.1, 3.2 and 3.3 show that the binding of ' ‘C-HCP to 
mitochondria is not affected by ADP, inhibitors, uncouplers of oxidative 
phosphorylation, ions, local anaesthetics and temperature. The
results obtained in the experiments carried out on the relationship 
14between C-HCP binding and phospholipid composition of mitochondria 
are shown in Fig. 3. 8, and clearly show the importance of phospholipids
14,
• M M A*
«
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3
Figure 3. 5 Inhibition of H-Atractyloside binding to submito- 
chondrial particles
3
Experimental conditions as indicated under Methods. H-Atractyl­
oside concentration used was 1 nmole/mg protein.
X -------X, C -Atr; • --------•  t BkA; A ------ -A ( agaric acid;
■ -------■  , SBP; O -------O, HCP.
The results are expressed as mean of four experiments ± S.D.
Binding assays were carried out as described under Method.
14C-HCP was added at concentrations ranging from 0.15 to 5
nmole/mg. The results are expressed as mean of four experiments.
High affinity site Low affinity site
K 2 . 2 x 1 0 ' ® M  1.5 x 10"5 Ma
n 0 .2 5  (nm ol/m g) 40 (nmol/mg)
mV it V-
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Binding assays were carried out as described under Methods. 
14
C-HCP was added at concentrations ranging from 0.15 to 15 
nmole/mg protein. The results are expressed as mean of four
experiments. High affinity site 
-8
Low affinity site 
-5
Kd 2.5 x 10 M 0 .9x10  M
n 0.4 (nmol/mg ) 34 (nmol/mg)
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14
The reaction medium contained 0.25 M sucrose, 1 mM EDTA, 10 mM Tris-HCl, 
pH 7.4 and 1 mg of mitochondrial protein (in a total volume of 2 ml at 0 °).
Inhibitors were incubated for 10 min with the mitochondria before the
14 14addition of C-HCP. 5 min after the addition of C-HCP, the suspension
was centrifuged at 10000 x g for 15 min and the pellets were assayed for
radioactivity as previously described.
TABLE 3.1
Effect of ADP. inhibitors and anaesthetics on C -HCP binding to
mitochondria
Inhibitor Concentration 
(nmol/mg protein)
14C -HCP concentration 
(nmoles)
14C-HCP bound 
(nmol/mg protein)
No inhibitor — 2.5 1.27 - 1.63
ADP 200-1600 2.5 1.48 - 1.80
Atractyloside 5-45 2.5 1 .42-1 .52
Carboxyatractyloside 26-52 2.5 1 .42 -1 .45
Bongkrekic acid 24-48 2.5 1.27 -1.37
SBP 2-48 2.5 1.39 -1 .52
No inhibitor — 0.5 0.29 - 0.37
ADP + 200 0.5 0.35
2 - 4  mM MgC^ 
ADP + 200 0.5 0.36
2 - 4  mM CaCl2 
Agaric acid 12-226 0.5 0.27 - 0.28
Rh6G 10-200 0.5 0.31 - 0.37
Amytal 110-220 0.5 0.34 - 0.37
Procaine hydrochloride 90-180 0.5 0.33 - 0.35
Butacaine 70-140 0.5 0.35 - 0.36
Valinomycin 10-20 0.5 0.34 - 0.35
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TABLE 3.2
The protocol for this experiment is the same as in Table 3.1. The
concentrations of DNP and FCCP were 10 pg/mg protei^and pep was
14
Effect o f uncouplers on C-HPC binding to mitochondria
5 -5 0  ng/mg protein.
14C-HCP bound (nmol/mg protein)
14
C-HCP concentration 0.25 0.5 2.5 25 2.50
(nmol/mg)
Control 0.16-1.17 0.30-0.32 1.18-1.42 9.43-9.00 45.38-55.45
DNP 0.15-0.17 1.27-1.32 9.53-9.70 45.4-47.2
FCCP 0.17-0.18 1.17-1.22 8.91 -9.50 49.8-50.3
pep — 0.29-0.32 — — —
TABLE 3.3
14Effect of incubation period and temperature on C-HCP binding to 
mitochondria
14Binding assays were carried out as described in Table 3.1. C-HCP was 
added at concentrations of 0. 5 nmol/mg protein. The results are expressed 
as mean of three experiments.
Period of incubation 
of 14C -HCP with 
mitochondria (sec)
14C -HCP bound 
(nmol/mg)
Temperature of 
incubation ( °C )
14C-HCP bound 
(nmol/mg)
0 0.29 0 0.31
15 0.33 10 0.34
30 0.35 20 0.34
45 0.33 30 0.34
60 0.34 40 0.33
110 0.32 50 0.34
130 0.32 60 0.33
150 0.32 70 0.33
C
-H
C
P 
bo
un
d 
(n
m
ol
/m
g 
p
ro
te
in
)
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Composition of mitochondria
Extraction and rebinding of phospholipids was carried out as described 
under Methods. Binding assays were carried out as described in Table 
3.1. The results are expressed as mean of three experiments ± S.D.
W
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importance of phospholipids in the low affinity binding sites of HCP.
14C-HCP in a concentration of 18 yM, the depletion of phospholipid
resulted in a decrease of about 40% in the mitochondrial capacity to 
14
bind C-HCP. When asolectin was reconstituted to the mitochondria,
14there was a slight increase in the amount of C-HCP bound. Mito­
chondria reconstituted with lecithin,, on the other hand were 
14
able to bind C-HCP to a greater extent than the untreated mitochondria, 
14
whereas the amount of C-HCP bound was nearly 1.7 times higher in
the case of cardiolipin. However, HCP is unlike other uncouplers
such as 2-azido-4-nitrophenol (NPA) slnceNpA binding site appears
not to involve the hulk of the mitochondrial lipids, and prior removal
of more than 80% of mitochondrial lipids with aqueous acetone did not
change the extent of NPA binding (Hanstein and Hatefi, 1974).
Since HCP is known to bind strongly to bovine serum albumen (BSA )
(Flores and Buhler, 1971 ) it was of interest to study the removal of 
14
C-HCP from mitochondria by consecutive washes with buffered 0.25 M
sucrose with or without added BSA (Fig. 3 .9 ). It was found that,
after three washes with 0.25 M sucrose buffer, more than 74% of the 
14original C-HCP was retained with the mitochondrial pellets. After
a single wash with the BSA-containing medium, only 18% of the 
14original C-HCP remained bound. These results are in agreement
with Caldwell et al. (1972). who carried out similar experiments on
rat liver mitochondria after intraperitoneal injection of the rats with 
14
a lethal dose of C-HCP (30 mg/kg). The above results show that 
HCP Is not covalently bound to mitochondria.
TABLE 3.4
Comparison between the binding of rhodamine compounds to mitochondria 
The experimental conditions as described under Methods. The results 
are expressed as mean of five experiments ± S.D.
14
C-HCP binding to mitochondria. This may be related to the
Rhodamine concentration 
(uM)
Rhodamine bound 
(nmol/mg protein)
Rh6G 50 36.0 ±2 .2
Rh3G 50 6.5 ± 1.0
RhB 50 0.0
RhS 50 0.0
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FJghye_3._9 Effect of washing on ^C-HCp binding to mitochondria
The wash medium represented by ( • ------- • )  contained 0.25 M
sucrose, 1 mM EDTA, 10 mM Tris-HCl( pH 7.4, while that
represented by ( O------- o )  contained 0.25 M sucrose, 1 mM EDTA,
10 mM Tris-HCl, pH 7.4 and 30 mg bovine serum alhamen. 2 sets of
four assay tubes containing mitchondria (10 mg protein/7 ml washing
14 omedium) and 0.5 nmol/mg C-HCP were incubated for 10 min at 0 .
After centrifugation the supernatant were decanted. Aliquots of pellets
14were examined for protein and C-HCP content after each wash. The 
pellets were resuspended in 7 ml of washing buffer and recentrifuged. 
This procedure was repeated a further three times.
The zero wash does not contain BSA.
The results expressed as mean of four experiments ± S.D.
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In studies of the binding of rhodamine compounds by mitochondria 
(Table 3.4) it was found that Rh6G bound to a greater extent followed 
by Rh3G. However, RhB and RhS did not bind to rat liver mitochondria. 
The results on Rh6G and RhB are in agreement with those obtained by 
Gear (1974) who showed that RhB, a free acid uncharged at pH 7, was 
completely without influence on mitochondrial energy-linked functions. 
The characteristics of Rh6G binding to mitochondria are shown in Fig. 
3.10, and the binding data analysed by Scatchard plot showed the 
presence of only one high affinity binding site, with a = 1 . 3x10   ^M 
present at a concentration of approximately 50 nmol/mg protein.
Leucinostatin, the ionophorous antibiotic, in a concentration of 1.28 
to 3.2 nmol/mg protein, slightly inhibits Rh6G binding affinity and also 
decreases the number of binding sites from 50 to 32 nmol/mg protein 
(Fig. 3.10). The same figure shows that calcium added in a 
concentration of 90 nmol/mg did not affect the affinity of Rh6G to 
mitochondria . However, the number of high affinity sites is decreased 
to 16 nmol/mg protein; the influence of calcium appears to be non­
competitive . Similar effects to calcium on Rh6G binding were found 
with TET and DBCT (Fig. 3.11). Valinomycln and 1799 (Fig. 3.12) 
caused a slight decrease of both the affinity and the number o f binding 
sites. It was also found that,anaesthetics, such as butacaine and amytal 
also inhibit the binding of Rh6G to mitochondria (Fig. 3.13).
The results of the present study show that with 50 nM Rh6G the 
amount of Rh6G bound is 35-40 nmol/mg protein, which is similar to 
the finding of Yaginuma et al. (1973).
On the other hand, it was found that (Table 3.5) the period of 
incubation of Rh6G with mitochondria, the temperature of incubation, pH 
and the inhibitors of oxidative phosphorylation, have no effect on Rh6G 
binding.
An experiment carried out on the relationship between Rh6G binding 
and phospholipid composition of mitochondria is shown in Fig. 3.14.
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Figure 3.10 Effect o f leucinostatin and calcium on Rh6G binding to 
mitochondria
The experimental conditions as described under Methods. The results 
are mean of four experiments.
• ------ •  ,
X ------ X,
■ ------ " ,
O,
K d ( M )
no inhibitor 1.3 x 10
+ 1.28 nmol/mg^ leucinostatin 2 .5x10  
+ 3.2 nmol/mg^ leucinostatin 2.8 x 10 
+ 90 nmol/mg^CaC^ 1 .6x10
n(nmol/mg protein )
50
44
32
O 16
IFigure 3.11 Effect of TET and DBCT on Rh6G binding to mitochondria 
The experimental conditions as described in the Methods. Results are
mean of three experiments.
K j(M  ) n(nmol/mg protein )
•  — — •  t no inhibitor 1.3 x 10’ 5 50
X — X, + 40 nmol/mgTET 1.5 x 10 "5 24
A — +31 nmol/mg^ DBCT 1.6 x io  5 12
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Figure 3.12 Effect of valiaomycin and 1799 on Rh6G binding to mitochondria 
The experimental conditions as described in the Methods. Results are mean 
of three experiments.
no inhibitor
Kd(M ) 
1.3 x1 0 ‘ 5
O, +9  nmol/mg/valinomycin 
■ X, +25 nmol/mg/1799
4.4 x 10 
6.6 x 10
-5
n(nmol/mg protein)
50
44
40
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Figure 3.13 Effect of butacaine and amytal on Rh6G binding to 
mitochondria
The experimental conditions as described in the Methods. The 
results are expressed as mean ± S.D. of three experiments.
• no inhibitor
0 — 0. + 4 y,mol/mg butacaine
X ---- X. + 1 y,mol/mg amytal
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TABLE 3.5
Effect of incubation periods, temperature and pH on Rh6G binding to 
mitochondria
The experimental conditions were as described under Methods. Rh6G 
concentration, 50 pM. pH was adjusted with Tris-HC1. The results are 
expressed as mean o f four experiments ± S.D. Inhibitors incubated for 
10 min with mitochondria before adding Rh6G._________________________
'eriod of incubation o f Rh6G with 
the m itochondria
Rh6G bound 
nm ol/m g protein
0 sec 33 ± 3.1
7 sec 38 ± 3 .3
15 sec 34 ± 2 .5
60 sec 33 ± 1.9
3 min 36 ± 2 .0
5 min 34 ± 2.6
10 min 34 ± 1 . 8
T em peratu re  of incubation medium (° c)
0 34 ± 2.9
5 36 ± 3 .0
10 33 ± 2 .4
15 37 ± 1 .8
20 35 ± 2 .0
25 36 ± 3.1
30 33 ± 2 .7
pH of incubation medium
6 .0 36 ± 3 .3
6 .5 35 ± 2 .8
7 .0 37 ± 2.9
7 .5 34 ± 2.1
8 .0 33 ± 1.9
8 .5 35 ± 2 .4
9 .0 36 ± 3 .2
/continued
TABLE 3.5 (continued)
Inhibitors Concentrations 
(nmol/mg)
Rh6G bound 
nmol/mg protein
No Inhibitor — 35 ± 2.4
Atractyloside 1-100 35 ± 2.4
Carboxyatrac ty lo s ide 1-100 35 ± 2.4
Bongkrekic acid 0.5-46 35 ± 2.4
Sulfobromophthalein 6-660 35 ± 2.4
Agaric acid 6-660 35 ± 2.4
Figure 3.14 Relationship between Rh6G binding- and phospholipid composition 
of mitochondria
Extraction and rebinding of phospholipids and binding assays were carried out 
as described under Methods. Asolectin and cardiolipin have similar effects 
to phosphatidylinositol. The results are expressed as mean of three 
experiments ± S.D.
This experiment; shows the necessity of mitochondrial phospho­
lipid in Rh6G binding. Rh6G in a concentration of 50 |j,M, the 
depletion of phospholipid resulted in a decrease of about 80% in 
the mitochondrial capacity to bind Rh6G. When lecithin was 
reconstituted to the mitochondria , there was a double increase 
in the amount of Rh6G bound. However, mitochondria 
reconstituted with other phospholipids (phosphatidyl inositol, or 
asolectin, or cardiolipin) were able to bind Rh6G to a greater 
extent than the untreated mitochondria, whereas the amount of 
Rh6G bound was nearly two times higher in the case of 
phosphatidyl-ethanolamine.
In order to find whether or not Rh6G is easily removed from
mitochondria, an experiment (Fig. 3.15) was carried out in which
Rh6G removed by consecutive washes with buffered 0.25 M sucrose.
It was found that Rh6G was completely removed from its binding
sites after four washes, with or without BSA. These results
shew that Rh6G is not covalently bound to rat liver mitochondria,
and also that-it is more easily removed from mitochondria as 
14
compared with C-HPC.
3.4 DISCUSSION
The results of the present study, Fig. 3.1, show that ADP
3
completely abolished the high affinity site of H-Atr in agreement
with the findings of Vignais_et jtl. (1971b; 1973a; 1973b). SBP and
3
agaric acid were also found to abolish the high affinity site of H-Atr,
3
which indicates clearly the interaction between H-Atr binding and
these inhibitors. However, HCP did not affect the binding affinity,
but it did decrease the number of high affinity binding site per mg
protein, indicating the noncompetitive type of inhibition. Other
3
uncouplers such as DNP and FCCP did not affect H-Atr binding to 
mitochondria (with Fig. 3 .4 ). These findings differentiate HCP 
from other uncouplers.
■
H
i
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The wash medium represented by ( • -------• )  contained the same
buffer mentioned in Methods^ while that represented by (O ------O)
contained the same buffer +50 mg bovine serum albumen. 2 sets 
of 4 assay tubes containing mitochondria (10 mg protein/10 ml 
washing medium) andlOO nmol/mg Rh6G were incubated for 5 min 
at 0°; after centrifugation, the amount of bound dye was 
determined from the abosrbance of the dye in the supernatant.
The pellets were resuspended in 10 ml of washing buffer and 
recentrifuged. This procedure was repeated a further four times.
After each wash the-protein concentration and Rh6G bound was examined. 
The zero wash does not contain BSA. The results are expressed as mean 
of four experiments ± S.D.
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Binding of HCP to membrane phospholipids could exclude the normal
3
membrane binding sites and thus affect H-Atr binding sites. This
confirms the findings of Vignais^t al_. (1973a) that removal of lipids
from mitochondria results in a striking decrease in the total amount
o f Atr binding. Further, Fig. 3.8 shows that HCP binding depends on
the phospholipid composition o f the mitochondrial membrane.
3
The effect of SBP, agaric acid, HCP, CAT and BkA on H-Atr 
binding to submitochondrial particles (right-sided particles ) (Fig. 3.5) 
show that SBP, agaric acid, HCP and BkA caused less than 80% 
inhibition. However, CAT caused nearly 90% inhibition. This great
3
inhibition of H-Atr binding by CAT,may be due to the high affinity of 
CAT which is about 25-fold higher than that of Atr (Scherer et a l..
1973).
14
The results presented in Table 3.1 show that the binding of C-HCP
to mitochondria is not affected by a variety of inhibitors, and also that
it is not affected by certain uncouplers (Table 3 .2 ). However, the
binding of other uncouplers such as NPA is competitively inhibited by some
uncouplers, e .g . DNP, PCP, Cl-CCP (Hanstein and Hatefi, 1974).
It was shown that the amount of HCP bound to mitochondria (after
Injection ) is directly proportional to the degree of uncoupling (Caldwell
et al_., 1972) and the chlorinated bisphenols have also been shown to
bind strongly to serum protein (Flores and Buhler, 1971), and to
various polypeptides (Hague and Buhler, 1972). Moreover, it is shown
14that in Fig. 3.8 the binding of C-HCP to mitochondria depends on the
mitochondrial phospholipids, especially lecithin and cardiolipin; thus
HCP differs from other uncouplers such as NPA whose binding site
appears not to involve the bulk of the mitochondrial lipids (Hanstein and
Hatefi, 1974). In this respect HCP binding is similar to atractyloside
and ADP binding (Klingenberg et_a_U, 1974; Vignais_et ah, 1973a).
14
Thus, C-HCP have properties of both uncouplers (e.g. FCCP) and 
Inhibitors (e.g. Atr and HcA) o f oxidative phosphorylation.
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The inhibition of Rh6G binding to mitochondria by leucinostatin( 
valinomycin, DBCT, TET, calcium and 1799 (Figs. 3.10, 3.11 and 
3.12) may be due to the disturbance of proton gradient in mitochondrial 
membranes.. According to the chemiosmotlc hypothesis of oxidative 
phosphorylation( uncouplers act by rendering the mitochondrial 
membrane freely permeable to protons, (Mitchell, 1961), since a 
proton is ejected into the medium (in exchange for Rh6G),in order 
to maintain electroneutrality (Yaginuma et a l. . 1973; Gear, 1974).
On the other hand, the inhibition of Rh6G binding to mitochondria 
by anaesthetics (butacaine and amytal) may be due to the disorder in 
membrane structure caused by anaesthetics (Spencer and Bygrave,
1974). These changes in membrane 'fluidity' probably reflect inter­
action of the anaesthetics with membrane phospholipid (Seeman, 1972; 
Fayle^t al_., 1975). Thus, the inhibition of Rh6G binding by butacaine 
and amytal may be due to the interaction of these anaesthetics with 
phospholipids, which form the phospholipid environment of the binding , 
leading to an alteration in Rh6G binding. The mechanisms by which 
anaesthetics interact:with these phospholipids is at present unknown, 
although it is likely (in the case of butacaine) to involve both electro­
static and hydrophobic interactions (Seeman, 1972).
The results of the present work (Fig. 3.14) indicate the importance 
of mitochondrial.phospholipids in Rh6G binding, and also support the 
suggestion that a lipid binding step is involved in the action of Rh6G 
(Gear, 1974).
The work in this chapter supports the findings shown in Chapter 2, 
that SBP and agaric acid are competitive inhibitors with both ADP
3
translocase and H-Atr binding. However, HCP competes with neither 
3
ADP translocase nor H-Atr binding. On the other hand, the present 
results show that the inhibitors of ADP translocase (e.g. Atr, BkA, CAT, 
SBP, agaric acid) have no effect on Rh6G binding, in agreement with 
the previous findings (Table 2.2) that Rh6G has no effect on ADP 
translocase, and in contrast to Gear (1974) who showed that Rh6G 
competes with adenine nucleotide binding to mitochondria.
4.1 INTRODUCTION
The reason for studying calcium transport and binding by 
mitochondria in the present work is related to the following facts :
(a) calcium is important in the regulation of a number of mitochondrial 
functions, and the calcium pumped in or out o f mitochondria may be an 
essential factor in the control of several reactions taking place in the 
cell (Table 1.1), (b) in biological membranes, the divalent cations,
J j  | |
chiefly Ca and Mg # seem to control the stability of the membrane 
by formation of a ternary complex between the anionic groups of a 
protein and a phospholipid molecule (Binet and Volfin, 1975b), (c ) 
calcium is needed to couple the electrical events of the membrane
j j
to the physiological response of the cell, and intracellular Ca may 
regulate the permeability of the cell membrane for both ions and 
neutral solutes (Seeman, 1972).
In the present study (Fig. 4.1 ) it was found that hexachlorophene 
(HCP) inhibits calcium-stimulated mitochondrial respiration. This 
inhibition of respiration may be due to prevention of calcium uptake 
by mitochondria, and this is the main reason which prompted us to 
carry out studies on the effect of HCP on calcium transport.
In view of the association between HCP binding and mitochondrial 
phospholipid composition (Fig. 3.8) and the inhibition of calcium 
uptake by HCP, the relationship between calcium binding and phospho­
lipid composition of mitochondria can be examined. Figure 4.7 
shows that DBCT and TET cause a release o f mitochondrial calcium 
in a way similar to that of HCP. The toxicological effects of TET 
and HCP are similar. In the present work, the effects of TET and 
DBCT on calcium transport and binding were studied. The effect of 
other uncouplers of oxidative phosphorylation and inhibitors, such as 
ruthenium red and Rh6G, and ionophorous antibiotics were also 
studied in comparison.
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CHAPTER 4
CALCIUM TRANSPORT IN MITOCHONDRIA
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3
Figure 4.1 Inhibition of calcium stimulated respiration in rat liver 
mitochondria by HCP.
Respiration was measured with a Clarke oxygen electrode in 3 ml of
0.25 M sucrose^ 20 mM Tris-HCl( 5 mM MgClj, 10 mM KC1, 5 mM
KH^PO^, pH 7.4 buffer at a temperature of 30°. Mitochondria (6.0
mg protein) were preincubated in the respiration buffer for 1 min
before adding 10 jil of 1.0 M succinate (S), 5 y,l of 50 mM of ADP and 10ul of
50 mM CaClj (Ca++) as indicated on the traces.
Trace 1 was a control experiment with 10 ul of ethanol added at A.
In trace 2, HCP in 10 u,l of ethanol was added (25 nmoles).
Trace 3 shows the inhibition of ADP stimulated respiration by HCP.
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The energy-linked uptake of calcium (Fig. 4.2) is inhibited by
(a) agents which block ATP hydrolysis, such as ollgomycin (Carafoll,
1975a) and probably TET, DBCT and Rh6G, (b) agents which inhibit
the respiratory chain (antimycin A ), (c ) agents which cause energy
dissipation like uncouplers of oxidative phosphorylation (e.g. DNP,
| |
1799) and probably HCP. However, Ca uptake is also inhibited 
by agents which inhibit the calcium carrier, such as ruthenium red 
(Moore, 1971).
In this chapter, the work done on the effect of HCP, Rh6G, DBCT 
and TET on calcium transport, binding and release by mitochondria, 
is reported with a view to assessing whether these inhibitors act on 
the calcium carrier or as an uncoupler of oxidative phosphorylation 
or block ATP hydrolysis or by combination of these effects.
U .K .). Hepes,ruthenium red, gramicidin D, EGTA, succinate,rotenone, 
and antimycin A were obtained from Sigma (London) Chemical 
Co., Kingston-upon-Thames, U .K. DBCT was a gift from Dr. K.
Cain (Department of Molecular Sciences, University of Warwick, England). 
Asolectin (soybean phosphatides) was purchased from Associated 
Concentrates (Woodside, N .Y . ). Lecithin (egg lecithin) was obtained
I j
Ca Transport
Respiratory chain
Respiratory inhibitors Oligomycin
---- ^ ------>  A 'ATP
Dissipation (uncoupling)
[ |
Figure 4.2 Energy-linked Ca transport in mitochondria (from
Carafoli et a l.. 1975a).
4.2 MATERIALS AND METHODS 
Materia Is
45CaC^ was obtained from the Radiochemical Centre (Amersham,
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from Lipid Products, (South Nutfield NR, Redhill, Sy). Cardiolipin 
(ex bovine heart), DL-3-phosphatidylethanolamine and phosphatidyl­
inositol were obtained from Koch-Light Laboratories, Ltd., (Colnbrook, 
Buckinghamshire, England). The other chemicals were obtained 
from the sources mentioned in Chapter 2. A ll other chemicals were 
of A .R . grade.
Methods
Preparation of mitochondria
Preparation of rat liver mitochondria and protein determination
were carried out as described in Chapter 2.
45 -H-Estimation of Ca uptake by mitochondria
The experimental conditions are essentially those described by 
Carafoli and Rossi (1971 ): the reaction medium (25°, 2 ml final 
volume) contained 80 mM NaCl, 10 mM sodium succinate, 10 mM 
Tris-HCl, pH 7.2, and 1.0 mg of mitochondrial protein. Inhibitors 
were incubated for 30 sec with the mitochondria before the addition 
of labelled calcium. At 20 sec after the addition of labelled calcium, 
the suspension was filtered by rapid Millipore filtration (as described 
in Chapter 2) followed by washing with 4 ml of incubation medium.
The radioactivity on the filters was used to calculate the amount of
45 ++Ca uptake.
45 ++
Estimation of Ca binding to mitochondria.
The experimental conditions are those described above by Carafoli
and Rossi (1971 ). Mitochondria were preincubated with 1 pM rotenone
and 0.5 pg antimycin A for 5 min followed by incubation with inhibitors
for 1 min before adding labelled calcium. 30 sec after the addition of
labelled calcium (0.4 - 80 nmol/mg protein) the suspension was
centrifuged at 10000 x g for 15 min, and the distribution of radioactivity
between the pellet and the supernatant was measured. Results expressed 
| | | |
as B=bound Ca (nmol/mg protein); F = free Ca (pM); B/F= bound/free 
and n = number of binding sites , as described by Scatchard (1949).
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Extraction and rebinding of phospholipid to mitochondria
Phospholipid-depleted mitochondria were prepared according to 
the method of Fleischer_et ah (1967), using 1 volume mitochondrial 
suspension and 24 volumes of a mixture of 90% acetone + 10% water 
+ 12 pul NH at 0°. Mitochondria collected by centrifugation at 
10000 x g, followed by washing twice with buffer (0.25 M sucrose,
10 mM Tris-H C l, pH 7.4). ^The restoration of the phospholipid 
content was obtained using the individual phospholipids, according 
to the method of Scarpa and Azzone (1969). Phospholipid-depleted 
mitochondria corresponding to 20 mg mitochondrial protein, were 
incubated at 0° in a medium containing^ in 2 ml: 0.25 M sucrose,
10 mM Tris-HCl (pH 7.4) and 50 mg (lecithin),or 25 mg (cardiolipin) , 
or 50 mg (asolectln),or 25 mg (phosphatidylethanolamine),or 25 mg 
(phosphatidyl-inositol); after an incubation time of 10 min, the 
mitochondria were sedimented at 10000 x g and washed twice with 
the sucrose-Tris medium at 0°, in order to remove the unbound 
phospholipid present in the supernatant.
The binding experiments were carried out essentially as described
by Scarpa and Azzone (1969), in 2 ml of medium (0.25 M sucrose, 10
mM Tris-HCl, pH 7.4 at 0 °). The added mitochondria (1 mg protein)
were preincubated for 5 min in the presence of 5 nM rotenone and 1 y,g
antimycin A, and incubated for 5 min in the presence of labelled
calcium; the mitochondria were sedimented at 10000 x g for 15 min.
The pellets were washed twice in cold sucrose and the radioactivity
in the pellets was measured.
Measurement of radioactivity 
4SCa in a Triton X-100/toluene/butyl PBD scintillation mixture was 
counted using a Packard Tricarb Scintillation counter, as described in 
Chapter 2 (Patterson and Green, 1965).
i
4.3 RESULTS
Effect of pH on calcium transport
As Is shown in Fig. 4.3, It is clear that the calcium transport
Increases as the pH increases from pH 6.5 to 7.5. The results
indicate that there is little significant variation in V (nmol/mln/mg
protein) with pH values between 7.5 and 9.5. The results of the
present study are in agreement with the findings of Reed and Bygrave
(1975a), who showed that the rate constant for calcium binding is
largest at high pH. Conversely,the rate constant for calcium release
is highest at low pH.
ATP-supported calcium accumulation
The effect of ATP is known to promote the accumulation of calcium
by Isolated mitochondria (Carafoli and Rossi, 1971; Spencer and Bygrave,
1973; Brand and Lehninger, 1975; Jacobus et aL, 1975; Lazarewicz and
Hamberger, 1975; Sulet al_., 1976). This is in agreement with the
present work, shown in Fig. 4.4. It is clear from this figure that
Rh6G (12.3 pM) abolishes the ATP-stimulated calcium accumulating.
Jacobus et a_L (1975) showed that mitochondria have the ability to
transport calcium and that the process could be energized by either
the activity of the respiratory chain or the hydrolysis of ATP.
Factors affecting respiration driven calcium uptake by mitochondria
The Km value of calcium uptake (Fig. 4. 5) was found to be 13 pM
which is slightly more than the range (1-9 pM) determined by previous
workers (Carafoli and Azzi, 1972; Spencer and Bygrave, 1973;
Reynafarje and Lehninger, 1973; Carafoli£tal_., 1975b). The
difference may be due to the variations in the experimental methods.
The results shown in F ig. 4.6 indicate that ruthenium red Is a
powerful inhibitor of mitochondrial calcium uptake, in agreement with
the findings of several workers (Binet and Volfin, 1975a; Carafoli,
1975a; Sordal and Silver, 1975). Ruthenium red at a concentration of
9 nmol/mg caused an increase of the K value of calcium uptake nearly
m
sixty times, as shown by double reciprocal plots (Fig. 4.5).
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Figure 4.3 Effect of pH on calcium uptake
The experimental conditions are essentially those described by Reed
and Bygrave (1975b). Mitochondria (1 mg protein) were incubated
In 2 ml of 0.25 M sucrose, 2 mM Hepes, 2 mM succinate. The pH
o 45was adjusted with Tris . Temperature, 0 . CaCl2 was added to 
a final concentration of 200 y.M. The incubation lasted for 15 sec and 
was stopped by 1 ml of Incubation medium supplemented with 2 mM 
EGTA and 6 pM ruthenium red ; after 5 min the mitochondria 
separated by Millipore filtration (as described in Chapter 2), 
followed by washing with 3 ml of incubation medium . The results 
shown are the mean ± S.D. of three experiments.
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Experimental conditions are essentially those described by Spencer and 
Bygrave (1973). Mitochondria (1 mg protein) were incubated in 2 ml of
0.25 M sucrose, 0.5 pg antimycin A, 2 mM Hepes-Tris, pH 7.4 for 30
o 45 j j
sec at 25 with or without Rh6G, followed by addition of ATP and Ca
45 ++Ca added to a final concentration of 200 pM. The incubation lasted for 
30 sec and was stopped by rapid Millipore filtration, followed by washing 
with 2 m l of incubation medium.
Results expressed as mean of four experiments ± S.D.
O----- o , no Rh6G
X-------X. +12.3 pM Rh6G
i 'T * -
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Experimental conditions are essentially those described by Spencer and 
Bygrave (1973). Mitochondria (1 mg protein) were incubated in 2 ml of
0.25 M sucrose, 0.5 |ig antimycin A, 2 mM Hepes-Tris, pH 7.4 for 30
o 45 | |
sec at 25 with or without Rh6G, followed by addition of ATP and Ca
45 ++Ca added to a final concentration of 200 nM. The incubation lasted for 
30 sec and was stopped by rapid Millipore filtration, followed by washing 
with 2 m l of incubation medium.
Results expressed as mean of four experiments ± S.D.
O------- o  , no Rh6G
X------- X, +12.3 nM Rh6G
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Figure 4.5 Effect of ruthenium red. DNP and HCP on calcium uptake 
by mitochondria
The experimental conditions as described in Methods. Results are 
mean ± S.D. of four experiments.
•  -------•  , no inhibitor K (Ca++) = 13 nM
■ ------- ■ ,+9 nmol/mg> ruthenium red, (Ca• * * ) = 800 p,M
X ------- X,+0.2 nmol/mg, DNP, Km (Ca++) = 285 nM
□ ------- n+0.74 nmol/mg, HCP, K (C a ^ ) = 250 nM
A ------- A ,+ 0.24 nmol/mg, HCP
100
45 -H-Figure 4.6 Inhibition of Ca uptake by mitochondria
The same conditions as in Fig. 4.3.
The inhibitors incubated for 5 min with mitochondria at 0° before 
45 | |
the addition of Ca . pH 7.4.
O ------- O .+H CP; • --------•  , + ruthenium red; A -------A ,+R h 6 G .
In addition, Rh6G (48 nmol/mg protein) caused 65.1 ±6.7% inhibition 
of calcium uptake.
The results are expressed as mean ± S.D. of four experiments.
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Figures 4.5 and 4.6 show that HCP is a potent Inhibitor of calcium
uptake in mitochondria. HCP (0.74 nmol/mg) incsased the K value
m
of calcium uptake by nearly 20 times. When comparing the effect of
HCP (0.74 nmol)withthat of DNP (0.2 |imol/mg protein), (Fig. 4. 5), it
is apparent that HCP is nearly 300 times more effective than DNP.
The inhibitory effect of uncouplers on calcium uptake,found in the
present study, confirmed the previous findings of Renafarje and
Lehninger (1974) and Reed and Bygrave (1974b). Rh6G (12 nmol/mg
protein) caused 20% inhibition of calcium uptake (Fig. 4.6). However,
with higher concentration (48 nmol/mg protein) it caused 65%
| |
inhibition. The inhibition of Ca uptake by higher concentrations of 
Rh6G may be due to a Rh6G uncoupling effect, since Rh6G in higher 
concentrations uncouples oxidative phosphorylation (Gear, 1974).
Figure 4.7 shows that both DBCT and TET are similar to ruthenium 
red; DNP and HCP are uncompetitive inhibitors of calcium uptake 
since they affect both (nmol/20 sec/mg protein) and K . DBCT 
(31 nmol/mg) and TET (40 nmol/mg) increased the Km value of 
calcium uptake 13 times.
Maintenance of accumulated calcium in mitochondria
Table 4.1 shows that after 3 min of addition of 10 mM Pi and
calcium, there is a great release of mitochondrial calcium in agreement
with the results of Carafoli and Rossi (1971). Table 4.1 also shows
that the addition of HCP, 1799, Rh6G, DBCT, leucinostatin or X-537A
to mitochondria 3 min after the addition of calcium,caused a release o f
•mitochondrial calcium. A similar finding has been reported by
Carafoli and Rossi (1971), Vallieres_et ai. (1975) and Luthra and Olson,
(1976). The release of mitochondrial calcium by leucinostatin and
| |
X-537A/may be due to the release of mitochondrial Mg , as was shown 
by Blnet and Volfin (1975b) that the addition of an ionophorous antibiotic
| j | [
(A 23187) to Ca -loaded mitochondria induces a fast release of Mg-j |
followed by the efflux of Ca .
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Figure 4,7 Effect of DBCT and TET on calcium uptake 
The same conditions as described in Methods.
no Inhibitor K (Ca * m ' )  = 13 nM
158O -------O. + 31 nmol/mg DBCT K (Ca )
X -------X, + 40 nmol/mg, TET, Km (Ca4* )  = 158
The results are expressed as mean ± S.D. of four experiments.
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TABLE 4.1
Release of mitochondrial calcium by inhibitors, uncouplers and
t
lonophores
The experimental conditions are essentially those described by
Carafoli and Rossi (1971 ) and Carafoli^t al_. (1976). The
reaction medium (25°, 2 ml final volume) contained 80 mM NaCI,
10 mM sodium succinate, 10 mM Tris-HCl, pH 7.2 and 1 mg of
45 -H-mitochondrial protein. At zero time, 300 pM Ca was added, 
and the uptake was allowed to proceed for 3 min. 15 sec later, 
the compounds listed below were added. After a further 15 sec, 
the mitochondria were separated by Millipore filtration. The 
results are mean ± S.D. of four experiments.
45 -H-
Inhibitor Concentrations of 
inhibitors
Ca in mitochondria 
nmole/mg/prote in
— — 60.0 ±5 .2
*
Pi 20 wmole/mg protein 22.3 ± 2.4
HCP 2.46 nmole/mg protein 23.0 ± 3.0
Rh6G 12.4 nmole/mg protein 31.0 ± 2.7
DBCT 15.4 nmole/mg protein 11.0 ± 1.0
1799 12. 8 nmole/mg protein 11.0 ± 1.2
Leucinostatin 3.2 nmole/mg protein 20.0 ± 1.7
X-537A 8.5 nmole/mg protein 14.0 ±2.1
*
Pi incubated at zero time with calcium.
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Figure 4. 8 shows the results obtained by measuring the movement 
of protons in and out of mitochondria, with an expanded scale pH 
meter, to further elucidate the effect of HCP, ruthenium red, DBCT, 
TET, uncouplers, ionophorous antibiotics and respiratory inhibitors 
on calcium release. It was shown that the ejection of calcium 
induced by uncouplers is complete, and is at least as rapid as the 
uptake after membrane loading. HCP, DBCT and TET caused a 
release of calcium in away similar to DNP. Drahota et al. (1965) 
and Carafoll (1974a) showed that, if the energy flow is interrupted 
by uncouplers, the accumulated calcium leaves mitochondria down 
Its concentration gradient. In addition to uncouplers, a number of 
agents capable of inducing rapid release of calcium from mitochondria 
have been described, among them respiratory inhibitors (antimycin), 
lonophorous antibiotics (valinomycin), and, under some circumstances, 
ruthenium red. It is noteworthy that ruthenium red induces release 
only if added while calcium is being transported to its binding sites 
in the Inner membrane (Rossi_et a_l., 1973; Carafoli, 1974a). No 
release is observed if ruthenium red is added after the energy-linked 
accumulation of calcium has been completed (Fig. 4 .8 ). The present 
results on the effect of ruthenium red are in agreement with those of 
Carafoll (1974a).
*
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Figure 4. 8 shows the results obtained by measuring the movement 
of protons in and out of mitochondria, with an expanded scale pH 
meter, to further elucidate the effect of HCP, ruthenium red, DBCT, 
TET, uncouplers, ionophorous antibiotics and respiratory inhibitors 
on calcium release. It was shown that the ejection of calcium 
Induced by uncouplers is complete, and is at least as rapid as the 
uptake after membrane loading. HCP, DBCT and TET caused a 
release of calcium in away similar to DNP. Drahota et al. (1965) 
and Carafoli (1974a) showed that, if the energy flow is interrupted 
by uncouplers, the accumulated calcium leaves mitochondria down 
Its concentration gradient. In addition to uncouplers, a number of 
agents capable of inducing rapid release of calcium from mitochondria 
have been described, among them respiratory inhibitors (antimycin), 
lonophorous antibiotics (valinomycin), and, under some circumstances, 
ruthenium red. It is noteworthy that ruthenium red induces release 
only if added while calcium is being transported to its binding sites 
in the inner membrane (Rossi_et a_l., 1973; Carafoli, 1974a). No 
release is observed if ruthenium red is added after the energy-linked 
accumulation of calcium has been completed (Fig. 4.8). The present 
results on the effect of ruthenium red are in agreement with those of 
Carafoli (1974a).
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Figure 4. 8 Maintenance of accumulated Ca in mitochondria.
The experimental conditions are essentially those described by
Carafoli (1975b). Effect of respiratory inhibitors, uncouplers,
ionophorous antibiotics, DBCT, TET, ruthenium red and HCP.
| |
The movements of Ca were followed indirectly by measuring 
the opposite movements of protons in and out of mitochondria with 
an expanded scale pH meter. The reaction medium for experiments 
contained 80 mM NaCl, 2 mM Tris-HCl, pH 7.4, 5 mM sodium 
succinate and 2_4 mg of mitochondrial protein In a final volume of 
1.8 ml, at 25°. In the valinomycin experiment (* ), NaCl and 
sodium succinate were replaced by KC1 and potassium succinate 
respectively. The K+ -speciflc ionophore valinomycin induced 
release only in a K+ -containing medium, whereas the ionophore 
gramicidin was equally active in media containing either Na+ or K+*
;*r ■MM9 ■ (M
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Calcium binding by mitochondria
Three classes of calcium binding sites have been identified so
far (Carafoli and Rossi, 1971). The low affinity sites have a rather
large capacity for calcium, are probably phospholipid in nature, and
are equally distributed between the inner and outer membranes (Renafarje
and Lehninger, 1969 ; Carafoli and Gazzotti, 1973). From the results
expressed in Fig. 4.9, the number of low affinity sites were nearly
equal to 30 nmolq'mg protein and the value of was 4.4 x 10 ** M,
this confirming the previous results found by Rossi et al (1967 ),
Scarpa and Azzi (1968) and Carafoli and Lehninger (1971). The
results of the present study show that the number o f high affinity site
are 1.6 nmole/mg protein and that K = 3.5 x 10  ^M, within the
d 24-range reported previously (0. 5-2 nmoles of Ca /mg protein; =
0.1-1 |j,M), (Lehninger, 1969; Renafarje and Lehninger, 1969;
Carafoli and Sottocasa, 1974). A third class of inner membrane sites, 
specifically involved in the oxidation of a-glycerophosphate by the 
mitochondrial a-glycerophosphate dehydrogenase (Carafoli and Sacktor, 
1972) is probably not involved in the process of transmembrane 
calcium translocation.
Figure 4.9 shows that both ruthenium red and HCP abolished the
high affinity site of calcium binding, and that ruthenium red (9 nmol/mg)
has a slight effect on the low affinity site. However, HCP (1.28 nmol/mg)
decreased the number of low affinity site but had no effect on the K^.
The inhibition of calcium binding affinity by ruthenium red found in the
present study are in agreement with the findings of Carafoli (1974b),
Carafoli£t al_. (1974 ) and Carafoli and Sottocasa (1974). The effect
of DBCT and TET on the calcium binding is shown in Fig. 4.10. It is
clear that both DBCT (62 nmol/mg) and TET (78 nmol/mg) have no effect
on the K .; however both inhibitors caused a decrease in the number of 
d ’
high and low affinity sites. The number of high affinity site decreased 
from 1.6 to 0.8 nmol/mg protein in the presence of the inhibitors.
B (nmol/mg)
45 ++
Figure 4.9 Effect of ruthenium red and HCP on Ca binding. 
The experimental conditions as described in Methods. The results 
are mean of five experiments.
High affinity site Low affinity site
K .(M ) n(nmol/mg) K ,(M ) n(nmol/mg) 
d a
no inhibitor 3 .5x10"6 1.6 4 .4x10 '5 30.0• • .
+ 9 nmol/mg, 
ruthenium red
A  1 x .
1.5x10*4 25.0
o — O. + 1.28 nmol/mg, HCP 5x10*5 18.6
111
45 ++
Flgure 4.10 The effect of DBCT . TET and DNP on Ca binding.
The experimental conditions as described In Methods. The results are
mean of five experiments.
•---------•.
O --------O,
* --------- *
X.
no Inhibitors 
+ 62 nmol/mg, DBCT 
+78 nmol/mg( TET 
+0. 2 |imol/mg> DNP
High affinity site
K .(M ) n 
d (nmol/ mg )
3 .5x10 '6 1.6
2 x 10"6 0.8
2 x 10'6 0.8
Low affinity site
K ,(M ) n(nmol/mg) d
4.4x10 ^ 30.4
4.Ox io "5 25.2
3 .5x10 '5 21.2
1.25x10’ 4 32.0X
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Figure 4.10 shows that DNP (0.2 pmol/mg) blocks the high 
affinity site and decreases the low affinity binding site without 
affecting the number of low affinity site , confirming the previous 
works by Rossi et ah (1974).
Relationship between calcium binding and phospholipid composition 
of mitochondria.
The results shown in Fig. 4.11 indicate the importance of phospho­
lipids (e.g . phosphatidyl-ethanolamine( phosphatidyl-inositol, cardlo- 
lipln and asolectin) in calcium binding by mitochondria. According to 
Fleischer £t al_. (1967), the main phospholipid constituents of the 
mitochondrial membrane are lecithin, 43.3%,. phosphatidyl-ethanolamine, 
34.5% and cardiolipin, 17.2%. Minor components, including phospha- 
tldyl-inositol, make up 4.9%.
Another essential feature of artificial and natural membranes is the 
capacity to bind cations. According to previous reports, this property 
appears to be mainly dependent on the presence of phospholipids (Rojas 
and Tobias, 1965; Slater and Cleland, 1953).
The results of experiments on the role o f phospholipids in calcium 
binding are shown in Fig. 4.11. The depletion of phospholipids 
resulted in a decrease of about 66% in the mitochondrial capacity to 
bind calcium. When lecithin was added to the phospholipid-depleted 
mitochondria, there was a slight increase in the amount of calcium 
bound. Mitochondria reconstituted with other phospholipids, on the 
other hand, were able to bind more calcium than the untreated mito­
chondria, approximately 35% with asolectin, 42% with cardiolipin, 49% 
with phosphatidyl-inositol, whereas the amount of calcium bound was 
nearly 3 times higher in the case of phosphatidyl-ethanolamine than the 
untreated mitchondria. The calcium binding analysed above was 
Independent o f metabolism and occurred in the presence of rotenone and 
antimycin A. The above findings confirm those of Scarpa and Azzone 
(1969) except that cardiolipin caused a lot more increase in calcium 
binding in the present wor^than reported in the latter paper.
Figure 4.11 Relationship between Ca binding and phospholipid 
composition of mitochondria
The experimental conditions as described in Methods. The results 
are mean ± S.D. of three experiments.
I
4.4 DISCUSSION
ATP serves a dual function, that of being an ENERGY source and, 
by virtue of its strong ability to CHELATE calcium, that of creating a 
calcium 'sink'. (Spencer and Bygrave, 1973). In succinate-supported 
systems, ATP serves only the latter function, and thereby enables 
very low concentration of 'free' calcium to be presented to the mito­
chondria at any one time. It is known that one ATP molecule (or
hypothetical high energy intermediate) is required for the accumulation 
| |
of 2 Ca ions (Rossiand Lehninger, 1963). The inhibition of calcium 
accumulation caused by Rh6G (Fig. 4.4) is in agreement with the data 
of Gear (1974). The inhibition of calcium uptake by high concentration 
of Rh6G as well as its release when it is accumulated in mitochondria 
may be due to the uncoupling effect of Rh6G. It was shown that the 
uncoupler (1 pM, FCCP) caused rapid disappearance of ATP (Brand and 
Lehninger, 1975) and that when DNP was present, no stimulation of 
calcium accumulation by ATP was observed (Bielawski and Lehninger, 
1966; Spencer and Bygrave, 1973).
In the opinion of the present worker, the inhibition of calcium uptake 
by HCP, DBCT and TE T (Figs. 4. 5, 4.6 and 4.7)may be due either to 
(a) the uncoupling effect of these uncompetitive inhibitors, it was shown 
that HCP (Caldwell et a l . . 1972) and TET in the chloride medium 
(Selwyn et a l. . 1970a and b) are uncouplers of oxidative phosphorylation, 
and it was known that the energy-linked uptake of calcium is inhibited by 
agents which dissipate the membrane potential generated by respiration, 
like the uncouplers of oxidative phosphorylation );or (b) to the probable 
effect of these inhibitors on mitochondrial phospholipids necessary for 
calcium binding, a preliminary and necessary step in the sequence of 
events that lead to its translocation across the inner mitochondrial 
membrane.
From the data presented (Fig. 4.11) it appears that the phospholipids 
play an important role in determining some physical properties of the 
mitochondria, e .g . the rate of ion diffusion and the binding of cations.
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Among the effects of the various phospholipids, those of phosphatidyl- 
ethanolamine, which is a major component of mitochondrial phospho­
lipid, were the most efficient in causing the restoration of osmotic and 
ion-binding properties of the mitochondria. The addition of phospho­
lipids to phospholipid depleted mitochondria made it bind calcium more 
than untreated mitochondria, and this may be due to an increase in the 
low affinity binding site of calcium.
The information provided by the experiments (Fig. 4.8) with the
release-inducing agents, e.g . uncouplers, ionophores, DBCT, TET,
ruthenium red and HCP, has been important for the demonstration of
the reversibility of the calcium-transport process, which is perhaps
the most important parameter to be considered when discussing a role
ot mitochondria in the biological regulation of calcium. In regard to
the effect of leucinostatin and X-537A on calcium release, it was shown
by Binet and Volfin (1975b) that the stability of the membrane is
| |
regulated by the presence of a low amount of a Mg bound in or on the
j |
surface of the membrane. If this Mg is released, by the means of
| |
the ionophore, the membranar Ca becomes labile and this process 
leads to the loss of the impermeability of the mitochondrial membrane.
It can be concluded from this work that HCP, TET and DBCT inhibit 
the calcium uptake in a way similar to that of the potent inhibitor of 
calcium transport (ruthenium red); however, HCP, TET and DBCT caused 
a release of accumulated mitochondrial calcium in a way similar to 
dlnitrophenol; since the uncoupler can inhibit calcium uptake and binding. 
Thus, the effect of these compounds may be of the uncoupler type. The 
Inhibition of ATP-supporting calcium accumulation by Rh6G may be due 
to inhibition of ATP hydrolysis which is required to energize the 
mitochondria for accumulation of calcium. However, the inhibition of 
calcium uptake by higher concentrations of Rh6G may be related to the 
Rh6G uncoupling effect
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CHAPTER 5
QO
THE ATP- Pi EXCHANGE REACTION 
5.1 INTRODUCTION
This chapter describes another reaction catalyzed by the mito­
chondrion which is a partial reaction o f oxidative phosphorylation, 
namely the exchange reaction between orthophosphate and the terminal
phosphate of ATP which occurs in the absence of oxidation (Cooper and
32Lehninger, 1957). This reaction is designated as the ATP- Pi 
32
exchange. The ATP- Pi exchange was first observed in liver
mitochondria (Boyer et al.. 1956 and Swanson. 1956). Since the
reaction is inhibited by 2( 4-dinitrophenol at concentrations which
uncouple oxidative phosphorylation, it was concluded (Cooper and
32Lehninger, 1957) that the ATP- Pi exchange reaction is a reflection
of the activity of a terminal transphosphorylation reaction Involved
In oxidative phosphorylation. The exchange reaction requires the
preservation of an energized intermediate (X ~  I ) and the liberation of
32
Pi in the medium so that when the reaction is reversed, Pi is 
incorporated into ATP. Breakdown of an intermediate in the energy 
transfer sequence leads to ATPase activity (Sanadi et a l. . 1968).
The chemical intermediate theory of oxidative phosphorylation 
originally proposed by Slater (1953) and subsequently extended is
represented by Eq. 1.3.
ah2 + b+ i a ~ i + bh2 (1)
A ~  I + X ------* X ~  I +  A (2)
X ~  I + ADP<-P^=i X ~  I +  ATP (3)
Eq. 3 has been further broken down into two steps
X ~ I  + P -----  ^ X ~ P + I  (4)
X ~  P + ADP ^ = 5  X + A T P  (5)
where AH2 and B are adjactent members of the respiratory chain and 
I is a hypothetical coupling factor.
The chemiosmotic hypothesis of Mitchell (1961) considers 
separation of H+ and OH charges across the mitochondrial membrane , 
with a resulting development of membrane potential as the primary 
energy-conserving reaction. This potential then leads to the formation 
o fX ~ I ,  the nonphosphorylated energy-rich intermediate. The 
conformation-coupling hypothesis, a variation of the chemical theory, 
also considers a nonphosphorylated energized state of the redox protein 
or membrane as an intermediate step (Mitchell_et£l., 1967; Green et a l.. 
1968) in ATP formation.
The purpose o f this chapter is to describe the effect of sulfobromo-
phthalein (SBP), agaric acid (AA), hexachlorophene (HCP) and rhodamine 
326G (Rh6G) on ATP- Pi exchange reaction and to compare the effect of 
these Inhibitors with the effects of potent inhibitors and uncouplers of 
oxidative phosphorylation (Atr, oligomycin, venturicidin, TET, DCCD, 
FCCP, 1799, PCP or DNP) in both mitochondria and submltochondrial 
particles (SMP).
5.2 MATERIALS AND METHODS
Materials
32Pi was obtained from the Radiochemical Centre, (Amersham, U.K. ). 
Dithiothreitol (D TT ) and oligomycin (mixture of oligomycin A, 15% and 
B, 85%) were obtained from Sigma Chemical Co. Ltd. Dicyclohexyl- 
carbodiimide (DCCD) was obtained from the British Drug Houses, Ltd. 
Naphthalene (scintillation grade) was obtained from Fisons Scientific 
Apparatus, England. A ll other inhibitors and uncouplers of oxidative 
phosphorylation were obtained from the sources mentioned in Chapter 2.
All other chemicals were of A.R. grade.
Methods
Preparation of mitochondria and submitochondrial particles
Preparation of mitochondria and submitochondrial particles (SMP) 
and the protein determination were carried out as described in Chapter
38S
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32„Measurements of ATP- Pi exchange 
32The ATP- Pi exchange reaction was carried out according to the
method of Fisher etaU (1971). 0.1 ml of mitochondrial or submito-
chondrial particles suspension containing 1 mg protein were added to
0.9 ml of buffer containing 0. 25 M sucrose, 50 mM T r is  -H SO
32(pH 7.5), 10 mM potassium phosphate (pH 7.5) containing Pi with
10^  cpm, 10 mM MgCl^, 1 mM dithiothreitol. The reaction was
started by the addition of 10 mM ATP (pH 7.5) and the mixture was
Incubated at 30° for 10 min unless otherwise Indicated. The reaction
was terminated by the addition of 0. 5 ml of 20% trichloroacetic acid.
32Pi incorporated and Pi in the medium were determined as described
by Andreoli et al. (1965). After centrifugation,to 1 m l of the supernatant
fluid was added 0.1 ml bromine water, 1.5 ml of 2-5% ammonium-
molybdate in 2. 5 N H2SC>4, 1 ml acetone, 10 ml Isobutanol-benzene
(1:1), water saturated, and the mixture shaken for 10 sec. After
allowing the liquid phases to separate by standing for 5 min, the upper
isobutanol layer was removed by aspiration and discarded ; the lower
phase being re-extracted twice with isobutanol (10 m l). Traces of
isobutanol were removed by shaking the aqueous phase with 2 ml of
ethyl ether, and removing this by aspiration. An aliquot (0.5 m l) of
the aqueous phase was taken for determination of the radioactivity of
the organically bound phosphate. The amount of phosphate esterified
was calculated as the quotient of the total radioactivity of the organically
bound phosphate (CPM) over the initial specific radioactivity (counts/min/
nmole) of the orthophosphate. Phosphate was determined by the Fiske
and Subbarow method (1925).
Counting
32Pi was counted in a Packard Tricarb Scintillation counter in 5 ml 
of a dloxan based scintillation mixture, 60 g scintillation grade naphthalene, 
4 g PPO, 0.1 g dimethyl POPOP and 1 litre 1, 4-dioxan (Williams and 
Orr, 1976).
|
Rat liver mitochondria catalyze an extensive exchange of Pi with
the phosphate of ATP. The time course of this exchange reaction is
32shown in Fig. 5.1. The results show that the ATP- Pi exchange 
reaction continues in a nearly linear manner over the 15 min reaction 
period, which is in good agreement with the data on rat liver mitochondria 
Boyer et a l. (1956) and on beef heart submitochondrial particles 
Conover et_aL (1963).
The ATP-Pi exchange reaction occurs at significant and easily 
observable rates over a wide range of pH and concentrations of ATP 
and phosphate. Figure 5.2 demonstrates the effect of varying pH; it 
is seen that activity is shown over the whole range tested, with a peak 
at pH 7.5. Figures 5.3 and 5.4 demonstrate the effect of varying the 
concentration of ATP and phosphate. The value for ATP in the 
exchange reaction is approximately 2.9 mM and that for phosphate 
approximately 2 mM.
32The inhibition of the ATP- Pi exchange reaction , found in the
present work, can be classified as follows:
32(a) Inhibition of ATP- Pi exchange reaction in intact mitochondria.
It is shown in Figs. 5.5 and 5.6 that Atr, SBP, HCP and agaric acid 
Inhibit the exchange reaction in intact mitochondria, and this may be due 
to their property to inhibit adenine nucleotide translocase, as shown in 
Chapter 2. The results of the effect of Atr on the exchange reaction is 
in agreement with the findings of Vignais^t a l., (1961 and 1962), Groot 
_etjH .,( 1971), and Verdow and Bertina, (1973). The inhibition caused by 
Rh6G may be due to inhibition of oxidative phosphorylation in a way 
similar to oligomycin, venturicidin, TET or DCCD (Figs. 5.6 and 5.7). 
The present results on the inhibition of the exchange reaction by 
oligomycin are in agreement with the findings of Lardy ertal. (1964), 
K ovacetaL  (1968) and Boyer e ta L  (1975).
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5.3 RESULTS
Rat liver mitochondria catalyze an extensive exchange of J^Pi with
the phosphate of ATP. The time course of this exchange reaction is
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shown in Fig. 5.1. The results show that the ATP- Pi exchange 
reaction continues in a nearly linear manner over the 15 min reaction 
period, which is in good agreement with the data on rat liver mitochondria 
Boyer et al. (1956) and on beef heart submitochondrial particles 
Conover et al. (1963).
The ATP-Pi exchange reaction occurs at significant and easily 
observable rates over a wide range of pH and concentrations of ATP 
and phosphate. Figure 5. 2 demonstrates the effect of varying pH; it 
is seen that activity is shown over the whole range tested, with a peak 
at pH 7.5. Figures 5.3 and 5.4 demonstrate the effect of varying the 
concentration of ATP and phosphate. The value for ATP in the 
exchange reaction is approximately 2.9 mM and that for phosphate 
approximately 2 mM.
32The inhibition of the ATP- Pi exchange reaction , found in the
present work, can be classified as follows:
32(a) Inhibition of ATP- Pi exchange reaction in intact mitochondria.
It is shown in Figs. 5.5 and 5.6 that Atr, SBP, HCP and agaric acid 
Inhibit the exchange reaction in intact mitochondria, and this may be due 
to their property to inhibit adenine nucleotide translocase, as shown in 
Chapter 2. The results of the effect of Atr on the exchange reaction is 
in agreement with the findings of Vignais et a l., (1961 and 1962), Groot 
etiLi’ ,(1971), and Verdow and Bertina, (1973). The inhibition caused by 
Rh6G may be due to inhibition of oxidative phosphorylation in a way 
similar to oligomycin, venturicidin, TET or DCCD (Figs. 5.6 and 5 .7 ). 
The present results on the inhibition of the exchange reaction by 
oligomycin are in agreement with the findings of Lardy et^aL (1964), 
Kovacetad. (1968) and Boyer et al. (1975).
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Figure 5.1 Rate of ATP- Pi exchange reaction
32
The test system contained 10 mM ATP, 10 mM Pi, 1 mg mito­
chondrial protein, in a total volume of 1 ml,- incubated at pH 7. 5 at 
30°. The results are expressed as mean of four experiments ± S.D. 
For detail of the experiment , see Method.
Figure 5. 2 Effect of pH on ATP- Pi exchange reaction.
The test system contained in a final volume of 1 ml, 0.25 M
32
sucrose 50 mM T r is -H SO 10 mM Pi 10 mM MgCl_,
» l  4  i
1 mM DTT, 10 mM ATP and 1 mg of mitochondrial protein. 
pH adjusted with Tris-H 2S04. Incubated for 10 min at 30°. 
The results are expressed as mean of four experiments ± S.D.
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32Figure 5.1 Rate of ATP- Pi exchange reaction
32
The test system contained 10 mM ATP, 10 mM Pi, 1 mg mito­
chondrial protein, in a total volume of 1 ml,, incubated at pH 7.5 at 
30°. The results are expressed as mean of four experiments ± S.D. 
For detail of the experiment , see Method.
PH
32
Figure 5. 2 Effect of pH on ATP- Pi exchange reaction. 
The test system contained in a final volume of 1 ml, 0. 25 M 
sucrose, 50 mM T r is -H2S04 , 10 mM 32Pi, 10 mM MgClj,
1 mM DTT, 10 mM ATP and 1 mg of mitochondrial protein. 
pH adjusted with Tris-H 2S04. Incubated for 10 min at 30°. 
The results are expressed as mean of four experiments ± S.D.
Figure 5.3 Effect of ATP concentrations on exchange reaction.
32The system contained 10 mM Pi, ATP at the concentrations shown and 1 mg 
mitochondrial protein in a total volume of 1 ml and was incubated at pH 7.5 
at 30° for 10 min. The results are expressed as a mean of four experiments. 
For detail, see Method.
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Figure 5.4 Effect of Pi concentration on ATP- Pi exchange reaction 
The test system contained \ mg of mitochondrial protein, 10 mM ATP, 
phosphate in the concentration shown, final volume was 1 ml, and the 
incubation time 10 min at 30°; pH 7. 5. The results are expressed as mean 
of four experiments.
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Inhibitor (nmol/mg protein)
32Figure 5. 5^  Effect of Atr. SBP. agaric acid and Rh6G on ATP- Pi exchange 
reaction .
The same conditions as in Fig. 5.2. The inhibitors incubated for 5 min with
32mitochondria on ice before Initiating the reaction> with Pi and ATP, pH 7.5. 
The results are expressed as a mean of four experiments ± S.D. The 
uninhibited results are in the range of 0.25-0.30iimol Pi exchange/min/mg 
of mitochondrial protein.
A — — A ,  + Rh6G
• — — •  t + Atractyloside
O — —  O, + SBP
A — — A ( + agaric acid
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reaction
The same conditions as in Fig. 5.2. The inhibitors were Incubated
with 1 mg mitochondrial protein for 5 min on ice before initiating the 
32reaction with Pi and ATP, pH 7.5. The results expressed as mean 
of four experiments ± S.D.
The uninhibited results are in the range of 0»30"0.35 nmol Pi exchanged/ 
mln/mg of mitochondrial protein.
A -------> ,  +HCP
•  -------•  , + DCCD
A --------A , +TE T
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Figure 5.7 Effect of oligomycin and venturlcldln on ATP- PI 
exchange reaction
The same condition as in Fig. 5.2. The Inhibitors incubated for 5 min
32with mitochondria before initiating the reaction with Pi and ATP, pH 
7.5. The results are expressed as mean of three experiments ± S.D. 
The uninhibited results are in the range of 0. 25-0.30^mol Pi exchanged/ 
mln/mg of mitochondrial protein.
O -------Of + oligomycin (mixture of A and B)
• -------•  + venturicldin (mixture of A and B)
126
32
(b) Inhibition of ATP- Pi exchange reaction in submitochondria 1
particles. The effect of HCP and Rh6G are shown in Table 5.1. HCP
with low concentration (0.25 nmol/mg protein) caused 54 ± 8%
Inhibition, while Rh6G required in a higher concentration (14.8 nmol/mg
protein) to decrease the exchange reaction up to 43 ± 5.4 %. Table 5.1 
32shows that the ATP- Pi exchange reaction in SMP was also inhibited by 
the Inhibitors of oxidative phosphorylation (e .g . DCCD, TE T or 
venturicidin ); these results are in agreement with the findings of 
Serrano et a l. (1976) for reconstituted vesicles prepared from beef 
heart mitochondria.
32(c ) Inhibition of ATP- Pi exchange reaction in both intact mitochondria
and submitochondria 1 particles. It is shown in Figs. 5.5, 5.6, 5.7 and
5.8, and in Table 5.1 that HCP, Rh6G, TET, DCCD and venturicidin
inhibit the exchange.reaction in both intact mitochondria and in submito-
chondrlal particles.
32The ATP- Pi exchange reaction is also inhibited by many reagents 
which uncouple oxidative phosphorylation (Cooper and Lehnlnger, 1956; 
Boyer et a l. . 1975; Hatefl_et a_h, 1975). The data shown in Fig 5.8 and 
in Table 5.1 demonstrates that the exchange reaction in both intact 
mitochondria and in SMP was inhibited by low concentration of FCCP,
1799 and PCP. These findings are in agreement with the previous 
results reported in yeast mitochondria (Kovac^t ah, 1968; Groat et ah . 
1971 ) and in beef heart submitochondria 1 particles (Conover_et ah , 1963; 
Kagawa and Racker, 1971; Serrano et ah . 1976).
TABLE 5.1
Submitochondrial particles (1 mg protein) were incubated in 1 ml of
32
0.25M sucrose 50 mM Tris-H  SO pH 7.5 10mM Pi 10 mM 
* i  4
MgCl 1 mM DTT, 10 mM ATP for 5 min on ice with inhibitors, before
* 32 o
initiating the reaction with Pi and ATP, at 30 for 10 min. The results
are expressed as mean of three experiments ± S.D. The uninhibited
32Inhibition o f ATP- Pi exchange reaction in submitochondrial particles
results are in the range of 0.08- 0.09 M>m° l exchanged/min/mg of
submitochondrial particles protein.
Inhibitor Concentration 
amol/mg protein
% Inhibition
SBP 5 0
Agaric acid 5 0
Rh6G 4.9 26 ± 2.6
14.8 43 ± 5.4
HCP 0.12 37 ± 5.8
0.25 54 ± 8.0
DCCD 2.40 52 ± 6.0
14.40 63 ± 6.4
TET 0.98 35 ± 7.4
3.92 46 ± 3.3
♦Venturicidin .0.50 46 ± 2.5
3.00 58 ± 4.6
DNP 10.00 27 ± 4.0
30.00 40 ± 4.1
FCCP 0.80 26 ± 4.5
1.60 49 ± 4.0
1799 1.28 29 ±2 .2
5.12 52 ± 3.0
PCP 1.00 35 ± 1.0
5.00 43 ± 5.5
*
Venturlcidin concentration (pg/mg protein)
________I__________ I_________ I------------- »------------- *—
0 1 2 3 l, 5
Inhibitor (nmol/mg protein )
32
Figure 5. 8 Effect of FCCP. 1799. PCP and DNP on ATP- Pi 
exchange reaction
The same conditions as in Fig. 5.2. pH 7.5. The results are 
expressed as mean of three experiments ± S.D. The uninhibited 
results are in the range of 0.25-0.31 ^mol PI exchanged/min/mg 
of mitochondrial protein.
•  — --- • ,  + FCCP
A — — A ,  + 1799
0 — —  0, + PCP
A  — ----A  + 2  4-DNP» »
it
* . *. -■**•' rrt». •»• 'Z*
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5.4 DISCUSSION 
32
The ATP- Pi exchange reaction and the 2, 4-dinitrophenol- 
induced ATPase activity have been considered to represent partial
reactions of'the energy transferring chain in oxidative phosphorylation.
32The Inhibition of ATP- Pi exchange reaction by Atr (Fig. 5. 5) is
in agreement with the inhibition of mitochondrial adenine nucleotide
uptake (Chapter 2) by atractyloside. Agaric acid, SBP and HCP
effects may be explained in the same manner, like Atr, since the
three Inhibitors, SBP, HCP and agaric acid inhibit the uptake of
adenine nucleotide by mitochondria (Chapter 2). However, HCP also 
32
inhibits the ATP- Pi exchange reaction in submitochondrial particles
and this may be due to the uncoupling effects of HCP (Caldwell et a l. .
1972; Cammer and Moore, 1972). On the other hand, the effect of 
32Rh6G on the ATP- Pi exchange reaction (Fig. 5.5) may either be 
due to Rh6G uncoupling effect or to Rh6G behaving like the inhibitors 
of oxidative phosphorylation. The results of Gear (1974) demonstrate 
that low concentrations of Rh6G markedly reduce the rate of ATP 
formation, but at higher concentrations ( > 10 pM ), Rh6G uncouples 
oxidative phosphorylation.
According to the chemical hypothesis (Slater, 1953), oligomycin 
probably acts by inhibiting equation 2.
A ~  I + X X ~  I + A
thus preventing the formation of X ~  P from X ~  I. DCCD, TET and 
venturicidin, the inhibitors of oxidative phosphorylation, apparently 
have the same inhibitory effect as oligomycin (Beechey et a l., 1967; 
Hatefi et al. 1975). On the other hand, uncouplers are thought to 
act at A ~  I.
32It can be concluded from this work that the ATP- Pi exchange 
reaction catalysed by intact mitochondria was inhibited by SBP, HCP, 
agaric acid and Rh6G. Since SBP and agaric acid did not affect the 
exchange reaction in SMP, it can be concluded that the inhibition
.r-
n
I
caused by SBP and agaric acid may be due merely to the inhibition
of the adenine nucleotide and Pi translocase systems. The inhibition
by HCP of the exchange reaction may be related either to the
inhibition offhe adenine nucleotide and Pi transport systems^r to the
HCP uncoupling effect. However, the inhibition by Rh6G of the 
32ATP- Pi exchange reaction by mitochondria and submltochondrial
particles may be either due to its uncoupling effect, or it may be
that Rh6G has the same inhibitory effect as oligomycin.
The possibility of inhibition of phosphate transport system by
SBP, HCP or agaric acid, suggested above, prompted us to test-
32>. . the effect of these inhibitors on Pi transport,as will be 
shown in Chapter 6.
There is ample evidence that mitochondrial substrate transport 
Involves specific translocators (Mitchell, 1953). Thus phosphate 
exchanges with hydroxyl via a phosphate translocator (McGivan and 
Klingenberg, 1971; H oek^tal., 1971), dicarboxylate with phosphate via 
a dicarboxylate translocator (Chappell, 1968; Palm ieri_etjil., 1971;
Robinson and Williams, 1970), tricarboxylate with malate via a tricarboxylate 
translocator (Palm ieri_et£l., 1972), a-oxoglutarate with certain dicarboxylate 
ions via an ce-oxoglutarate translocator (Chappell et al_., 1968) and aspartate 
with glutamate via an aspartate translocator (A zz i££ah , 1967). The Pi-OH 
exchange serves to neutralize the charge imbalance occurring from uptake 
of ADP and efflux of ATP during oxidative phosphorylation. While the 
Pi-dicarboxylate exchange acts catalytically to allow net uptake of anionic 
substrates at the expense of the mitochondrial pH gradient (McGivan and 
Klingenberg, 1971).
hydroxyl r z ------ ;— s.^ Pi carrier j
phosphate-
malate or 
succinate
Membrane
Rehear boxy la tb^  
carrier
tricarboxylat
L
SBP ? 
phosphate
SBP ?
malate or 
succinate
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^
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Figure 6.1 Scheme of sequential action of metabolite carriers 
SBP = sulfobromophthalein
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The substrate-binding site of the tricarboxylate carrier (Palmierl 
jet a l., 1972) will accept molecules with at least two carboxyl groups 
such as malate,or with three neighbouring carboxyl groups such as 
citrate,or with one carboxyl group and a phosphate group such as 
phosphoenol pyruvate.
Fonyo and Bessman (1968) and Tyler (1969) have shown that some 
sulphydryl-binding reagents specifically interfere with the transport of 
phosphate across the mitochondrial membrane. Mersalyl (Tyler, 1969;
Papa et a l.. 1973), p-hydroxymercuribenzoate (Fonyo, 1968) inhibit 
both translocation systems of phosphate. While N-ethylmaleimide (Coty 
and Pedersen, 1974) only inhibits the phosphate-hydroxyl exchange, n-butyl- 
malonate (Johnson and Chappell, 1973) which does not react with thiols, 
has been used to inhibit the phosphate-dicarboxylate exchange. 6, 6 -dithio- 
dinicotinic acid (CPDS), a non-penetrating thiol agent, blocks only a few 
-SH groups on the outer surface of the inner mitochondrial membrane 
and affects several mitochondrial functions in a way different from that 
of mersalyl (Abou-Khalil_et jab , 1975a).
Meisner (1973) mentioned the possibility that SBP is a potent 
Inhibitor of the Pi/OH as well as Pi/malate uptake of mitochondria, but 
no experimental verification has so far been reported. It was, therefore, 
interesting ;
(a ) to reinvestigate in detail the effects of SBP, HCP, agaric acid and Rh6G
32 32on Pi transport and on Pi-Pi exchanges. Studies on the effects of
mersalyl, p-hydroxymercuribenzoate, trlethyltin, ionophorous antibiotics
32
and other uncouplers and inhibitors of oxidative phosphorylation on Pi 
32transport and on Pi-Pi exchanges were performed for comparison;
(b) to reinvestigate the effect of SBP on dicarboxylate transport system 
by studying the effect of SBP on dicarboxylate uptake, dicarboxylate - 
dicarboxylate exchange and dicarboxylate-phosphate exchange, which are 
mediated by the dicarboxylate carrier.
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The substrate-binding site of the tricarboxylate carrier (Palmieri 
jet ah, 1972) will accept molecules with at least two carboxyl groups 
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sulphydryl-binding reagents specifically interfere with the transport of 
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Papa et a l. . 1973), p-hydroxymercuribenzoate (Fonyo, 1968) inhibit 
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and other uncouplers and inhibitors of oxidative phosphorylation on Pi 
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6.2 MATERIALS AND METHODS 
Materials
32 14 14
Pi, L [U - C] malic acid, [1 ,4- C] succinic acid (sodium salt)
were obtained from the Radiochemical Centre,(Amersham, U.K. ).
DCCD, sodium malate, sodium succinate and sodium malonate were
obtained from British Drug Houses, Ltd. The following compounds
were obtained from the Sigma Chemical Co.:- antimycin A, oligomycin,
sodium mersalyl, amytal, p-chloromercuribenzoic acid (p-CMBA) and
N-ethylmaleimide (NEM). A ll other chemicals were obtained from the
same sources mentioned in Chapter 2. A ll other chemicals were of
A .R. grade. p-CMBA was dissolved in distilled water and Tris base
was added to the final concentration of 5 mM (Fonyo and Bessman, 1968).
Methods
Preparation of mitochondria
Preparation of rat liver mitochondria and the protein determination 
were carried out as described in Chapter 2.
32Measurements of uptake of radioactive phosphate ( P i)
32A ll Pi uptake measurements were made essentially as described
by Williams and Orr (1976) as follows, unless indicated otherwise in
Individual experiments. Assays were carried out in a standard medium
of 37 mM sucrose, 37 mM KC1, 37 mM Tris-HCl, 0.2 mM MgSO^ and
oligomycin (1.5 ng/ml), pH 7.4 at 0°. A ll assays were carried out at
0°, in tubes surrounded by ice-cold water. Mitochondria (1 mg protein)
were incubated in the assay medium (final volume, 1 m l) with or without
inhibitors for 10 min at 0°, after which phosphate uptake was initiated 
32by the rapid addition of Pi (final concentration, 2.0 mM); the tubes 
were mixed briefly, using a Vortex mixer, and after incubation for 1 min 
uptake was stopped by rapid Millipore filtration (as described in Chapter 
2) using 0.45 |iin Millipore filter, followed by washing of the mitochondria 
with 4 ml of the assay medium, and the amount of radioactivity remaining 
in the filter that contained the mitochondrial pellets was estimated. 
Correction was made for the sucrose permeable space by subtraction 
of values obtained with 50 nmoles mersalyl/mg protein added before 
32P1 (Abou-Khalil e^aL , 1975b).
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32Estimation of Pi-Pi exchange 
32The Pi exit from preloaded rat liver mitochondria in exchange
for external Pi were carried out essentially as described by Abou-
Khalil et^aL (1975b). Liver mitochondria (70 mg protein) were 
32 o 32incubated with 20 nmole Pi at 0 t in Pi-uptake assay medium
(shown above); after 10 min the mitochondria were separated by
centrifugation at 10000 x g, washed with the same incubation medium
and suspended at 10 mg protein/ml. The exchange reaction was
started by incubation of mitochondria (1 mg protein) with 2 mM
32unlabelled Pi, following the same steps for Pi uptake shown above.
The radioactivity found in 1 mg of mitochondrial protein before and 
after addition of unlabelled Pi were estimated.
Technique for measuring the kinetics of dicarboxylate uptake.
14A . Estimation of C-ma late uptake
14Estimation of * C-malate uptake were made essentially as described
by Palm ieri^t al_. (1971) as follows, unless indicated otherwise in
Individual experiments. Assays were carried out in a medium
containing 100 mM KC1, 25 mM imidazol buffer, pH 6.3, 1 mM EGTA,
0. 5 ng rotenone, 0. 5 p,g antimycinA.5 ng oligomycin, 1 mg mitochondrial 
14protein, and C-malate at the concentration; indicated below each 
figure (Figs. 6.8 and 6.10). Reactions were carried out at 9° C; in a 
final volume of 1 ml. 5 sec after the addition of labelled malate, the 
reaction was stopped by rapid Millipore filtration, followed by washing 
of the mitochondria with 4 ml incubation medium. The amount of 
radioactivity in the filter that contained the mitochondrial pellets was 
estimated.
14B. Estimation of C-succinate uptake
14Estimation of C-succinate uptake was as described above, in a 
medium containing 80 mM KC1, 50 mM Tris-HCl, pH 6.3, 1 mM EDTA, 
1 ng rotenone, 1 ug antimycin A, 10 tig oligomycin, 1 mg mitochondrial 
protein and 14C-succinate at the concentration shown below each figure 
(Figs. 6.9 and 6.12). Temperature 11°. Final volume, 1ml.
Technique for measuring the kinetics of dicarboxylate efflux 
14 14Estimations of C-malate or C-succinate efflux from mitochondria
were made essentially as described by Lofrumento et al. (1974).
Mitochondria (50 mg protein) were loaded with labelled malate or
succinate by incubation for 10 min at 4° in the presence of 2 ml of
0.25 M sucrose, 5 tig oligomycin, 0.34 tig rotenone, 0.17 tig antimycin A, 
14 14
2 mM of C-malate or 6 mM C-succinate. The mitochondria were
centrifuged at 10000 x g and washed twice. Loaded mitochondria (1 mg
protein) were incubated in a medium containing 200 mM sucrose; 20 mM
Tris-HCl, pH 7.2; oligomycin, rotenone and antimycin A at the
concentrations indicated above. Reactions were carried out at 9° C in
a final volume of 1 ml. 5 sec after the addition of unlabelled substrate,
the reaction was stopped by rapid Millipore filtration, as described
above.
Counting
32Pi was counted in a Packard Tricarb liquid scintiallation counter,
14
in a Triton X-100/toluene/butyl PBD scintillation mixture. C was 
counted in a POPOP/PPO system, as described in Chapter 2 (Patterson 
and Green, 1965).
6.3 RESULTS
32A. Characters of Pi uptake
32Figure 6.2 demonstrates the kinetics o f Pi uptake by rat liver
mitochondria. The experimental conditions are similar to those
employed by Williams and Orr (1976) and the results obtained are in
good agreement. Figure 6.2 shows that the maximum amount of
phosphate uptake occurs after 1 min incubation period./rJ In the majority
of the present experiments, incubation was carried out for 1 min. The
present results also show a secondary slow increase which does not
appear to be complete even after 10 min.
The measured uptake of 17.0 ±4.1 nmoles per min per milligramme
of mitochondrial protein is also in agreement with the results of Williams
32
and Orr (1976). Fig. 6.3 demonstrates that the Km value of Pi
uptake is approximately equal to 0.22 mM,which is nearly 28 times more
| [
than the K for ADP and 17 times more than the K for Ca uptake, 
m m
as shown in Chapters 2 and 4 respectively.
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32Figure 6. 2 Time dependence of Pi exchange from medium 
to mitochondria
The assay conditions and the technique for measuring the exchange
32
are as described under "Methods". Pi concentration was 2 mM( 
pH 7.4, temperature 0°. The results are expressed as a mean 
of five determinations ± S.D.
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32The experimental conditions are described under "Methods Pi
Incubated for 1 min with mitochondria. The values plotted are the 
mean of four determinations.
K ( Pi) = 0-22mM. 
m
B. Factors affecting Pi uptake
_ 32
It was found (Fig. 6.4) that a 50 per cent inhibition of Pi uptake
32
with approximately 2.5 nmole SBP/mg protein as compared with 20 
nmoles p-CMBA/mg protein. Results of the inhibition of phosphate 
uptake by p-CMBA are in agreement with the findings of Tyler (1968) 
Coty and Pedersen (1975) demonstrated that p-CMBA reacts with the 
same sulfhydryl group of the phosphate transport system.
Figure 6. 5 shows that there is a 50 per cent inhibition of phosphate 
entry into mitochondria with 10 nmoles mersalyl/mg protein, 2 nmoles 
X-537 A/mg protein, 5 nmoles leucinostatin/mg protein and 11 nmoles 
valinomycin/mg protein. These results confirm the previous findings 
of Tyler (1968), Coty and Pedersen (1974) and Lardy et^aT (1975). 
Mersalyl and formaldehyde can inhibit reactions requiring phosphate, 
and may act by preventing the entry of phosphate into the mitochondria 
(Tyler , 1968). On the other hand, Lardy et al_(1975) showed that 
leucinostatin (A 20668) inhibits Pi uptake in rat liver mitochondria (80% 
Inhibition with 0.2 iig leucinostatin/mg protein) and that leucinostatin 
uncouples oxidative phosphorylation at a concentration of 0.11 ixM (Reed 
and Lardy, 1975).
As shown in Fig. 6.6, which demonstrates the comparison between 
FCCP, the classical uncoupler of oxidative phosphrylation and HCP, the 
two compounds have nearly similar effects on phosphate uptake, (50 per 
cent inhibition of phosphate entry into mitochondria, with 1 nmol FCCP 
or HCP/mg protein). The results of Parker (1965) Indicate that a 50 per 
cent inhibition of phosphate uptake from rat liver mitochondria was 
caused by 0.06 FCCP; 0.6 pM, Cl.CCP; 9 pM,PCP;and 30 pM,DNP.
Intact rat liver mitochondria contains 10 nmoles of Pl/mg protein. 
When placed In an isotonic medium at 0°, phosphate added to the medium 
is taken up into the mitochondria in amounts which exceed these 
endogenous levels about 1 to 3 fold (Coty and Pedersen, 1974).
HS
HS
Pi>SH
•SH
+ p-CMBA
H
139
The experimental conditions are described under "Methods". The 
data points are mean values ± S.D. of four experiments. Inhibitors
were incubated with mitochondria for 10 min at 0° before initiating
32 32the exchange with 2 mM PI. One min after the addition of Pi,
the reaction was stopped by rapid, Millipore filtration.
• ----- • ,  SBP
O -----O, p-CMBA
140
32Figure 6. 5 Effect of mersalyl and ionophores on Pi 
uptake
The experimental conditions are described under "Methods". 
The data points are a mean ± S.D. of four experiments.
A — — A f mersalyl
• — » leucinostatin
A — — A » X-537A
O — o. valinomycin
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32F igure 6 .6  Effect of HCP and FCCP on PI uptake
The experimental conditions are described under "Methods".
The data points are mean ± S.D. of three experiments.
O --------O ,HCP
• ------- • ,  FCCP
'Uptake is slightly inhibited by agaric acid (35.6 ± 8.1 per cent 
inhibition with 22 nmoles agaric acid/mg protein (Table 6.1). However, 
the results of Chavez and Klapp (1975) show a 12 per cent inhibition of 
Pi uptake with 40 p.M agaric acid. This difference between the results 
of the present work and those of Chavez and Klapp (1975) may be 
related to the differences In the experimental conditions followed in 
the present study and the last paper. With regard to the effect of 
Rh6G( the results of Gear (1974) show that Rh6G had little effect on 
the uptake of phosphate, but the results of the present study (Table 6.1) 
demonstrate a 26.5 ± 7.1 per cent inhibition with higher concentration 
of Rh6G (25 nmol/mg protein ).
The results of the present work (Table 6.1) show that 20. 2 ± 4.4 
per cent inhibition of phosphate uptake caused by 12 nmoles atractyloside/mg 
protein, in agreement with the findings of Vignais et al. (1962). However, 
Coty and Pedersen (1974) showed that atractyloside has no effect on 
phosphate uptake.
Phosphate uptake was also inhibited slightly by higher concentrations
of DCCD (48 nmol/mg protein) and TET (8 nmol/mg protein) which caused
32approximately 21% and 28% inhibition of Pi uptake respectively (Table 6 .1 ). 
It was shown by Tyler (1969) tha.t the concentrations o f DCCD and 
tributyltin, sufficient to block the coupled oxidation of respiratory-chain- 
linked substrates (40 nmoles DCCD/mg protein; 0.9 nmoles tributyltin/mg 
protein), caused about 10% inhibition of respiration stimulated by 
phosphate, and had no effect on the substrate-level phosphorylation 
reaction, indicating that these reagents have little effect on the entry of 
phosphate into mitochondria.
Table 6.1 also shows 38. 4 ± 4. 5 per cent inhibition of of phosphate
uptake with 16 nmoles CPDS/mg protein, a result which is in agreement
with the findings of Abou-Khalil et al. (1975a).
32C. Inhibition of Pi-Pi exchange reaction 
32. Pi-Pi exchange was catalyzed by both phosphate and dlcarboxylate 
carriers (Fig. 6.1), and in order to find the effect of SBP on the
r.J
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initiating the exchange with 2 mM Pi. After 1 min, the reaction 
was stopped by Millipore filtration. Temperature, 0°, pH 7.4 . 
The data points are mean values ± S.D. of three experiments.
Inhibitors Concentrations Inhibition %
Agaric acid 22.o nmol/mg protein 35.6 ± 8.1
Rh6G 24.6 nmol/mg protein 26.5 ± 7.1
Atractyloside 12.5 nmol/mg protein 20.2 ± 4.4
DCCD 48.0 nmol/mg protein 20.9 ± 3.1
TET 8.0 nmol/mg protein 28.3 ± 3.3
CPDS 16.0 nmol/mg protein 38.4 ± 4.5
Venturicidin 5.0 ng/mg protein 20.1 ± 4.6
Formaldehyde 5.0 nmole/mg protein 51.0 ± 6.8
DNP 20.0 nmol/mg protein 17.3 ± 2.7
1799 0.09 nmol/mg protein 30.4 ± 7.4
PCP 0.8 nmol/mg protein 20.7 ± 4.1
2.0 nmol/mg protein 40.6 ± 8.3
.C"'
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dicarboxylate carrier, the effect of SBP as well as mersalyl and
32p-CMBA were carried out on the Pi-Pi exchange. Fig. 6.7 shows
a titration of the action of SBP, mersalyl and p-CMBA on the
32exchange-diffusion between mitochondrial Pi and external
32unlabelled Pi. This was followed by exposing for 1 min Pi
loaded mitochondria to a second incubation with unlabelled Pi.
32Inhibitors were added to Pi-loaded mitochondria, 10 min before 
the exchange started. A 50 per cent inhibition of exchange caused 
with 5 nmoles SBP/mg protein, 12 nmoles mersalyl/mg protein, 16 
nmoles p-CMBA/mg protein. The present results of the effect of 
mersalyl and p-CMBA are concordant with the findings of(Meijer 
et a l. . 1970; Papa et a l . . 1973; Johnson and Chappell, 1973; 
Quagliar'ello £t aj_., 1974).
D. Inhibition of dicarboxylates transport
On comparing the dependence of substrate concentration on the
rate of malate uptake (Fig. 6.8) and succinate uptake (Fig. 6.9) it
is found that the K (malate) = 0. 50 mM and K (succinate) = 1.11 m m
mM. These results are in agreement with the results of,Palmieri
etal_., 1971, and Fonyo_etal., 1976). The inhibition of the rate of
malate uptake by SBP is shown in Fig. 6 .8; SBP (12 nmol/mg protein )
caused an increase in the Km (malate) from 0.5 mM to 1.6 mM,with
an uncompetitive type of inhibition. Moreover, SBP (12 nmol/mg
14protein) inhibited uncompetltively both the malate/ C-malate
14exchange (Fig. 6.10) and Pi/ C-malate exchange (Fig. 6.11), with
an increase in K from 0.42 to 5.0 mM and from 0.33 to 1.51 mM m
respectively. Thus the present results are in agreement with Meisner 
(1973) who briefly reported that SBP inhibits Pi/malate uptake in
mitochondria. On the other hand, SBP inhibits noncompetitively the
14 14C-succinate uptake (Fig. 6.9) and succinate/ C-succinate
exchange (Fig. 6.12).
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32Figure 6.7 Effect of SBP. mersalyl and p-CMBA on the Pi-PI 
exchange
32The assay conditions and techniques for measuring Pi-Pi exchange
were as described under "Methods” , using mitochondria (1 mg 
32protein) labelled with Pi, and the inhibitors were incubated with 
labelled mitochondria for 10 min before initiating the reaction with 
2 mM of unlabelled Pi. After 1 min, the reaction was stopped by 
filtration. The results are the mean ± S.D. of four observations.
O -----O, SBP
• ----- • ,  mersalyl
A ------£» , p-CMBA
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14Figure 6. 8 Kinetic analysis ofthe inhibition of C -malate uptake by SBP.
using the double reciprocal plot
The experimental conditions are described under "Methods” . SBP added to
14mitochondria 10 min before C -malate. The data points are mean of five 
experiments.
• ----- •  , no inhibitor, K (malate) =0.5 mM
X ----- X, 46 nmol/mg,SBP, Km (malate) = 0.8 mM
A ----------- 4-12 nmol/mg.SBP, Km (malate) = 1.6 mM
■ ------■  , +18 nmol/mg,SBP, Km (malate) = 2.5 mM
----O, 424 nmol/mg,SBP, K (malate) = 6.6 mM
j.
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Figure 6.9 Kinetic analysis of the inhibition of C-succlnate uptake by •
SBP. using:- A. Dixon plot, and B. double reciprocal plot.
The experimental conditions are described under "Methods". SBP added to
14mitochondria 10 min before C-malate. The data points are mean of five 
experiments.
• ------- • '  no inhibitor; X ------X, +12 nmol/mg/ SBP; A ------- A, + 24
nmol/mg SBP; O------O. + 36 nmol/mg/ SBP.
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14The efflux of C -malate from preloaded mitochondria was followed as
described under "Methods". SBP (12 nmol/mg protein) was incubated for 10
min with mitochondria before addition of malate. 5 sec after addition of
malate the reaction was stopped by Millipore filtration. In the absence of 
14unlabelled malate, the C -malate content of mitochondria relative to 1 mg
14protein was 3 *8 nmoles. A C -malate was determined by sub. tracting the
amount found in the presence of unlabelled malate from that in its absence.
The data points are mean of four experiments.
• ------•  no Inhibitor K (malate)=  0.42 mM* 9 m
X ----- X, + 12 nmol SBP/mg protein, Km (malate) = 5.00 mM
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Figure 6.11 Effect of SBP on the kinetics of C-malate efflux in exchange 
with external PI
Experimental conditions as in Fig. 6.10 .
The results are the mean of four experiments.
• -----•  no inhibitor, K (P i)=0 .3 3 m M* ’ m
O -----O + 10 nmol/mg,SBP K (Pi) = 1.51 mM• ' ’ m
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14Figure 6.12 Effect of SBP on the kinetics of C-succinate efflux
in exchange with external succinate 
14The efflux of C-succinate from preloaded mitochondria was followed
as described under "Methods". SBP (12 nmol/mg protein) incubated
for 10 min with mitochondria before addition of unlabelled succinate.
5 sec after the addition of succinate, the reaction was stopped by Millipore
14
filtration. In the absence of unlabelled succinate, the C-succinate
14content of mitochondria relative to 1 mg protein was 2. 8 nmoles. A C- 
malate was determined by subtracting the amount found in the presence 
of unlabelled malate from that in Its absence. The results are mean of 
four experiments.
• ------•  no SBP K (succinate) = 0. 28 mM’ * m
X ------X, + 12 nmol SBP/mg protein, Km (succinate) = 0.28 mM
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6.4 DISCUSSION
It is well established that Pi moves across the mitochondrial 
membrane only when the side of the membrane opposite to that 
occupied by Pi^is exposed to specific substrates, or the OH 
concentration is raised (Lofrumento ^ t al. ( 1974). This indicates 
that the translocating system can be considered to be in the 'resting 
state' when it is bound to its substrates on only one side of the 
membrane, and is in the 'functional'state' when it is bound on both 
sides to a specific couple of substrates, namely Pi-OH , Pi-Pi or 
Pi -dicarboxy late.
Mitchell's chemiosmotic theory (Mitchell, 1961) postulates that
the free energy released during the activityof the respiratory chain
leads to ejection of protons in the extramitochondria 1 space, thus
creating a transmembrane pH gradient. There is indeed a pH
difference of approximately 0.4 to 1.0 pH units between outside and
Inside, and this leads to the influx of phosphate, pyruvate and
glutamate as a result of an exchange for internal hydroxyl ions that
are more concentrated inside (Sluse and Sluse-Goffart, 1974).
32In Scheme 6.1, Pi can enter the mitochondria in exchange for
OH ion via the phosphate carrier. In the presence of inhibitors of
phosphate transport, such as SBP, mersalyl and p-CMBA, the uptake 
32of Pi was prevented (Figs. 6.4 and 6 .5 ). This may be due to
32inhibition of phosphate carrier. In Pi-loaded mitochondria, the 
32Pi can leave mitochondria against externally added unlabelled Pi 
or dicarboxylate ions, via a dicarboxylate carrier. The last carrier 
may be sensitive to SBP, mersalyl or p-CMBA (Fig. 6 .7 ). Moreover, 
the phosphate transport was also inhibited by a variety o f inhibitors 
and uncouplers, as shown in Table 6.1.
Treatment with uncouplers (FCCP, DNP, 1799 and PCP), however, 
greatly decreases phosphate uptake by dissipation of the pH gradient.
Two major classes of uncouplers are nitrophenols and halophenols, which 
are typified by 2, 4-dinitrophenol and pentachlorophenol respectively.
The chlorinated bisphenols, such as HCP, have many physical and 
chemical similarities to these simple phenols. In addition, Caldwell
et al. (1972) have shown that,HCP, acts as an effective uncoupler of
mitochondrial oxidative phosphorylationf and this can be considered
as the reason of inhibition of phosphate uptake by HCP.
It was proposed that the concentrations of Rh6G above 10 nM
uncouple mitochondrial respiration (Gear, 1974), and this may be
32the reason for inhibition of Pi transport by high concentrations of 
Rh6G. On the other hand, A 20668 is both a unique uncoupler and 
Inhibitor of phosphoryl transfer reactions in mitochondria (Reed and 
Lardy, 1975).
32The slight inhibition of Pi uptake by TET, found in the present
study, are in agreement with Aldridge and Street (1971) and this 
32inhibition of Pi uptake may be related to the changes in intramito- 
chondrial pH values (Dawson and Selwyn, 1974) since it was shown by 
Skilleter (1975) that the primary event in KC1 media is that the TE T - 
mediated Cl /OH exchange, one consequence of wh ich is a fall in the 
intramitochondrial pH.
The Inhibition of phosphate transporter by mersalyl or formaldehyde 
is presumably due to the formation of complexes, between mersalyl or 
formaldehyde and the thiol and amino groups of an inner-membrane 
protein or lipoprotein, resulting in the modification of groups catalysing 
ion -exchange processes, during phosphate transport or in a less 
specific effect on the conformation of the protein concerned in the 
transporter mechanism (Tyler, 1969). Moreover, the finding o f Papaet al. 
(1973) suggested that mersalyl inhibits the transport of Pi in mitochondria 
by fixing the anion on binding site in the mitochondria.
Fonyo (1968) proposed that p-CMBA blocks those reactions of 
mitochondria in which permeation of inorganic phosphate into the 
mitochondria was involved. Oxidative phosphorylation is absolutely 
dependent on inorganic phosphate. The mercurial sensitivity of phosphate 
permeation may seem to give SH-groups a specific role in the process. 
However, p-CMBA might act without any specific involvement of SH-groups 
In translocation. One of the alternative possibilities is that p-CMBA is
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bound to an SH-group not directly involved in phosphate permeation, 
but after combination with the mercurial a change in protein 
conformation occurs( and thus the carrier function of the membrane 
protein is losit.
Results o f the present study (Table 6.1) show that CPDS inhibits
phosphate entry into mitochondria, and this may be due to inhibition
of Pi-OH exchange (Abou-Khalil et a l . . 1975b). The residual
phosphate which enters into mitochondria in the presence of CPDS 
J :
must proceed by Pi-fcarboxylate exchange.
14SBP inhibits the C-malate uptake (Fig. 6 .8 ); with 12 nmol/mg
SBP, the K (malate) increased nearly three times, while the 
m 14inhibition o f C-succinate uptake (Fig. 6.9) requires greater 
concentration of SBP.
The results obtained from studies on the inhibition of the dicarboxylate/ 
dicarboxylate exchange (Figs. 6.10 and 6.12) and the Pi/dicarboxylate 
exchange (F ig . 6.11) by SBP substantiate the suggestion (of the present 
worker) that SBP may interfere with the dicarboxylate translocator.
The exchange of dicarboxylates are not affected greatly by SBP as 
much as the phosphate exchange is. This may be due to the fact that 
a system other than the dicarboxylate transporting system can catalyse 
dicarboxylate exchanges. The most likely candidates for this role are 
the 2-oxoglutarate and citrate transporting system, both of which have 
affinities fo r L-malate and other dicarboxylate anions (Chappell et a l..
1968; Chappell and Robinson, 1968).
Ultimately it can be concluded that the action of SBP, mersalyl, as 
well as other thiol reagents, on phosphate transport through the inner 
mitochondrial membrane,may be interpreted as a consequence of an 
Inhibition o f a more or less specific "phosphate translocator". Moreover, 
due to the inhibition of Pi-Pi, dicarboxylate-dicarboxylate, and Pi-dicarboxy­
late exchanges by SBP, it can also be concluded that SBP may inhibit the 
dicarboxylate carrier. It remains unknown whether SBP can or cannot 
Inhibit the tricarboxylate and 2-oxoglutarate transporting system.
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CHAPTER 7
GENERAL DISCUSSION AND CONCLUSIONS
The results presented in this thesis show that sulfobromophthalein 
(SBP), agaric acid (AA) and hexachlorophene (HCP) compounds are 
potent inhibitors o f mitochondrial transport systems (e.g. ADP, calcium, 
phosphate and dicarboxylate). The effect of SBP( AA or HCP on ADP 
translocase was further supported when it was found that these 
compounds inhibit the 2, 4-di-nitrophenol-stimulated mitochondrial 
ATPase activity but are inactive on submitochondrial particles ATPase. 
Thus, the above inhibitors are similar to the potent inhibitors of 
adenine nucleotide translocase, namely atractyloside, carboxyatractyloside 
or bongkrekic acid. The effects of SBP and AA were also carried out on 
the ADP and atractyloside binding to rat liver mitochondria and the 
observation of inhibition of ADP and atractyloside binding by SBP, AA 
or HCP, substantiate the conclusion that they are inhibitors of ADP 
translocase. It can be concluded that the mode of action of SBP and AA 
on ADP translocase is similar to that of atractyloside. The mechanism 
by which HCP inhibits ADP translocase is not clear at this time. Several 
possibilities are currently under examination , one of which involves 
Interaction of the HCP with the lipoprotein translocator. Results 
presented in Fig. 3.8 Illustrated the dependence of HCP binding on 
mitochondrial membrane phospholipids. Other works by Klingenberg 
(1975) and Thorne and Bygrave (1974) provide strong evidence for the 
direct involvement of phospholipids in adenine nucleotide translocation.
A second possibility of inhibition of ADP uptake by HCP; may be due to its 
uncoupling effect.
Due to the importance of atractyloside, HCP and Rh6G in the present
study the binding prop- erties of these compounds to mitochondria was
14Investigated. It was found that C-HCP has a high affinity binding site
-8
in mitochondria (K =2*2 x 10 M)wk:ck is present at a concentration ofa  3  _ g
0.25 nmol/mg protein, while H-Atr high affinity site (Kd = 5*4 x 10 M)
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was present at a concentration of 0.18 nmol/mg protein. However,
Rh6G has one affinity site o f relatively low affinity (K^ = 1 »3 x 10  ^M ) 
and present at a concentration of 50 nmol/mg protein. The points 
which may differentiate the mode of action of HCP from other uncouplers 
such as DNP or FCCP are:- (a ) HCP Inhibits the dinitrophenol-
3
stimulated mitochondrial ATPase; (b) HCP inhibits the H-Atr binding
to both intact mitochondria and submltochondrial particles , while
3
DNP or FCCP did not affect the H-Atr binding; (c ) the importance 
14of phospholipids in C-HCP binding to mitochondria, unlike the other
uncouplers such as 2-azido-4-nltrophenol, which binding site
appears not to involve the bulk of the mitochondrial lipids.
In the opinion of the present worker, the inhibition of mitochondrial
calcium uptake by HCP, DBCT, TET and Rh6G, may be either due to
the, (a ) uncoupling effect of these compounds, since it was known, that
the energy-linked uptake of calcium is inhibited by agents which
dissipate the membrane potential generated by respiration, like the
uncouplers of oxidative phosphorylation, (b) or maybe these compounds
affect mitochondrial phospholipids,which are necessary for calcium
binding, the preliminary and necessary step in the sequence of events
that leads to passage of cations across the mitochondrial membrane.
The last point was substantiated when it was found that HCP or Rh6G
binding to mitochondria depends on mitochondrial-phospholipid composition.
32The inhibition of ATP- Pi exchange reaction in mitochondria by SBP,
HCP or AA found in the present study, may be related to the inhibition of 
A T P  and P i transport by mitochondria. However, the inhibition caused 
by Rh6G may be either due to inhibition of oxidative phosphorylation or 
to a Rh6G uncoupling effect. Gear (1974) demonstrated that low 
concentration of Rh6G markedly reduced the rate of ATP formation, but 
at higher concentrations > 10 nM, Rh6G uncouples oxidative phosphorylation.
It is apparent from this thesis that SBP and HCP are potent inhibitors 
of Pi transport system, while AA and Rh6G are weak inhibitors. It can be
PS?
concluded that the action of SBP and the remaining inhibitors on Pi 
transport through the inner mitochondrial membrane may be 
Interpreted as a consequence of an inhibition of a more or less
i
specific phosphate translocator. Moreover, due to the inhibition 
32of Pi-Pi exchange by SBP, it can also be concluded that SBP may 
Inhibit the dicarboxylate carrier. This was further substantiated 
when it was found that SBP inhibits dicarboxylate transport and 
dicarboxylate-dicarboxylate exchange through mitochondrial 
membrane.
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